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PREFACE 
The objective of this dissertation is to determine the role of uterine unfolded protein 
response (UPR) preconditioning in the maintenance of myometrial quiescence. The 
overarching hypotheses is that preconditioning the myometrial UPR would allow for the 
maintenance of non-apoptotic caspase 3 (CASP3) activity, and thus sustain uterine 
quiescence. In chapter one, we test the specific hypothesis that preconditioning the UPR 
in vitro in the immortalized human myocyte would be effective in activating and 
maintaining CASP3 in a non-apoptotic state. Following Tunicamycin (TM) or Thapsigargin 
(Thaps) preconditioning, ERSR activation and apoptosis will be examined along with 
inflammatory responses. In the second chapter, we expand our hypothesis and test the 
role of endogenous pregnancy-generated stress stimuli in preconditioning the 
myometrium for the maintenance of uterine quiescence. Using a pregnant mouse model 
with phenyl butyric acid (PBA)-dependent sub-preconditioned mice, we will analyze the 
effects of inappropriate UPR preconditioning on gestational length, the regulation of 
uterine CASP3, inflammation and the process of luteolysis. In the final chapter we will 1) 
characterize the UPR-generated secretome in stressed uterine myocytes, 2) test the 
functional capacity of the UPR-secretome to transmit the stress response in a paracrine 
and endocrine manner and 3) evaluate changes in the UPR secretome with pregnancy 
associated pathologies. We hypothesize endoplasmic reticulum stress (ERS) in the 
uterine myocyte produces a unique secretome that has the capability of propagating the 
ERS response in a paracrine and endocrine manner and may be used in modulating 
systemic adaptations to pregnancy. The following work will review our results and discuss 
the main implications of this collection of studies. 
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CHAPTER 1 
General Introduction 
Preterm Birth 
Preterm birth (PTB), which is classically described as the delivery of a baby prior 
to 37 weeks of gestation, is the number one cause of mortality in children under 5 years 
of age.1 Each year approximately 15 million babies are born premature worldwide, and 
this number continues to rise.2,3 Due to the incomplete development of vital organs at 
birth, premature infants that are fortunate enough to survive often suffer major health 
complications. Consequently, the risk of health problems and mortality associated with 
preterm delivery is inversely correlated to gestational age and organ development at the 
time of birth.4 As a result of immature organ development, babies born preterm have an 
increased risk of neurologic and developmental disabilities, such as cerebral palsy, 
hearing and vision impairments, as well as respiratory complications.5,6 Recent studies 
have also demonstrated direct correlations between PTB and latent diseases such as 
asthma, insulin resistance and hypertension.7-9 Unfortunately, the treatment of such 
conditions, in addition to direct complications of preterm birth, poses as a major financial 
hardship for affected individuals. In the United States alone, the treatment of PTB and 
resulting acute and chronic disorders costs nearly 26.2 billion dollars annually.10   
To reduce the burden of premature delivery and improve subsequent maternal and 
neonatal treatment a large portion of clinical research has begun to examine maternal 
risk factors associated with preterm delivery. As such, a few of the major discernable risk 
factors for preterm labor include low socioeconomic status, advanced age, tobacco use, 
high stress, inflammation, infection, short cervical length and race.11-17 In 2014, the final 
U.S birth reports revealed a continuation of extreme preterm birth rates in the Black 
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population; compared to Caucasians or Hispanics, Black women had a 50% greater 
chance of delivering prematurely.14 While the exact genetic component responsible for 
the disproportionate rate of preterm birth remains elusive, one study examining genetic 
predispositions for PTB identified multiple single nucleotide polymorphisms in black 
women that augment infection and inflammatory responses, which could increase the 
individual’s risk of preterm delivery.18 Independent of race, women who have reduced 
cervical length at term, multiple fetuses, or previously undergone preterm birth are also 
at an increased risk of early delivery.19 
Currently there is no cure for preterm birth, but three preventative treatments are 
available 1) mid-trimester progesterone, 2) cervical cerclage and 3) cervical pessary. To 
date, four key randomized, double-blinded, placebo-controlled clinical trials have been 
performed examining the effectiveness of mid-trimester vaginal progesterone treatments 
in delaying the onset of labor in women at high risk for delivering preterm.20-23  In each of 
these studies all women included were found to be at risk of undergoing preterm birth due 
to 1) having a cervical length between 10-20mm, 2) previously having a spontaneous 
preterm birth, 3) having a uterine malformation or 4) having a twin pregnancy.  Overall, 
vaginal progesterone significantly reduces the risk of preterm birth at less than <32 weeks 
of gestation (RR, 0.47; 95% CI, 0.24-0.91) and decrease composite perinatal morbidity 
and mortality (RR, 0.43; 95% CI, 0.20-0.94).24 Unfortunately, mid-trimester vaginal 
progesterone treatment did not reduce the frequency of preterm birth in a multicenter 
randomized control trial in which women with a cervix of less than <30mm were included. 
Besides mid-trimester vaginal progesterone, cervical cerclage has also been examined 
as a potential treatment for reducing the risk of preterm birth.25-29  In a recent retrograde 
meta-analysis reviewing five control trials, cervical cerclage significantly decreased the 
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risk of preterm birth less than <32 weeks of gestation (RR, 0.66; 95% CI, 0.48-0.91) and 
lessened composite perinatal morbidity and mortality (RR, 0.64; 95% CI, 0.45-0.91) in 
women previously identified as being at risk of preterm birth primarily due to having a 
cervical length of <25mm.24 When comparing the effectiveness between mid-trimester 
vaginal progesterone or cervical cerclage in women with a cervical length less than 
<25mm or who have previously had a spontaneous preterm birth, no differences were 
found.24 The last treatment method currently being used/studied as a preventative option 
for preterm birth is cervical pessary. Studies examining the use of cervical pessary have 
given more convoluted results than either progesterone or cervical cerclage. One 
multicenter randomized control trial performed in Spain, cervical pessary in women 
between the ages 18-43, with a cervical length of 25mm or less found spontaneous 
delivery less than 34 weeks was significantly reduced (12 [6%] vs 51 [27%], odds ratio 
0.18, 95% CI 0.08–0.37; p<0.0001) with cervical pessary compared to the expected 
management group.30 Further, Goya and colleague found no significant differences 
between the effectiveness of 1) vaginal progesterone, 2) cervical cerclage or 3) cervical 
pessary as a management strategy for preterm birth in women with singleton 
pregnancies, a history of preterm birth and a sonographic short cervix.31 On the contrary, 
a more recent large multicenter randomized control-trial with 932 participant only 
including women with a cervix length of 25mm or less did not find cervical pessary 
reduced the risk of spontaneous preterm delivery before 34 weeks of gestation.32 
Similarly, in a randomized control trial of 1180 women, the use of cervical pessary did not 
reduce the risk of preterm birth in women undergoing a twin pregnancy when compared 
to routine treatment.33 Subsequently, more research is necessary accurately elucidate 
the effectiveness of cervical pessary. 
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With the number of preterm births occurring annually, it is clear there is still much 
work needed to increase the effectiveness of preventative treatments and additionally, 
the tocolytic drugs given to women who are actively undergoing premature contractions. 
Currently, the best tocolytic agents available are only effective in impeding the immediate 
processes of active labor by 24-48hrs.34,35 The most common of these agents used 
include Nifedipine, a calcium channel blocker, Indomethacin, a cyclooxygenase 2 inhibitor 
(COX-2).36,37 While 24-48hrs is not a long period of time it does allow for the 
administration of antenatal corticosteroids and magnesium sulfate to improve respiratory 
and neurological fetal development, thereby reducing fetal morbidities.38,39 Unfortunately, 
once a woman presents with premature contractions, there is nothing that can be done 
to stop at that point to stop the labor from occurring. Consequently, for the continuation 
of therapeutic development and successful prevention of preterm birth it is imperative that 
we first understand the complex regulatory networks responsible for the maintenance of 
uterine quiescence and subsequent transition into parturition during both term and 
preterm birth. 
The Female Reproductive System 
For a complete understanding of gestational regulation, it is necessary to start by 
reviewing the female reproductive system including the primary female sex organ (ovary), 
secondary female sex organs (oviducts, uterus and vagina) and the menstrual cycle 
(ovarian and uterine). 
Ovary 
In a developed female there are two ovaries located slightly superior and bilateral 
to the uterus within the pelvic girdle, which are held in place via the broad ligament.40 
Each ovary can be separated into two distinct regions, the medulla and the cortex. The 
5 
 
innermost region of the ovary is referred to as the medulla, and is comprised of loose 
connective tissue, spiral arteries, autonomic nerves and hilus cells. The cortex 
surrounding the medulla, which is made up primarily of dense connective tissue, functions 
to maintain primordial follicles. Primordial follicles are the most basic form of a female 
gamete. Following puberty, a small proportion of stored primordial follicles will undergo 
folliculogenesis, which will lead to the development of a mature oocyte. At the time of 
ovulation, an oocyte is released into the oviducts for further fertilization. Subsequent to 
ovulation, the corpus luteum will remain within the cortex until fertilization and/or luteolysis 
(degradation of the corpus luteum) occurs.41 
Oviducts 
Directly adjacent to the ovaries are bilateral tube-like structures known as the 
oviducts. These structures function to transport the ovum from the ovary to the uterus, as 
well as provide an appropriate environment for fertilization of the ovum by sperm. The 
luminal membrane of the oviducts consists primarily of cuboidal and columnar epithelial 
cilia and secretory cells, which are surrounded by multiple layers of smooth muscle.42,43 
Each oviduct can be divided into three sections: the infundibulum, the ampulla, and the 
isthmus. The infundibulum is the distal most part of the oviduct and is primarily comprised 
of finger-like structures projecting towards the ovary, known as fimbriae. During ovulation 
when the cumulus-oocyte complex is released from the ruptured follicle in the cortex of 
the ovary it is collected by the fimbriae of one of the oviducts.44 Upon retrieval, the ovum 
then passes through the ampulla, located proximal to the infundibulum, and is fertilized 
within the ampulla/isthmus junction.45 While smooth muscle contraction and mucosal 
secretions play a role in ovum transport, it is generally accepted that ciliary action is 
largely responsible for propelling the ovum through the oviduct.46 Approximately 80 hours 
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after being taken in by the oviducts, the fertilized embryo exits through the isthmus into 
the superior region of the uterus.47   
Uterus 
The uterus is a hollow organ made up of multiple components. Most notably, the 
uterine body can be separated into two functional domains: the fundus and corpus. For 
this review, I will not discuss tissue specific differences between the fundus and corpus 
regions but will instead describe the body of the uterus as a whole. The uterine body can 
be delineated into three specific layers of tissue: the endometrium, the myometrium, and 
the perimetrium. The endometrium lines the lumen of the uterine cavity, and functions to 
support the implantation and growth of a fetus. The endometrium, exposed to the uterine 
cavity, is a single layer of columnar epithelial cells. These cells are bordered by the 
functionalis, which is primarily composed of epithelial and stromal cells. The 
endometrium, along with the majority of the functionalis is shed from the uterus following 
the secretory phase of the menstrual cycle in a non-pregnant uterus.48 In contrast, the 
basement layer of the endometrium, termed the basalis, remains largely intact throughout 
menstruation. The basalis is rich in stromal cells, as well as secretory glands that have 
been demonstrated to extend proximally into the functionalis and deep into the circular 
layer of the neighboring myometrium.49,50 The myometrium is the smooth muscle layer of 
the uterus located between the endometrium and the perimetrium. Structurally, it is made 
up of two distinct muscle layers arranged in a circular and then longitudinal pattern, 
respective to the endometrium, to enhance the contractile potential of the tissue.51,52 
However, the myometrium remains in a quiescent state through the active suppression 
of contraction throughout the majority of gestation to allow for proper fetal development. 
It is not until the onset of labor at approximately 40 weeks gestation that the contracting 
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myometrium must expel the fetus from the uterus.53,54 The perimetrium, a serosal 
membrane collectively surrounding the myometrium, functions to support the uterus and 
acts as a protective barrier.55  
Cervix 
The cervix is a tightly regulated canal structure which connects the uterine cavity 
to the vagina.56 In the average woman, the cervical canal is between 3-4 centimeters in 
length and is comprised of: the endocervix located superior to the vagina, the external 
and internal os junctions located where the cervix meets the vagina and uterine cavity, 
respectively and the exocervix located inferior to the vagina.57 The interior portion of the 
cervix is comprised of the extracellular matrix and to a lesser extent a cellular 
component.58 The extracellular matrix is predominantly comprised of collagens type 1 
(70% and type 3 (30%), but also contains elastin fibers intertwined between the 
collagen.58 The inner cellular component is made up of smooth muscle, fibroblasts, blood 
vessels and the epithelium, which lines the cervical canal.58,59 Specifically, simple 
columnar epithelia within the endocervix and both columnar and squamous epithelia 
within the exocervix.57 Similar to the endometrium, the cervical epithelia contains glands, 
which secrete a hormone regulated-sugar rich mucosal substance, which primarily 
contains water, electrolytes and mucins.60,61 Together, the three main functions of the 
cervix/cervical mucosa are 1) act as a protective barrier against external microorganisms, 
2) maintain intrauterine integrity during fetal development and 3) undergo cervical 
remodeling late in gestation to facilitate parturition.61-63 The detailed process of cervical 
remodeling is discussed in the following parturition section. 
Vagina 
The most distal organ in the reproductive tract is the vagina, which functions as an 
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intermediate organ connecting the uterus to the external genitalia.64 Unlike the cervix, the 
epithelial lining of the vagina is a thick layer of stratified squamous cells approximately 
0.15-0.2 centimeters in length. This epithelial lining can be categorized into three 
sections: the basalis comprised of round-shaped cells with prominent nuclei, an 
intermediate zone with flatter cells, and the hormone responsive superficial layer of 
cornified cells.59 Encasing the vaginal epithelium is a smooth muscle layer, continuous 
with the uterine muscle previously discussed. 
Parturition 
Much of how the dynamic regulatory network functions throughout the course of 
gestation remains largely unknown. Subsequently, the advancements in tocolytic 
therapies over the past decade have been minimal. To improve upon the development of 
future preventative treatments for preterm delivery, it is necessary to further our 
understanding of the basic mechanisms that maintain uterine quiescence and those that 
coordinate the progression of the myometrium from a quiescence state to a fully 
functioning contractile unit with the onset of parturition. 
Initiation of Uterine Activation 
While the exact mechanisms responsible for the commencement of parturition 
remains undefined, it is well described that induction of parturition is demarcated by 
heightened uterine inflammation in both term and preterm labor.65,66 Uterine inflammation 
is observed as the infiltration of both activated innate (macrophages, neutrophils, mast 
cells) and adaptive (B-lymphocytes and T-lymphocytes) immune cells, and increased pro-
inflammatory cytokines in the amniotic fluid, myometrium, cervix, decidua and fetal 
membranes.67-69 As term approaches integrated endocrine signaling and mechanical 
stretch of uterine myocytes induce uterine chemoattractant proteins, i.e. SP-A, CXCL8-
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CXCL11, CCL2 and CCL5.70 Chemoattractant proteins then act to propagate 
macrophage and neutrophil migration, as well as alter the ratio of adaptive pro-
inflammatory CD4+ effector T-cells to immunosuppressive naïve regulatory T cells in favor 
of increased inflammation.70-75 Subsequently, both innate and adaptive inflammatory cells 
secrete major labor modulating cytokines such as IL-1β, interleukin-6 (IL-6), interleukin-8 
(IL-8) and tumor necrosis factor α (TNFα) into the surrounding uterine tissue.76-78 Within 
uterine tissues, increased pro-inflammatory cytokines leads to the activation of the 
multifactorial transcription factor nuclear factor kappa B (NFB) and the activating protein 
1 (AP-1) family of transcription factors (jun, fos or ATFs).75 Prior to stimulation, NFB is 
held inactive within the cytoplasm bound to the inhibitor protein termed inhibitor kappa B 
alpha (IκBα).79 With the binding of the pro-inflammatory cytokines IL-1β, IL-6 and TNFα 
to their appropriate receptors proteasome-mediated degradation of IκBα occurs and 
NFB is able to translocate to the nucleus.80-84 Upon nuclear translocation, NFB 
increases the expression of inflammatory and contractile associated proteins (CAPs), as 
described in the following section Contractile Associated Proteins.80,82,85-88 Consequently, 
the AP-1 family of transcription factors, which are primarily regulated at the level of 
transcription, are also induced upon cytokine stimulation.89 Together, AP-1 and NFB 
mediated increases in CAP expression transform the uterus into a uterotonic sensitive, 
synchronous contractile organ which allows for the successful expulsion of the fetus at 
term.90,91 
Contractile Associated Proteins 
Cyclooxygenase 2- Prostaglandin endoperoxide synthase 2 (cyclooxygenase 2, or 
COX-2) is an inducible contractile associated enzyme upregulated in human gestational 
tissues with the onset of spontaneous labor.92,93 The biochemical role of COX-2 in vivo is 
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to mediate prostaglandin synthesis.94 Accordingly, COX-2 assists in the conversion of 
arachidonic acid, which has been liberated from phospholipids in the membrane, into the 
unstable intermediate endoperoxide.94 Thereafter, prostaglandin specific synthases 
further transform endoperoxide into their respective prostaglandin products. Analysis of 
NFB targets in human myometrial cells revealed IL-1-mediated binding of the NFB 
subunit RelA to the promoter region of the COX-2 gene increases mRNA levels of COX-
2.82,95 Furthermore, increasing mechanical stretch and estrogen signaling within the 
myometrium at term directly increases the expression of COX-2 via AP-1 mediated 
induction of COX-2 transcription.91,96 Consequently, the upregulation of COX-2 leads to 
the increase in prostaglandin synthesis, specifically prostaglandins E2 (PGE2) and F2α 
(PGF2α), which act as uterotonic agents within the pregnant uterus. 
Prostaglandins- PGE2 and PGF2α have classically been recognized as major 
contributors to the onset of parturition, and as previously mentioned, are both highly 
upregulated during the process of labor.97-99 Through activation of G-coupled protein 
receptors EP1-4 and FP respectively, PGE2 and PGF2α primarily function to 1) stimulate 
smooth muscle contraction of the myometrium, 2) prime the cervix for delivery of the fetus 
and 3) initiate rupture of the fetal membranes.  Prostaglandins are potent CAPs, as the 
application of exogenous PGF22α alone is enough to stimulate myometrial contractions.100 
The mechanism in which PGF2α is capable of stimulating myometrial contractility is by 
directly and indirectly altering intracellular calcium concentrations.101 With the binding of 
PGF2α to its Gαq-coupled protein receptor, phospholipase C (PLC) is activated. 
Subsequently, PLC second messenger signaling transduction through inositol 1,4,5-
triphosphate (IP3) and diacylglycerol (DAG) stimulate ligand-regulated calcium channels 
within the cell membrane and calcium channels within the sarcoplasmic reticulum to 
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increase mobilization of intracellular calcium.102 Increased intracellular calcium 
concentrations decrease the electrochemical gradient across the plasma membrane 
which in turn activates membrane bound voltage-gated calcium channel causing further 
mobilization of calcium into the cell.103 Consequently, increased calcium concentrations 
trigger the cycling of actin and myosin to generate smooth muscle contractions; further 
outlined in the upcoming section Smooth Muscle Contraction. PGE2 binding to the EP1 
receptor also triggers intracellular calcium mobilization. However, this is through a loosely 
defined PLC-independent process which involves activation of G inhibitory protein.104 
Secondary to the regulation of myometrial contractility, prostaglandins also partake in 
cervical remodeling. As the major role of the cervix prior to parturition is to act as a 
mechanically competent protective barrier for the uterine cavity, extensive remodeling of 
the cervical tissue must occur before the delivery of the fetus through the cervical-vaginal 
canal. The process of cervical ripening, in which the cervix becomes soft, thin and easily 
stretched, is typically characterized by the reorganization and altered biochemical 
properties of cervical collagen.105 One mechanism in which prostaglandins in the 
endocervical canal contribute to cervical ripening is by stimulating the upregulation of 
matrix metalloproteases (MMPs) secretion and collagenase activity.106 Increased MMP-1 
and collagenase activity leads to decreased collagen concentrations which increases the 
compliance of the cervical canal.107 Similarly, prostaglandin stimulation has also been 
shown to increase the synthesis of hydrophilic glycosaminoglycans, which act to increase 
collagen solubility and thereby increase cervical pliability.108 However, as cervical 
mucosal concentrations of prostaglandins do not increase during late gestation and 
inhibitors of prostaglandin synthesis inhibit cervical ripening, further studies are necessary 
to elucidate the dynamic prostaglandin-mediated regulation of cervical ripening.109,110 In 
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addition to cervical ripening, prostaglandins also participate in the remodeling (i.e. 
rupture) of fetal membranes during parturition.  In both term and preterm labor, the rupture 
of fetal membranes in utero is an integral step in the expulsion of the fetus from the uterine 
cavity.111,112 As in the cervix, PGE2 and PGF2α in fetal membranes have been shown to 
stimulate the production of MMPs, specifically MMP-2 and MMP-9.113,114 As a result, 
increases in MMPs synthesis, concomitant to a labor associated decline in the expression 
of tissue inhibitors of MMPs, leads to the decreased structural integrity of fetal 
membranes and membrane rupture via extracellular matrix degradation.115   
Prostaglandin Receptor Regulation- In addition to increased concentrations of 
COX-2 and prostaglandin E2 and F2α, recent studies have also demonstrated augmented 
prostaglandin receptor expression in the uterus at the time of parturition.80 When 
comparing expression of both EP and FP receptors in non-pregnant versus pregnant 
myometrium, there is a significant reduction in pregnant uterine tissues to suppress 
contractility while the fetus develops.116 Subsequently, in the laboring versus non-laboring 
pregnant myometrium prostaglandin FP receptors are highly upregulated.116,117 Further 
studies have since shown, increased FP receptor expression late in gestation is induced 
by IL-1β/NFB-mediated transcriptional regulation.80,118 Unlike the FP receptor, which 
only participates in myometrial contractility, it has been demonstrated that various EP 
receptors isoforms can propagate both myometrial relaxation (EP2 and EP4), as well as 
myometrial contractility (EP1 and EP3). Multiple studies examining gestational regulation 
of the EP receptor isoforms have found that the relaxation associated EP2 receptor is high 
in the myometrium throughout early and mid-gestation, but significantly declines as term 
approaches, which is in agreement with receptor function.119,120 Taken together, 
differential regulation of COX-2, prostaglandins and prostaglandin receptors during late 
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gestation contributes to the multifactorial process of parturition indirectly by priming the 
uterus for optimal prostaglandin activity and directly through the initiation and propagation 
of myometrial contractility, cervical ripening and fetal membrane rupture. 
Oxytocin- Unlike prostaglandins E2 and F2α, the uterotonic nonapeptide hormone 
oxytocin is highly upregulated in the myometrium only after parturition has been 
initiated.121 Subsequently, oxytocin is not responsible for stimulation of uterine 
contractions, but instead increases contractile force after the commencement of labor.  
Typically, oxytocin is synthesized in the magnocellular neurons in the supraoptic and 
periventricular nuclei of the hypothalamus in the form of a pro-peptide.122 The pro-peptide 
is processed into the mature nonapeptide via neurophysin, while being transported via 
secretory vesicles down the neuronal axons, which terminate in the posterior lobe of the 
pituitary.  Upon depolarization, oxytocin is released into circulation through exocytosis.123 
However, during pregnancy oxytocin is also locally produced in the myometrium, 
endometrial epithelium, corpus luteum and placenta.124-126 At the time of parturition in 
particular, oxytocin mRNA is approximately 70-fold greater in the uterus than in the 
hypothalamus. 
Oxytocin Receptor- Within target tissues, such as the myometrium, oxytocin exerts 
its physiological effect via ligand binding to the G-coupled rhodopsin-type class 1 oxytocin 
receptor (OTR).127 Activation of the OTR at the end of gestation is thought to increase 
myometrial contractility through multiple mechanisms, one being the alteration of 
myometrial calcium dynamics. Like prostaglandins, oxytocin acts to increase intracellular 
Ca2+ concentrations through a multifactorial process, which involves the mobilization of 
Ca2+ entry, as well as inhibition of Ca2+ efflux from the cytosol. Currently, there is evidence 
to support two modalities of OTR-mediated Ca2+ entry: 1) through the activation of PKC 
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and downstream signaling events which stimulate store-operated calcium entry (SOCE) 
channels within the plasma membrane and 2) via the release intracellular calcium stores 
from the sarcoplasmic reticulum to directly increase the intracellular concentrations of 
calcium.128-130 Secondary to both SR Ca2+ release and SOCE channel dependent 
increases in the membrane potential, voltage operated L-type calcium channels open to 
further increase the influx of extracellular Ca2+.131 In addition, oxytocin/OTR activity 
inhibits the SR Ca2+ ATPase (SERCA) responsible for sequestering cytoplasmic Ca2+ and 
relocating it back into the lumen of the SR; this process again, indirectly raises 
cytoplasmic Ca2+ to concentrations which are necessary for calmodulin activation and 
subsequent myosin/actin cross-bridge cycling.132 More recently, there has been evidence 
to suggest oxytocin receptor activity may also indirectly increases contractility through the 
inhibition of myosin light chain phosphatase, which is an enzyme that de-phosphorylates 
myosin light chain kinase (MLCK). As phosphorylation is necessary for MLCK to take part 
in Ca2+/calmodulin mediated myosin/actin cross-bridge cyclin, an increase in its 
phosphorylation state leads to heightened uterine contractility.133,134 Conclusively, 
oxytocin has also been demonstrated to upregulate the expression of the CAPs PGF2α, 
in which we have previously discussed, and connexin 43.135-137 
Oxytocin Receptor Regulation- An additional level of oxytocin signaling regulation 
occurs through the augmentation of oxytocin receptor expression. Unlike increases in 
uterine oxytocin expression, which occurs subsequent to the initiation of parturition, it is 
well established that the concentration of uterine OTR mRNA is significantly increased 
prior to the onset of labor.138-140 Similar to FP receptor expression, IL-1β mediated NFB 
activity plays a synergistic role with CCAAT/enhancer-binding protein-β to increase OTR 
promoter activity and concomitantly OTR mRNA late in gestation.86,141 Additional studies 
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have demonstrated that estrogen also significantly stimulates OTR gene 
expression.142,143 Furthermore, independent of inflammatory or estrogenic effects, 
increasing mechanical stretch, as experienced by the myometrium near term, was shown 
to increase OTR mRNA in uterine myocytes.144 Not surprisingly, following the 
multifactorial increase in OTR mRNA, OTR protein expression is significantly increased 
within the myometrium at term compared to early gestation and post parturition.145 The 
physiological consequence of augmented OTR expression at term is heightened 
myometrial sensitivity to oxytocin at the time of parturition and thus increased myometrial 
contractility.146 
Connexin 43- The ultimate responsibility of the myometrium at the time of 
parturition is to produce contractions forceful enough to expel a fetus from the uterine 
cavity, through the cervical canal and out of the vagina. As the contraction of a single 
uterine myocyte does not produce the amount of force required for successful parturition 
of the fetus, the myometrium must contract as a synchronous unit. To do this, regional 
intercellular communication must be established which allows for the propagation of 
periodic contractile signaling. Similar to the majority of other cell types in the body, 
myocytes achieve cellular connectivity through the formation of permeable gap junction 
channels within the plasma membrane.147,148 Generally, gap junction channels are formed 
between adjacent cells through the attachment of porous hexameric structures termed 
connexins, located within the plasma membrane. The formation of permeable channels 
between series of cells allows for chemical and electrical signals to pass freely through 
intracellular compartments, thereby speeding up the processes of intracellular 
communication.149 In the uterus, the establishment of electrical conductance between 
myocytes is particularly important for the propagation of calcium signaling at the time of 
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parturition.150,151 With intercellular coupling, calcium signals that originate in the fundal 
region are transduced throughout the body of the myometrium creating a powerful 
synchronous contraction that is capable of generating sufficient force to expel the 
fetus.152,153 While there are numerous types of connexins present throughout the human 
body, connexin 43 (Cx43) is the primary gap junction protein expressed within the 
myometrium. During a normal pregnancy multiple factors e.g. the biological withdrawal of 
progesterone activity further discussed later in this chapter, myometrial stretch, estrogen, 
prostaglandins and AP-1/c-jun, stimulate the induction of Cx43 expression in the 
myometrium as late as 24hrs prior to start of labor.154-158 It is known that increased Cx43 
late in gestation is necessary for successful parturition, because multiple studies in mice 
have demonstrated that the functional loss of Cx43 prior to labor causes impaired uterine 
contractility and delays the onset of birth.159,160  
Smooth Muscle Contraction 
Thus far, each of the CAPs discussed contributes to myometrial contractility by 
altering intracellular calcium ([Ca2+]i) signaling and/or sensitivity in uterine myocytes. 
Appropriate regulation of [Ca2+]i across gestation is extremely important, as the level of 
[Ca2+]i is the primary determinant of myometrial contractile potential.161 In the 
myometrium, [Ca2+]i is derived from two separate compartments, the plasmalemma and 
the sarcoplasmic reticulum. The primary method of extracellular Ca2+ mobilization is 
through voltage-gated Ca2+ channels e.g. transient receptor potential channel (TrpC) 1 
and TrpC6.162 However, as previously mention, receptor-operated and store-operated 
Ca2+ channels also facilitate the internalization Ca2+.102 Within the cell, Ca2+ release from 
the sarcoplasmic reticulum is mediated through the ryanodine receptor.163 While type 1, 
2 and 3 of the ryanodine receptor exist within the myometrium, type 2 is the only receptor 
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differentially upregulated during pregnancy.164 Once in the intracellular space, four Ca2+ 
molecules will cooperatively bind calmodulin, which in turn activates MLCK through n-
terminal binding and conformational changes in the enzyme.165,166 Active MLCK then 
initiates contraction through the modulation of smooth muscle cell (SMC) contractile 
architecture. The canonical SMC contractile architecture consists of two primary 
components, the thick filament (myosin) and the thin filament (actin). The myosin filament 
can further be broken into three units, two heavy chains and a pair of regulatory and 
essential light chains (MLC20 and MLC17, respectively).167 The heavy chains, are 
comprised of a globular head domain attached to the end of long rod-like base.168 The 
thin filament is comprised mainly of actin polymers that form an alpha helical coil. Upon 
activation, MLCK phosphorylates Ser-19 on the MLC20. In the phosphorylated state, 
MCL20 significantly increases actin-dependent myosin ATPase activity which produces 
the energy necessary for cross-bridge formation.169 In a study utilizing Wortmannin and 
ML-9, inhibitors of MLCK, diminished MLCK activity in both human and rat myometrium 
completely abolished uterine force, illustrating its importance during labor.170 During 
cross-bridge cycling, myosin ATPase activity perpetuates continual binding and release 
of the myosin head to the actin filament in a specific motion that collectively shortens the 
longitudinal axis of a SMC to generate contractile force.168 It is then, only through 
coordinated regional contractions of uterine SMCs, that sufficient force is produced and 
parturition commences. 
Transition of the Uterus from Quiescence to Contractility 
Progesterone 
Thus far, we have discussed the role in which inflammation and CAPs participate 
in promoting myometrial contractility and the cellular mechanisms required to produce a 
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contraction. However, as premature labor is deleterious to fetal development the 
myometrium must be maintained in a quiescent state for 40 weeks until the fetus has 
reached full term. Current evidence suggests that the steroid hormone progesterone (P4), 
acting through the P4 receptor (PR), may be the master regulator of uterine quiescence.171 
For most mammals, such as mice, rats, horses, cows and rabbits, circulating P4 is 
maintained by the corpus luteum throughout the length of gestation.172 Whereas, in 
humans and non-human primates, luteal P4 synthesis by the ovary declines between 6-8 
weeks due to reduced human chorionic growth factor (hCGF) stimulation, and placental 
trophoblast instead become the major source of P4 production for the remainder of 
gestation.173 Compared to pre-ovulatory concentrations of less than 1ng/ml, circulating P4 
concentrations are significantly higher, ranging from 11-90ng/ml during the first and 
second triamesters.174-178 P4 activity is mediated through ligand binding to the PR. The 
PR exists as two isoforms transcribed from the same gene, termed PRA and PRB.179 In 
vivo, PRB is the predominant transcription factor, which acts to regulate the expression of 
progesterone-responsive genes.180 In contrast, PRA is a ligand-dependent dominant 
negative transcription factor that functions to inhibit the genomic action of PRB.181 
Differential expression of PRA/PRB in the myometrium throughout gestation is thought to 
play a role in the maintenance of quiescence, as well as the transition to uterine 
contractility.182 Two major pieces of evidence support the role of P4/PR as the main 
regulator of myometrial quiescence 1) the inhibition of P4/PR activity in mammals at any 
point throughout gestation, via progesterone receptor antagonist e.g. RU486 or 
misoprostol, results in spontaneous abortion of the fetus and 2) the treatment of 
exogenous P4 to mice late in gestation blocks the onset of labor indefinitely.70,183 
Encouragingly, as previously mentioned, the administration of vaginal P4 to women with 
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high risk of preterm delivery reduces the rate of spontaneous preterm birth by 45%.23 
Examination of the mechanisms in which P4, through the PR, inhibits uterine contractility, 
a select set of anti-contractile processes have continued to present as important 
downstream consequences of P4 activity. These processes primarily include, but may not 
be limited to, the inhibition of inflammation, estrogen signaling and expression of CAPs. 
Inhibition of Inflammation, Estrogen Signaling and CAPs by Progesterone 
Inflammation- As previously described, the induction of labor is demarcated by an 
upregulation of uterine inflammation largely characterized by infiltration of leukocytes and 
a subsequent induction of cytokines and chemokines within the myometrium.69 Prior to 
labor however, the myometrium is subjected to relatively low levels of inflammation due 
to the inhibitory actions of P4 and the PR.  The effect of hormones, including P4, on uterine 
inflammation was first characterized by examining leukocyte infiltration during a normal 
menstrual cycle.184,185 These studies found that macrophage and neutrophil invasion is 
highest during the estrous cycle when concentrations of estrogen are elevated and the 
concentration of P4 remain low. In contrast, when levels of P4 increase throughout 
diestrus, and estrogen availability declines, the uterine macrophage and neutrophil 
population is substantially reduced. Further examination of the antagonistic properties of 
P4/PR using normal and PR knockout mice validated P4-dependent inhibition of estrogen 
mediated macrophage and neutrophil infiltration.186,187 In both studies, PRKO mice did 
not respond to exogenous P4 treatment, reiterating the importance of PR activity in the 
prevention leukocyte invasion. One mechanism by which P4/PR action can reduce 
leukocyte infiltration is through direct inhibition of the expression of certain 
chemoattractants.  During a normal pregnancy the concentration of uterine 
chemoattractants, such as monocyte chemoattractant protein-1 (MCP-1), do not increase 
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until late in gestation prior to the onset of labor. In a rat, MCP-1 expression is not seen to 
increase until gestation day 21-22.70 The delivery of RU486 to pregnant rats on gestation 
day 19 however, causes significant premature increases in both mRNA and protein levels 
of MCP-1, as well as substantial macrophage infiltration demonstrating that P4 action 
prevents myometrial inflammation.70 Whereas, rats given exogenous P4 during late 
gestation (E21-24) maintain low concentrations of MCP-1, comparable to levels seen 
during early gestation where there is minimal leukocyte infiltration.70 Secondary to P4/PR-
mediated inhibition leukocyte invasion in the myometrium, concentrations of canonical 
inflammatory cytokines (IL-β, TNFα and IL-6) are significantly reduced during early 
gestation compared to late in gestation.188,189 Consequently, downstream inflammatory 
signaling events, e.g. NFB and AP-1 activation, are depressed throughout early and 
mid-gestation in a P4/PR-dependent manner.190,191  
Estrogen- Similar to P4, estrogens (estrone [E1], estradiol [E2], estriol [E3]) are a 
major reproductive hormone derived from cholesterol.192 During human pregnancy, a 
large concentration of circulating estrogen is synthesized in the placenta where maternal 
cholesterol is aromatized via fetal aromatases.193 In all mammalian species, the level of 
circulating estrogens steadily increases across gestation, peaking prior to onset in 
parturition.176,194,195 In humans, estrogen concentrations peak at approximately 38 weeks’ 
gestation.196,197 Of the three ER agonists, E2 is the most abundant in circulation during 
pregnancy.196 The genomic effects of estrogen are mediated through ligand binding to 
the nuclear receptors ERα and ERβ.192 However, characterization studies of ER isoform 
expression within myometrium have demonstrated that ERα is the dominant receptor.182 
While the expression of myometrial ERβ remains relatively low and unchanged across 
gestation, there is a sharp increase in ERα expression late in gestation.182 Consequently, 
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increased levels of ERα leads to increased estrogen responsiveness within uterine 
tissues.  Functionally increased estrogen responsiveness near term is important because, 
as previously mentioned; estrogen activity contributes to uterine activation through the 
up-regulation of AP-1 transcriptional activity, as well as COX-2, OTR and Cx43 
expression.96,158,198-200 P4 inhibits estrogen activity in the uterus, with the purpose of 
preventing E2-mediated premature myometrial contractility.201 Initial studies identified 
differential ER expression as a mechanism for decreased estrogen responsiveness; the 
dynamic regulation of P4 and estrogen signaling within the uterus was not clearly defined 
until recently.  Mesiano and colleagues demonstrated for the first time in 2002, that the 
ratio of PRB/PRA expression was important for the regulation of ERα expression in-
utero.182 Consequently, increased expression of PRB/PRA is inversely correlated to the 
expression of ERα.  It is thus extrapolated that similarly to inflammation induced proteins, 
P4 through PRB inhibits ERα expression and subsequently minimizes myometrial 
estrogen responsiveness and prevents estrogen mediated uterine activation. 
Nuclear Factor Kappa B- In addition to the downregulation of upstream 
inflammatory and estrogen signaling, P4 acting through the PR is able to directly disrupt 
myometrial NFB activity.191 While multiple mechanisms contribute to P4/PR mediated 
NFB inhibition the most conventional method is binding of the PR to the RelA subunit 
(p65).202 In doing so, PR physically inhibits the DNA binding domain, located on p65, from 
attaching to the promoter region of target genes and altering transcription. Interestingly, 
in vitro evidence suggests PR binds p65 in a ligand-independent, as well as ligand-
dependent manner. Both mechanisms however, require an intact DNA binding domain 
on the PR for successful antagonism.202 Secondary to direct inhibition, P4/PR also 
regulates inflammatory signaling by reducing NFB nuclear translocation.190 In order for 
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nuclear translocation to occur the inhibitor protein, IBα, must be phosphorylated and 
degraded by the proteasome to expose the nuclear localization sequence (NLS) on the 
p65 subunit.203 To prevent exposure of the NLS, PR-mediated transcriptional regulation 
of the IBα gene leads to increased intracellular concentrations of both IBα mRNA and 
protein.190 P4/PR activity has also been shown to inhibit IL-β dependent decreases in IBα 
protein concentrations, suggesting PR action may prevent IBα degradation.190 
Subsequently, increased transcription and decreased degradation leads to an 
upregulation of active IBα and the reduction of NFB nuclear translocation.  A third, less 
defined, method of NFB inhibition has been proposed in which downstream events of 
P4/PR-mediated activation of MAPK-phosphatase-1 (MKP-1) lead to inhibition of NFB 
nuclear translocation.171 Using T47D human breast cancer cells, Chen and colleagues 
demonstrated PR binding to P4 response elements downstream of the MKP-1 
transcription start site induces MKP-1 expression.204 An additional study, examining the 
effects of MKP-1 on NFB nuclear translocation in prostate tissue, discovered MKP-1 
expression inversely correlates with nuclear translocation of NFB.205 These findings 
suggest MKP-1-mediated inhibition of NFB is due to decreased p38 MAPK expression, 
which is known to activate NFB.206 Together, these P4/PR regulated mechanisms work 
to depress nuclear NFB activity and therefore reduce overall inflammatory signaling. 
Activating Protein 1- Like NFB, the AP-1 family of transcription factors must be 
gestationally regulated to prevent premature induction of labor. However, the regulatory 
actions of P4/PR on AP-1 transcription factors (fos, jun and ATFs) within the uterus 
remains largely undefined compared to the regulation of NFB. Never the less, it has 
been demonstrated within the myometrium specifically, the pretreatment of P4 attenuates 
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stretch induced activation of c-fos and fosB.207 Beyond inhibiting AP-1 protein expression, 
PR activity also decreases AP-1 DNA binding and therefore transcriptional activity. In the 
endothelial cancer cell line Hec50, chromatin immunoprecipitation findings demonstrate 
reduced AP-1 binding at the promoter of its target gene cyclin D1 in the presence of P4.208 
Based on these studies, it is reasonable to propose P4/PR activity further attenuates 
uterine inflammation by augmenting AP-1 signaling. 
Contractile Associated Proteins- AP-1 and NFB signaling increase expression of 
CAPs e.g. COX-2, prostaglandins, OTR and Cxn43, which function to prime the 
myometrium for labor and initiate uterine contractions. However, the expression of CAPs 
is also tightly controlled via P4/PR action during early and throughout mid-gestation to 
prevent the uterus from establishing premature contractility. The main mechanism in 
which P4 represses the expression of CAPs, such as COX-2, OTR and Cxn43, is by 
inhibiting AP-1 and NFB transcriptional activity.190,209,210 Subsequently, the direct 
inhibition of inflammatory signaling pathways indirectly prevents uterine activation and 
therefore facilitates the maintenance of quiescence. Interestingly, certain P4 responsive 
microRNAs (miRNAs) and downstream targets have also recently been shown to regulate 
the expression of certain CAPs.171 More specifically, Renthal and colleagues 
demonstrated the zinc finger E-box binding homeobox transcriptional repressor proteins 
(ZEB)-1 and ZEB-2 directly inhibit transcription of the contractile associated genes 
encoded for OTR and Cx43.211 Moreover, ZEB-1 and ZEB-2 were later found to 
upregulate the microRNA cluster miR-199a and miR-214, during early and mid-gestation 
in a P4 dependent manner.212 Functionally, active miR-199a and miR-214 target and 
inhibit transcription of the COX-2 gene. In the absence of uterine COX-2, OTR and Cx43, 
prostaglandin synthesis is limited, calcium signaling is disrupted and the contractile 
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potential of the myometrium is insufficient to induce labor.213 
Luteolysis and Progesterone Decline in Lower Mammalian Species 
Just as it is important that the uterus remains quiescent during pregnancy, it is also 
imperative the uterus undergoes appropriate transformation prior to onset of labor to allow 
for successful deliveries of the term neonate. In most lower mammal species, such as 
rabbits, rats and mice, prostaglandin-mediated regression of the corpus luteum near term 
induces a sharp decline in circulating P4.214 As term approaches heightened estrogen 
action in the uterus, increases the concentration of oxytocin receptors within the 
endometrium.210 Together, endometrial estrogen and oxytocin activity stimulate the 
production of prostaglandins (e.g. PGE2 and PGF2) by regulating the enzymes 
necessary for prostaglandin synthesis, particularly phospholipase A2 (PLA2) and 
prostaglandin synthase.215-217 PLA2 exists in three forms: calcium sensitive cytosolic 
(cPLA2), secretory (sPLA2) and calcium independent PLA2, which all function to 
enzymatically convert membrane bound arachidonic acid into free arachidonic acid.218 In 
the context of prostaglandin synthesis, free arachidonic acid is important as it is the initial 
substrate for prostaglandin endoperoxide synthase-dependent synthesis of PGG2, which 
is then converted into PGH2 in a COX1/2-dependent reaction.219 Subsequently, as COX 
expression is regulated by NFB activation as previously mentioned, the classical 
increase in inflammation in the uterus as term approaches further augments 
prostaglandin synthesis.82 PGH2 is then converted by tissue specific prostaglandin 
synthase into multiple prostaglandins, including PGF2 and PGE2.219 Following 
synthesis within the endometrium, PGF2 leaves through the uterine vein and enters the 
ovarian artery to act through its receptor at the level of the corpus luteum.220 Within the 
corpus luteum, PGF2 acts to reduce the enzymes necessary for the P4, cytochrome 
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P450 side-chain cleavage enzyme and 3-beta-hydroxysteroid-dehydrogenase 
(HSD3B2).221 As circulating P4 acts in an autocrine manner to preserve the corpus 
luteum, PGF2-dependent decreases in P4 cause the subsequent regression of the 
corpus luteum and further decreases in circulating P4 necessary for the induction of labor 
in lower mammalians.222 
Functional Progesterone Withdrawal 
In higher mammal species e.g. chicken, sheep and baboons, a developmental-
dependent increase in fetal corticotrophin-releasing hormone results in elevated levels of 
adrenocorticotropic hormone and thus increased circulating cortisol.223,224 Heightened 
cortisol, augments steroidogenesis in the placenta promoting the synthesis of estrogen 
from C21 steroids e.g. P4.225 For many years it was accepted that the withdrawal of 
circulating P4 increased inflammatory signaling pathways, E2/ERα activity and expression 
of CAPs to allow for the cessation of labor.182,195,226 However, it has since been 
established that although the levels of P4 in the circulation are significantly reduced, they 
still remain above the Kd for binding to the PR, meaning the levels of P4 are sufficient to 
bind PR and induce P4/PR downstream signaling.227 Furthermore, in humans and primate 
species, circulating levels of P4 continue to rise until parturition has commenced and the 
placenta is expelled.177 Subsequently, despite having circulating concentrations of 
approximately ≤300ng/ml P4 during the third trimester, the majority of women mount an 
appropriate contractile response within the myometrium and undergo active labor around 
40 weeks’ gestation.178 Taken together, these observations suggested the existence of a 
secondary mechanism for diminished P4 activity at term.  Thus, in 1965 Csapo theorized 
a mechanism of functional withdrawal of P4 within the uterine tissues, which then would 
allow for the progression of labor.228 In decades since, multiple regulatory mechanisms 
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have been shown to contribute to the functional withdrawal of P4 as seen in the uterus 
prior to the onset of labor independent of circulating levels of P4. 
Progesterone Availability- While in circulation, P4 can be found in two major forms 
1) unbound or free and 2) bound to the corticosteroid-binding globulin transcortin.229 
Characterization of plasma samples taken from pregnant women across gestation 
revealed the binding capacity of transcortin for P4 increases linearly between 10 and 20 
weeks’ gestation.230 Furthermore, increased transcortin binding capacity was found to be 
estrogen dependent. These results suggest estrogen-mediated increases in the 
sequestration of active P4 by transcortin over time may contribute to a reduction in the 
bioavailability of P4. Additional studies have also established a secondary mechanism in 
which is P4 availability is diminished through the regional upregulation of P4 metabolism.  
Initially, increases in the P4 metabolite 20α-dihydroxyprogesterone were observed in 
human myometrial tissue late in gestation.231 These results can be explained by additional 
studies examining local P4 metabolism, which established an upregulation of myometrial 
P4 metabolizing enzyme 20α-hydroxysteroid-dehydrogenase (20 α-HSD).232-234 
Importantly, mice deficient in 20 α-HSD experience delayed parturition, delivering the 
fetuses several days late. Recently, novel clusters of miRNAs have been identified that 
further regulate P4 metabolism. In particular the miR-200 family of miRNAs, under the 
control of E2/ERα mediated signaling processes, act to oppose P4/PRB function.211,233 
Microarray analysis of miRNA and gene expression of uterine tissues revealed 
concentrations of miR-200 family members to be abundant at term.233 Analysis in mice 
models of term and preterm labor validated these findings and further demonstrated an 
increase in the expression of miR-200s late in gestation, concomitant to a downregulation 
in the P4 responsive anti-contractile transcriptional repressors ZEB1, ZEB2, miR199a and 
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miR214. Importantly, the upregulation of miR-200s facilitated the inhibition of signal 
transducer and activator of transcription (STAT5b), which had previously been shown to 
repress the expression of 20α-HSD in reproductive tissues.235 Taken together, the 
increased metabolism of myometrial P4 and decreased availability of circulating P4 limits 
the bioactivity of P4 and thus its anti-contractile properties. 
Regulation of Progesterone Receptors- In addition to the direct inhibition of P4 
activity through decreased regional P4 concentrations, indirect inhibition occurs via 
modulation of downstream P4 signaling pathways.  One mechanism in which myometrial 
P4 signaling is regulated is by differential PR isoform expression.236 As previously 
mentioned, the P4 receptor exists as two functionally distinct isoforms PRA, the dominant 
negative receptor, and PRB, the transcriptionally active form.179 In term laboring tissues, 
the ratio of PRA/ PRB mRNA and protein levels are 2-fold greater than in non-laboring 
term tissues.182,236 Furthermore, across gestation the ratio of PRA/PRB mRNA positively 
correlates with the expression of ERα suggesting that differential PR isoform expression 
both diminishes P4 responsiveness and heightens estrogen responsiveness, leading to 
increased myometrial contractility at term. Another mechanism in which P4/PR signaling 
modulated at term is through differential expression of PR co-activators. Specifically, 
mRNA and protein expression of cAMP-response element-binding protein and steroid 
receptor co-activators 2 in the uterus are reduced during labor.237 As nuclear receptor co-
activators typically increase PR transcriptional activity through the stabilization of the pre-
initiation complex, a decrease in PR co-activators inherently reduces the transcription of 
P4-responsive genes.238 Thus, the differential expression of P4 co-activators at term 
further hampers the transcriptional activity of P4/PRB indirectly increasing myometrial 
contractility. 
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Endoplasmic Reticulum 
The endoplasmic reticulum (ER) is an intracellular reticular membrane structure 
that is contiguous with the nuclear envelope. The ER can be defined by two functionally 
distinct sub-domains, the rough ER and the smooth ER.56 Structurally, there is no 
definitive separation between the two compartments.239 However, the rough ER is 
demarcated by an increased number of ribosomes embedded within the cytosolic portion 
of the membrane, which is lacking in the smooth ER. Functionally, the smooth ER is 
primarily responsible for lipid synthesis and drug metabolism, while the rough ER is 
associated with managing intracellular calcium stores, regulating the synthesis and 
folding of secretory and membrane bound proteins, and coordinating protein trafficking to 
the adjacent Golgi apparatus.240-244 
Endoplasmic Reticular Milieu 
To maximize the process of protein folding, the ER compartment maintains a 
distinct luminal milieu.245 For example, the ER lumen maintains a greater oxidative state 
than the cytosol.246 While the major intracellular redox buffer for both compartments is 
glutathione, the ratio of reduced to oxidized glutathione is between 1:1 and 3:1 in the ER 
lumen, whereas the ratio is greater than 50:1 in the cytosol.247 This unique oxidative 
environment is optimal for protein disulfide isomerase (PDI) mediated disulfide bond 
formation in the ER, which is necessary for proper protein folding.247 In addition to altered 
redox state, Ca2+ concentrations are augmented in the ER lumen.  As the major site of 
intracellular storage, ER Ca2+ concentrations are 50 times that of the cytosol, i.e. 5mM 
versus 0.1mM respectively.248 Increased Ca2+ availability in the ER is advantageous as 
Ca2+ participates in electrostatic interactions with newly synthesized proteins in a manner 
that further propagates appropriate hydrophobic interactions essential for protein 
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maturation.249 Additionally, Ca2+ binding is required for chaperone protein function.250,251 
Chaperone proteins by definition aid in proper protein folding during the process of protein 
maturation.252 Compared to all other compartments, the ER lumen is equipped with a 
heightened quantity of chaperone folding proteins that refine protein-folding processes. 
These chaperones include glucose regulated protein 78 (GRP78), calreticulin, calnexin 
and PDI.253-256 Another important factor involved in chaperone protein function is 
adenosine triphosphate (ATP).257 To maintain energy demands the ER actively 
translocates ATP through multiple antiporters located in the ER membrane.258 In addition 
to participation in chaperone function, ATP further assists in disulfide bond formation and 
protein glycosylation.257,259 Taken together, the distinct chemical and protein composition 
of the ER lumen enhances the processes of protein folding to allow for more dynamic and 
complex protein structures to be synthesized. 
Co-Translational Translocation, Folding and Protein Trafficking  
It is important that secretory and membrane bound proteins are synthesized within 
the tightly controlled environment of the ER lumen, rather than the cytoplasm. In general, 
these proteins consist of both hydrophobic/transmembrane and hydrophilic/cytoplasmic 
domains, which require precisely, coordinated post-translational modification, e.g. 
disulfide bond formation, hydrophobic interactions and glycosylation, for successful 
maturation.260,261 In addition, the ER secretory pathway, which is responsible for 
trafficking proteins to the cytoplasmic membrane, is necessary to ensure secretory and 
membrane bound proteins reach their appropriate destination following completion of 
translation.262 However, as messenger RNA is secreted into the cytosol following 
transcription, it must first be targeted to the ER membrane via a signal recognition 
sequence located within the nascent peptide.263 When the signal recognition sequence is 
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initially translated by the ribosomal complex, it is immediately identified by free cytosolic 
signal recognition particles (SRPs).264 Binding of the SRP to the nascent peptide-
ribosomal complex within the cytoplasm has two effects 1) it temporarily inhibits protein 
translation and 2) it shuttles and attaches the nascent peptide-ribosomal complex to a 
protein-conducting channel within the ER membrane.265 These protein-conducting 
channels, termed translocons, are aqueous pores that span the entire length of the ER 
membrane.266 After binding to the translocon, elongation of the nascent peptide is re-
initiated and co-translational translocation of the protein into the ER lumen occurs.267,268 
With the help of chaperone proteins the N-terminus of the nascent peptide begins to 
undergo post-translational modifications, such as protein folding, glycosylation, disulfide 
bond formation, etc., immediately after entering into the ER lumen.267,269 Upon completing 
translation, proteins 1) further undergo oligomer formation, if necessary 2) are recognized 
by cargo receptors and 3) are sorted via surveillance protein complexes composed of a 
small ras-related GTPase (Sar1p) and two Sec proteins (Sec23p-Sec24p) or membrane 
adaptor protein complexes located within in the ER transition zone.270,271 Clathrin or coat 
protein complex II vesicles packaging cargo proteins are then trafficked out of the ER 
lumen to the cis-Golgi network.272 In the event of inappropriate maturation however, 
proteins are inhibited from being trafficked to the cis-Golgi network, and instead are 
retained within the ER lumen by a series of quality control processes. 
Protein Quality Control 
To prevent cellular dysfunction, abnormal protein products e.g. proteins with point 
mutations, deletions, insertions or intermediate glycosylation states, are withheld from 
cis-Golgi apparatus trafficking.273,274 While some proteins are recycled through the protein 
folding process and eventually become folded properly, others become are unable to 
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reach their appropriate conformational state. In the case of soluble proteins, terminally 
misfolded proteins collect as misfolded aggregates within the ER.275,276 These protein 
aggregates are cross-linked by inter-chain disulfide bonds, and are irreversibly bound by 
the chaperone folding protein BiP.276-278 Evidence suggests, binding of aggregates to 
GRP78 is necessary for maintaining proteins in a retrotranslocation competent state and 
recognition of unfolded proteins by ER associated degradation (ERAD) proteins.279,280 In 
the instance of misfolded glycoproteins, targeting and recognition of ERAD substrates is 
instead mediated by cleavage of α1,2-linked mannose via α1,2 exomannosidase.281,282 
Targeted ERAD substrates are then retrotranslocated into the cytosol, via the Sec61 
translocon complex.283,284 Specifically, the ubiquitin-conjugating enzyme Ubc7p 
ubiquitinates ERAD substrates, which are then targeted for cytosolic proteosomal 
degradation via the 26S proteasome.285 Typically, compensatory-targeted protein 
degradation is sufficient to prevent cytotoxic protein aggregation and cellular distress.  
Though, in the event of increased protein synthesis, dysregulation of calcium, etc. ERAD 
may not be adequate to relieve ER stress and the ER stress response (ERSR), also 
known as the unfolded protein response (UPR) is activated to restore ER homeostasis 
and avoid cell death.     
Activation of the Unfolded Protein Response 
The ERSR is comprised of three distinct molecular networks that function 
harmoniously to deplete unfolded proteins from the ER lumen to regain homeostasis. With 
the accumulation of unfolded proteins, the chaperone protein GRP78 is released from 
three transmembrane receptors, inositol-requiring kinase 1 alpha (IRE1α), protein kinase 
RNA-like ER kinase (PERK) and activating transcription factor 6 (ATF6), to aid in proper 
folding.  Upon release of GRP78, IRE1α, PERK, and ATF6 are activated; initiating signal 
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transduction pathways collectively termed the UPR. 
Glucose Regulated Protein 78 
It has been well established that GRP78 dissociates from IRE1α, PERK and ATF6 
in the presence of unfolded proteins.286 The active form of GRP78, a monomeric 
structure, contains a C-terminal peptide binding domain and an N-terminal ATPase.287 
The C-terminal domain is capable of binding a variety of synthetic peptide sequences that 
exhibit vast sequence diversity.288 However, GRP78 does show preferential interaction 
for hydrophobic nascent peptide sequences that activate the N-terminal ATPase upon 
binding.289,290  As a chaperone folding protein, GRP78 does not contribute to the 
enzymatic action necessary for the folding of protein substrates; it instead assists by 
binding to exposed intramolecular hydrophobic regions on unfolded proteins, 
subsequently maintaining the substrate in a folding-competent state.252 Upon substrate 
binding, the bound N-terminal ATP is hydrolyzed to ADP and substrate affinity is 
significantly increased.290 In order for GRP78 to then release its substrate, the co-
chaperone glucose related protein E must catalyze an ADP/ATP exchange to return 
GRP78 to its low affinity ATP-bound confirmation.291 The shuttling of unfolded proteins 
through the ATP/ADP GRP78 cycle and folding pathways is the major mechanism in 
which GRP78 assists in the depletion of unfolded proteins within the ER. It is also capable 
of transporting permanently unfolded proteins to the translocon for retrograde 
translocation and further ubiquitin/proteasomal mediated degradation.280 By facilitating 
activation of ER stress signaling transducers, and assisting in protein folding and protein 
degradation GRP78 acts as a multifaceted protein to aid in the restoration of ER luminal 
homeostasis in the event of stress. 
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Inositol Required Kinase 1α 
IRE1α is an ER stress sensitive, kinase/endoribonuclease type I transmembrane 
glycoprotein receptor, which contains functional luminal and cytoplasmic domains. During 
times of ER homeostasis, IRE1α is locked in a monomeric inactive state through N-
terminal luminal binding of GRP78.286 Upon the accumulation of unfolded proteins and 
subsequent dissociation of GRP78, luminal domains of IRE1α form disulfide-linked 
heterodimers.292 While this suggests relief of GRP78 mediated inhibition of a luminal 
dimerization motif may be responsible for IRE1α dimerization, additional studies have 
demonstrated dimerization of IRE1α through direct binding of unfolded proteins to the 
luminal domain.292,293 Therefore, further studies are necessary to elucidate the exact 
mechanism of IRE1α dimerization. Following heterodimerization, oligomerization-
dependent conformational changes in the cytosolic tyrosine kinase domain induce trans-
autophosphorylation of IRE1α.294,295 Unlike traditional kinase signaling cascades, 
phosphorylation of IRE1α leads to the activation of its own endoribonuclease 
activity.296,297 Currently, the only known substrate of IRE1α RNase is mRNA encoding the 
transcription factor X-box binding protein 1 (XBP1) in humans or homologous to 
ATF/CREB1 (Hac1) in yeast.298,299 The alternative splicing of XBP1 mRNA results in the 
excision of an intronic region and leads to a frame shift during translation. In contrast to 
the naïve splice product, which represses UPR target genes, the alternative splice 
product is subsequently more stable and a strong activator of UPR gene targets.300 XBP1 
was originally discovered as a bZIP protein that bound the major histocompatibility 
complex two gene promoter in the cis-acting X-box region.301 More recently it has been 
demonstrated XBP1 is also capable of binding the endoplasmic reticulum stress response 
element (ERSE) in the presence of nuclear factor Y (NF-Y), the unfolded protein response 
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element (UPRE) and the endoplasmic reticulum stress response element II (ERSE 
II).298,302 XBP1 binding to ERSE, in conjunction with ATF6 and NF-Y, enhances the 
transcription of ER-localized molecular chaperone proteins e.g. GRP78 which act to 
reduce the accumulation of unfolded proteins and restore ER homeostasis.303 Similarly, 
XBP1 binding to the UPRE induces the transcription of ER degradation-enhancing alpha-
mannosidase-like protein (EDEM), an important mediator of the ERAD processes.304 
Furthermore, XPB1-ERSE II binding was recently shown to increase the expression of 
the homo-cysteine-induced endoplasmic reticulum protein (Herp), an ubiquitin-domain 
containing protein that also participates in ERAD.302,305 Upon diminished ER stress, 
IRE1α endoribonuclease activity is repressed, there is decline in XBP1 alternative splicing 
and increased un-spliced XBP1 acts as a negative feedback regulator of sXBP1.306 
Therefore, UPR-dependent transcription levels are reestablished to a basal state upon 
restoration of ER homeostasis. 
Activating Transcription Factor 6 
ATF6 is a type II transmembrane protein that acts separately from IRE1α as a 
signal transducer of the ERSR. Similarly, in a state of ER homeostasis, the luminal 
domain of ATF6 is bound by GRP78.307 Unlike IRE1α and PERK, the dissociation of 
GRP78 does not induce oligomerization, but instead unmasks a Golgi localization 
sequence in the luminal domain.307 Exposure of the Golgi localization sequence to the 
ER lumen subsequently induces translocation of ATF6 to the Golgi complex. Within the 
Golgi complex, ATF6 is further processed from a 90kD protein to an active 50kD bZIP 
transcription factor through the cleavage of the N-terminal domain by site-1 and site-2 
proteases (S1P and S2P, respectively).308 Following processing, ATF6 is translocated to 
the nucleus where it augments the expression of multiple UPR regulated genes. Similar 
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to XBP1, ATF6 is capable of binding three response elements 1) the ATF/cAMP response 
element (CRE) 2) the ERSE I and 3) the ERSEII.298,302,309 In concert with NF-Y, the 
binding of ATF6 to ERSE I and ERSE II acts to upregulate ERAD gene products, as well 
as increase the expression of chaperone folding proteins, particularly GRP78.302,310,311 
Furthermore, ATF6, in collaboration with XBP1, also binds the XBP1 promoter to increase 
expression of XBP1.298 Therefore, through both indirect and direct mechanisms of action, 
ATF6 reduces the unfolded protein load within the ER lumen in the event of ER stress. 
Protein Kinase RNA-like ER Kinase 
Protein kinase RNA-like ER kinase is a type I transmembrane receptor that 
constitutes the last of three unfolded protein response mediated signal transducers. The 
luminal portion of the receptor contains an ER stress-regulated oligomerization domain.312 
As previously mentioned, the exact mechanism of PERK receptor oligomerization is yet 
to be determined. However, with the release of GRP78 from PERK an oligomerization 
domain is exposed and the receptor forms an oligomer structure.313 Oligomerization of 
the receptor induces trans-autophophorylation of the cytoplasmic tyrosine kinase domain. 
Phosphorylation dependent activation of the cytoplasmic kinase then leads to further 
phosphorylation of the α-subunit of eukaryotic translation initiation factor-2 (eIF2α) and 
nuclear factor erythroid 2-related factor 2 (Nrf2).314 Subsequently, the phosphorylation of 
eIF2α functionally inhibits GTP/GDP cycling, which significantly reduces the rate of global 
cellular translation. In return, the load of newly synthesized proteins in the ER is 
concomitantly decreased, helping to relieve the accumulation of unfolded proteins. Not 
surprisingly, the whole cell knockout of PERK increases cellular sensitivity to ER stress. 
This phenotype was then partially relieved with the addition of protein synthesis inhibitors 
such as cycloheximide, reiterating the importance of PERK-mediated translational 
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inhibition in the event of ER stress.315 The inhibition of eIF2α provides the opportunity for 
active translation of mRNAs that contain short upstream open reading frames (uORFs).316 
In particular, ER stress mediated translational repression enhances the expression of 
activating transcription factor 4 (ATF4).317 Within two hours of being exposed to stress, 
the upregulation of ATF4 can further induce an increase in the expression of the basic-
region leucine zipper (bZIP) protein activating transcription factor 3 (ATF3). When the cell 
is unable to restore ER homeostasis due to prolonged or severe ER stress, ATF3 can 
activate the apoptosis-inducing protein GADD153, which has been demonstrated to 
trigger cell death through caspase 3 (CASP3) mediated apoptosis.318 
Extracellular Functions of the Unfolded Protein Response 
Beyond the ER, components of the UPR, such as GRP78, are expressed on the 
extracellular surface of many cell types and in the extracellular space in addition to the 
ER.319,320 GRP78 has also been found in the serum, synovial fluid, saliva and oviductal 
fluid.320-323 The mechanism whereby components of the UPR signaling cascade traffics 
from the ER to the cell surface and the extracellular space is not fully resolved. It has 
been confirmed however that extracellular GRP78, does not arise from apoptotic cell 
death mediated protein leakage during ER stress, as GRP78 release into the extracellular 
space precedes any evidence of apoptotic cell death.324 Moreover, in cells exposed to 
Brefeldin A, which inhibits ER to Golgi protein transport, extracellular levels of GRP78 
were significantly decreased while intracellularly they continued to increase, suggesting 
that extracellular GRP78 is actively trafficked.324 In addition, it has been observed in vitro 
that the relative amount of GRP78 versus non-secreted proteins, is increased within the 
media when compared to whole cell lysates.324,325 More recently the extracellular 
trafficking of UPR proteins was confirmed by the finding that prostate apoptosis response-
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4 (Par4) was identified as a partner for GRP78 that was necessary for its translocation to 
the cell surface during periods of ER stress in normal and cancer cells, underscoring the 
regulated nature of GRP78 translocation to the cell surface.326 In this study TM-treated 
telomerase immortalized human myometrial cells (hTERT-HM) were all found to be viable 
at the time of media collection, adding to the observation that GRP78 is actively secreted 
due to activation of the UPR and not leaked out of the cell in an apoptotic manner (Figure 
15). However, as the GRP78 amino acid sequence contains the classical ER retention 
signal (KDEL) in its C-terminal it is not entirely resolved how GRP78 is actively secreted. 
The KDEL sequence should dictate that GRP78 is a lumen bound, ER resident protein, 
which cannot traffic to the surface of cell or be secreted extracellularly. It is thought that 
an oversaturation of the specific KDEL receptors in the ER during periods of ER stress, 
may allow for GRP78 to escape the KDEL retention system and accumulate in the plasma 
membrane and the extracellular space.325,327-329 The severity of ER stress needed to 
facilitate GRP78 secretion into the extracellular space however, remains ambiguous and 
further studies are needed to characterize cell-type and stimulus specific thresholds. 
Extracellular GRP78 has been demonstrated to play a critical role in the transmission of 
biochemical stress signals from one cell to another. Specifically, this form of paracrine 
and potentially endocrine signaling allows for amplification and expansion of a local tissue 
response to a systemic alarm or danger signal. GRP78 mediated transmission of ER 
stress has been observed when conditioned media isolated from stressed tumor cells 
was exposed to naïve macrophages and resulted in UPR induction in the naïve cells.330 
Cell free GRP78 has also been demonstrated to confer an anti-inflammatory pro-survival 
phenotype by binding to target cell surface receptors such as Cripto-1, which allows for 
the attenuation of transforming growth factor beta tumor suppressor functions.331 Further, 
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extracellular GRP78 has been demonstrated to block p53 action and thereby inhibit its 
pro-apoptotic targets, BOK and NOXA.319 Taken together these data suggest that 
activation of the UPR intracellularly and secretion of the UPR into the extracellular space 
has the capacity to confer an anti-inflammatory, pro-survival phenotype. 
CASP3-Dependent Apoptosis 
As previously mentioned, if the UPR is unable to restore cellular homeostasis 
PERK/ATF4/ATF3-dependent activation of GADD153 induces CASP3-mediated 
apoptosis. Overall, the activation of CASP3 is the final step in three cellular signaling 
pathways that result in apoptotic cell death: the extrinsic pathway, the intrinsic pathway 
or the UPR.332,333 In the extrinsic pathway, ligand-induced activation of a well 
characterized subset of death receptors, such as tumor necrosis factor receptor 1, fatty 
acid synthetase receptor or death receptor 3 leads to the formation of the death-inducing 
signaling complex, the autocatalytic activation of initiator caspase 8 and subsequent 
activation of CASP3.334 In the intrinsic pathway, damaging cellular stimuli cause 
dysregulation of mitochondrial homeostasis that results in the opening of the 
mitochondrial permeability transition pore.335 Increased mitochondrial membrane 
permeability facilitates the construction a multi-protein complex called the apoptosome, 
containing the active initiator caspase 9, which proceeds to activate CASP3.336 As 
previously mentioned, ERSR-mediated activation of CASP3 occurs through the signaling 
cascade of ATF4, ATF3 and GADD153 resulting in the activation of initiator caspase 12, 
which activates the terminal caspase, CASP3.337 Following activation, CASP3 acts in a 
multi-factorial manner to induce cellular apoptosis. Specifically, within the nucleus CASP3 
will 1) degrade inhibitor of caspase activated DNAse (ICAD) resulting in chromosomal 
degradation and chromatin condensation via active DNAse, 2) further target and degrade 
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DNA repair molecules, such as PARP and 3) disrupt cytoskeleton organization and intra-
nuclear transport through the degradation of gelsolin, an actin binding protein necessary 
for actin polymerization.338-340 We know cellular apoptosis is extremely important process 
in the maintenance of cellular homeostasis and many normal physiological functions, as 
the CASP3 knockout in mice reduces the rate of live births and results in premature death 
of the live pups.341-343 Subsequently, CASP3 apoptotic action has been found to be critical 
for the development of the nervous and immune system; wound healing and overall 
remodeling in adult tissues.344-346 In contrast, the dysregulation of normal apoptotic 
processes can lead to various pathophysiological states. In cancer a resistance to 
apoptosis, decreased cell death, cell cycle dysfunction and abnormal proliferation leads 
to the formation of a tumor.347 Additionally, CASP3-mediated apoptosis in tumors 
undergoing radiation has been demonstrated to increase growth and proliferation in the 
surviving tumor cell population further promoting tumorigenesis.348 In other disease like 
autoimmune deficiency syndrome, increased apoptosis of the T-cell population causes 
extreme immunodeficiency and in some cases death.349 
Non-Apoptotic CASP3 Function 
While CASP3 activity is typically a hallmark of cellular apoptosis or programmed 
cell death, non-apoptotic CASP3 function has been described in many physiological 
processes such as muscle tocolysis, cellular differentiation and synaptic plasticity.350-352 
As a protease with over 34,000 identified protein targets containing a cleavage motif 
(DXXD) within the human genome, it is not entirely surprising that emerging evidence 
supports critical non-apoptotic functions of CASP3.353 Our laboratory, as well as others, 
have previously demonstrated the capacity of non-apoptotic CASP3 to selectively target 
and degrade actin isoforms (e.g.  and ).354 In the context of myometrial smooth muscle, 
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selective actin degradation inhibits contraction from occurring. Further, in catabolic 
conditions such as diabetes, skeletal muscle CASP3 activity has been observed to 
degrade actomycin and actin, resulting in muscle atrophy.355 Beyond regulating 
contraction and muscle proteolysis, non-apoptotic CASP3 activity is also involved in 
skeletal muscle differentiation.356 In the CASP3 knockout mouse, myoblasts displayed 
deficiency of myofiber and myotube formation, presumably due to loss of Mammalian 
Sterile Twenty-like kinase activity.357 Non-apoptotic and incomplete apoptotic CASP3 
action has similarly been shown to facilitate differentiation lens epithelial cells, monocytes, 
erythrocytes, keratinocyte, megakaryocytes and potentially neurons.358-363 Interestingly, 
increased non-apoptotic CASP3 expression in hippocampal CA1 neurons is also thought 
to facilitate neuroplasticity through propagation of long-term potentiation.352 Multiple 
neuronal CASP3 targets are thought to aid in CASP3-dependent neuroplasticity (e.g. 
GluR1, IP3R and PKC), but the exact mechanism responsible for long-term potentiation 
is still unresolved.353 Taken together, these studies and more suggest CASP3, acting in 
both an apoptotic and non-apoptotic manner, is important for both normal and 
pathophysiological conditions and warrants further inquiry. 
The UPR and Inflammation 
Inflammation and the ERSR are two distinct signaling cascades that are highly 
interconnected during periods of cellular distress through various mechanisms. Briefly, 
activation and nuclear translocation of the inflammatory transcription factor NFB has 
been achieved through both the IRE1and PERK signaling pathways.364 With the 
autophosphorylation of IRE1, a cytosolic conformational change of the receptor leads to 
the recruitment of tumor-necrosis factor- receptor-associated factor 2 and subsequent 
activation of IB kinase resulting in degradation of IB and nuclear translocation of 
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NFB.365 Separately, as the half-life of IB is significantly shorter than that of NFB, 
PERK-dependent phosphorylation of eIF2 and the inhibition of protein translation have 
been shown to free NFB from IB-dependent cytosolic localization and thus allow for 
nuclear translocation.366 Lastly, within the mouse liver it has been demonstrated that ER 
stress initiates the translocation of CREBH from the ER to the Golgi, where it is processed 
and activated in a similar manner to ATF6.367 Typically, CREBH is induced by 
inflammatory cytokines, e.g. TNF and IL-1and mediates an acute phase response that 
activates serum amyloid P component and C-reactive protein.367 However, CREBH does 
not increase the expression of UPR regulated genes, and further studies are necessary 
to delineate the functional role of CREBH in this ER stress-mediated inflammatory 
response.367 
Preconditioning 
A broad definition of preconditioning is the act of preparing for a subsequent action. 
The process of preconditioning biological systems against pathophysiological events can 
be observed in multiple forms, one example is vaccination. In 1796, Dr. Edward Jenner 
demonstrated that the inoculation of a small titer of smallpox virus into a young boy 
thereafter provided him with life-time immunity against the deadly disease.368 It has since 
been shown, that presentation of a non-lethal dose of bacterial or viral infection into the 
body acts paradoxically to increase the production of neutralizing antibodies within the 
immune system.369,370 Increased antibody production will 1) eliminate the acute infection 
and 2) boost the immune response in the event of future exposure to that same infection, 
increasing one’s chances of overcoming the disease and its effects.369 Recent evidence 
suggests novel-preconditioning paradigms may prepare patients and limit damage from 
other lethal events such as heart attacks, strokes, or liver failure.371-373  
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Ischemia/reperfusion preconditioning has become an increasingly active area of interest 
over the last three decades.374 In the event of acute ischemia, i.e. myocardial infarction 
(MI), transient brain ischemia or liver transplant, persistent hypoxia induces both cellular 
necrosis, and apoptosis in the area of infarct, as well as apoptosis in the bordering tissue 
zone.371-373 Studies examining the effects of ischemia/reperfusion preconditioning in 
these tissues have demonstrated that multiple applications of brief ischemic events prior 
to prolonged ischemia reduces subsequent tissue damage.373,375,376 Murry and 
colleagues demonstrated the application of brief ischemic events prior to a prolonged 
myocardial infarction reduced the infarct size by approximately 25 percent compared to 
control animals that did not receive ischemic preconditioning.375 While the methods and 
modalities conditioning are continuously evolving, many preconditioning-mediated cardio-
protective effects have been linked to mitochondria stabilization via G-protein coupled 
receptor activation and canonical downstream events, release of circulating humoral 
factors and neurogenic activation of protein kinase C and the ERSR.374,377-381 As ongoing 
studies continue to examine the molecular mechanisms responsible for 
ischemia/reperfusion preconditioning effects in the various tissue paradigms, it has 
become abundantly clear that low dose stress facilitated pre-induction of cellular 
readiness has paradoxical effects against further cellular damages. 
Preconditioning of the Endoplasmic Reticulum Stress Response 
The benefits of preconditioning are not isolated to ischemia/reperfusion injury 
alone.  There is a growing body of evidence demonstrating that preconditioning of the 
cellular ERSR with minor stresses enhances cell viability upon exposure to a subsequent 
more damaging stress. Various cellular stressors such as hypoxia, inflammation and 
glucose deprivation activate the ERSR.382,383 Importantly, it has been demonstrated that 
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the pre-activation of adaptive ER stress signaling pathways provide cytoprotection and 
enhance cell viability against exposure to various cellular insults such as oxidative stress, 
inflammation, and hypoxia.384-388 
Oxidative Stress- In 2003, Hung and colleagues examined the effect of ER stress 
preconditioning against oxidative injury in LLC-PK1 renal epithelial cells, utilizing both TM 
and Thaps. In this study, cells were pretreated with TM and Thaps (1.5µg/ml and 0.3µg/ml 
respectively) for 12-16 hours prior to the exposure of 0.5-1mM H2O2. As determined by 
LDH release, increased concentrations of intracellular Ca2+, cell injury was significantly 
reduced in cells preconditioned with either TM and Thaps, compared to non-
preconditioned controls. The preconditioning effects against oxidative injury however, 
were negated in LLC-PK1 cells expressing a GRP78 antisense RNA. Therefore, the 
authors suggested the expression of GRP78 is necessary for successful ER stress 
preconditioning against H2O2 induced oxidative injury. These results corroborated other 
preconditioning models of ischemia/reperfusion, which demonstrate that increased 
expression of ER chaperones is positively correlated with cell survival.389 In addition, 
increased phosphorylation of extracellular signaling-kinase regulated protein (ERK) was 
found to be necessary for ER stress mediated resistance against oxidative stress and 
was associated to increased GRP78 expression following TM and Thaps 
preconditioning.386 A later study, utilizing three additional renal cell lines (NRK-52E, 
HEK293 and MDCK), similarly examined the effect of 24hr pretreatment with TM, Thaps 
or oxidized DTT, which alters protein folding by augmenting the ER redox state, against 
subsequent oxidative insults.385,390 In agreement with previous studies, ER stress 
preconditioning significantly increased cell viability. However, they found both the cell type 
and the method of ER stress induction affected the quality of cytoprotection. Originally, 
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the authors speculated the variation in cytoprotective effects to be linked to the cell type 
specific dose-dependent induction of GRP78 protein levels, but no relationship was found 
between the extent of GRP78 induction and the afforded cytoprotection. Consequently, it 
is important to note that these results suggest the cytoprotective effects mediated by ER 
stress preconditioning are cell type specific and are influenced by the mechanism of ER 
stress induction. Moreover, because GRP78 expression levels in this study did not 
directly correlate to the amount of cytoprotection provided, it is likely supplementary 
factors are responsible for modifying ER stress preconditioning effects.   
Inflammation- In an additional study characterizing the effect of ERSR 
preconditioning against retinal endothelial inflammation, XBP1 was described to play a 
critical role in blunting pathophysiological responses to the inflammatory cytokine tumor 
necrosis factor-alpha (TNFα).384 Specifically, the upregulation of spliced XBP1, afforded 
by low dose treatment of TM, inhibited both TNFα mediated IB kinase/NFB activity and 
prevented the expression of downstream inflammatory markers (e.g. soluble intercellular 
adhesion molecule-1 and vascular adhesion molecule). These cytoprotective effects 
could be mimicked in cells overexpressing spliced XBP1 with the transfection of 
adenovirus encoding spliced XBP1 and annulled using an XBP1 silencing RNA. In 
agreement with previous studies, increased IRE1α expression induced by TNFα 
treatment was buffered to basal levels in cells overexpressing XBP1.365,391 The authors 
proposed the buffering capacity of XBP1 might be due to an XBP1-dependent increase 
in GRP78 that ameliorates ER stress and IRE1α activation. Additional studies however, 
have demonstrated ERSR preconditioning-dependent cytoprotection against 
inflammation independent of increased GRP78.392 Thus, further studies are necessary to 
delineate the exact mechanism of ER stress induced XBP1-dependent inhibition of 
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inflammatory responses to TNFα treatment.   
Hypoxia- Like ER stress preconditioning facilitated cellular protection against 
inflammatory processes, IRE1α-dependent XBP1 activation is required for cellular 
protection against hypoxic insults. While it is understood that ERSR pathways respond to 
hypoxia, the mechanism of ERSR regulated hypoxic sensitivity was relatively unknown 
until recently.393 Utilizing loss of function mutant alleles in various UPR genes, Mao and 
Crowder demonstrated the necessity of functioning IRE1α, XBP1 and ATF6 for 
appropriate ERSR mediated preconditioning against lethal hypoxic insults. In this study, 
null mutations for two GRP78 homologs had no effect, positive or negative, on TM 
preconditioning. Taken together, ER stress preconditioning mediated cytoprotection is a 
multifactorial process. The direct molecular signaling pathways responsible for priming 
cells seems to be dependent of the modality of applied ER stress and specific to the cell 
type undergoing preconditioning. While it has been shown to be highly beneficial in 
protecting cells against various forms of injury, future studies are required for the 
optimization of the technique prior to utilize as a therapeutic approach. 
Remote Preconditioning of the Endoplasmic Reticulum Stress Response 
Interestingly, the beneficial adaptations of prophylactic stress-mediated UPR-
preconditioning is not restricted to the tissue being conditioned. Remote preconditioning 
is defined by brief episodes of stress applied to a discrete tissue or organ that result in 
global cytoprotection against future lethal stresses.394 Similar to preconditioning, many of 
the first important studies characterizing the positive cytoprotective effects of remote 
preconditioning were performed in the context of myocardial ischemia/reperfusion 
injury.395,396  It has since been demonstrated that remote preconditioning is not limited to 
ischemia/reperfusion injury or cytoprotection of myocardial tissue alone. In the context of 
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the kidney, remote UPR preconditioning, via systemically administered pretreatments of 
TM or Thaps, ameliorated the consequences of a chemically induced form of 
glomerulonephritis in rats.397 In addition, remote systemic ER stress preconditioning has 
been shown to suppress translation of UPR apoptotic effector proteins ATF4 and 
GADD153, inhibiting TM-mediated apoptosis in splenic macrophages, renal tubule cells 
and hepatocytes, preventing hepatosteatosis and renal dysfunction.398 Based on these 
data, it is important to note for future studies that the UPR is a dynamic signaling network 
capable of exhibiting cell- and stimulus-specific responses.  
Thesis Aims 
This thesis consists of three primary aims. Our laboratory has previously 
demonstrated that the pregnant uterus facilitates uterine quiescence through UPR 
mediated activation of non-apoptotic myometrial CASP3.350 It is unknown however, how 
CASP3 is maintained in a non-apoptotic state to maintain myometrial quiescence. In Aim 
1 we looked to characterize the capacity of in vitro preconditioning of the ERSR to 
facilitate the maintenance of non-apoptotic CASP3. We hypothesize preconditioning the 
ERSR in uterine myocytes increases the ability of the myometrium to adapt to apoptotic 
stimuli through modulation of pro-survival and inflammatory responses, thus allowing for 
the maintenance of non-apoptotic CASP3. In Aim 2, we utilized our pregnant mouse 
model of ERSR induced preterm birth, previously described by Kyathnahalli and 
colleagues, to examine the in vivo effects of endogenous ERSR preconditioning on the 
regulation of myometrial adaptation to gestationally-induced uterine stressors.350 We 
hypothesize that an inappropriately preconditioned uterus or a uterus that is unable to 
host an adaptive preconditioning response is more likely to undergo premature uterine 
contraction and subsequently preterm birth. In Aim 3 we tested the hypothesis that 
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circulating factors, secreted from uterine myocyte in an ER-stress dependent manner, 
facilitate the transmission and activation of a potentially adaptive/preconditioning-like 
extracellular ERSR in a paracrine and endocrine manner. We further speculate that these 
secreted factors may act as potential biomarkers for uterine myocyte refractoriness. 
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CHAPTER 2 
Introduction 
In the context of the pregnant uterine myocyte, our laboratory has demonstrated 
active CASP3 is highly abundant across gestation and is critical for the regulation of 
uterine myocyte quiescence.350,399 Specifically, we have shown that active CASP3 within 
the uterine compartment targets and degrades multiple components of the contractile 
architecture, such as  actin,  actin and connexin 43 rendering the myocyte quiescent.350 
Classically, CASP3 activity has been linked to the execution of cellular apoptosis through 
proteolytic cleavage of DNA repair moles, such as poly (ADP-ribose) polymerase (PARP), 
resulting in intra-nucleosomal cleavage and fragmentation of DNA.400 Interestingly, at no 
point during gestation does the myometrium succumb to apoptosis, suggesting CASP3 is 
maintained in a non-apoptotic state within the pregnant uterus while fulfilling its tocolytic 
action. Subsequently, it is known that non-apoptotic CASP3 action is essential for 
inhibiting myometrial contractility, however the mechanisms necessary for the 
maintenance of CASP3 in a non-apoptotic state within the pregnant myometrium remain 
completely elusive. It has been demonstrated in previous studies that stress-dependent 
preconditioning can maintain CASP3 in a functioning non-apoptotic state. Subsequently, 
we hypothesize that preconditioning the uterine myocyte UPR with minor prophylactic 
stress events will facilitate the maintenance of non-apoptotic CASP3 following a 
damaging bolus. 
CASP3 can be activated through 1 of 3 signaling cascades: the extrinsic pathway, 
the intrinsic pathway or the UPR, as referred to in Chapter 1 Apoptosis.401,402 In the 
pregnant mouse myometrium, there is UPR-dependent activation of GADD153 and 
CASP12 around E6-8, with concomitant increases in XBP1s.403 As a result of 
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GADD153/CASP12 signaling, there is a robust activation of CASP3, as seen by a surge 
in its active cleavage fragments (14 and 17kD) at approximately E8-10.403 Active CASP3 
is then observed in high levels throughout early and mid-gestation, declining at 
approximately E17 prior to the onset of labor.403 Intriguingly, PARP cleavage, an indicator 
of CASP3 mediated apoptosis, is minimal in the myometrium at the time heightened 
CASP3 activity.404 Furthermore, there is no DNA fragmentation or positive TUNEL 
staining within the myometrium at any point in gestation, validating that active CASP3 is 
maintained in a non-apoptotic state during pregnancy. In other muscle systems such as 
the bladder, heart and diaphragm, non-apoptotic CASP3 has been described to have anti-
contractile function.405-407 While CASP3 targets were not identified in the smooth muscle 
of the bladder, CASP3 was found to target structural proteins in both the heart and 
diaphragm. In cardiac tissue specifically, both -actin and -actinin, components of the 
cardiac contractile architecture were directly cleaved by CASP3 and then further 
degraded. Similarly, we showed in the absence of apoptotic consequences non-apoptotic 
uterine CASP3 protease activity inhibits myometrial contraction in a tocolytic manner 
through the targeted cleavage and degradation of multiple components of the contractile 
architecture, i.e. connexin 43, α-actin and γ-actin.350,399 While the tocolytic function of 
CASP3 is imminently important and has been highly characterized, it remains widely 
unknown how the uterus capacitates active CASP3 in a non-apoptotic state during 
pregnancy. 
A growing body of evidence now suggests that non-apoptotic CASP3 action can 
be maintained through the process of cellular preconditioning.408-410 The process of 
preconditioning biological systems against pathophysiological events can be observed in 
multiple forms is strongly conserved in evolution, as discussed in Chapter 1 
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Preconditioning.411 In the context of neuronal ischemic preconditioning, active CASP3 
expression has been reportedly high in neuronal cells that do not undergo delayed 
neuronal cell death following ischemic injury.410 In this case, ischemic preconditioning 
was found to increase the expression and effectiveness of pro-survival inhibit-of-
apoptosis family members, cIAP. In a separate study examining the effects of 
preconditioning with minor periods of oxidative stress and low ATP on neuronal 
excitotoxicity, McLaughlin and colleagues demonstrated a sharp increase in non-
apoptotic CASP3 activity during the period of neuronal preconditioning. Further, when 
pan-caspase inhibitors were employed during the period of preconditioning the previously 
observed cytoprotective effects of KNC-dependent ROS generation were abrogated and 
cells exhibited increased apoptosis like that of the non-preconditioned neuronal 
population. In both of these studies, the preconditioning stimuli (hypoxia, oxidative stress 
and low ATP) that preserve non-apoptotic CASP3 activity have each been demonstrated 
to in turn activate the cellular UPR.412 Subsequently, we propose directly preconditioning 
the UPR within the uterine myocyte may be a potential mechanism whereby active 
CASP3 can be kept in a non-apoptotic state. 
In this current study we thus examined the cytoprotective effects of preconditioning 
the UPR in uterine myocytes, utilizing hTERT-HM cells. To test the hypothesis that UPR 
preconditioning facilitates the maintenance of non-apoptotic CASP3 and promotes cell 
viability, minor concentrations of TM and Thaps were applied prior to the exposure of a 
known cytotoxic dose in hTERT-HM cells. Herein we have identified preconditioning of 
the uterine UPR as the protective mechanism that facilitates the maintenance of non-
apoptotic CASP3 within the pregnant uterine myocyte. These studies clearly 
demonstrated in vitro UPR preconditioning facilitates augmented uterine myocyte cell 
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viability preventing apoptotic consequences of CASP3 action in the presence of elevated 
levels of CASP3 activation. Additionally, we have demonstrated UPR preconditioning 
decreases stress-dependent inflammatory responses in the human uterine myocyte.  
Materials and Methods 
Cell Culture 
For the in vitro cell culture model system, we utilized hTERT-HM cells.413 In detail, 
human myometrial cells were collected from the anterior wall of the uterine fundus in 
women of reproductive age undergoing a hysterectomy. The catalytic subunit of 
telomerase was then expressed in the myometrial cells via retroviral infection. In these 
studies, hTERT-HM cells were cultured in Dulbecco modified Eagle/F12 low glucose 
media (DMEM-F12) (Invitrogen Carlsbad, CA), supplemented with 10% fetal bovine 
serum (vol/vol) (Invitrogen) and antibiotic/antimycotic (10,000 U/ml; Invitrogen), and 
incubated at 37°C with 95% air and 5% CO2. 
Tunicamycin and Thapsigargin Treatments 
For all in vitro experiments, TM was suspended in 20μl 10M sodium hydroxide and 
brought to a final concentration of either 0.1μg/ml or 1.0μg/ml in DMEM-12 media with 
10% FBS and antibiotic/antimycotic. Thaps (Sigma-Aldrich, St. Louis, MO; Cat#T9033) 
was dissolved directly in cell culture media and brought to a final concentration of 10nM 
or 250nM. For TM preconditioned (P) and non-preconditioned (NP) treatments hTERT-
HM were given a 24hr treatment of 0.1μg/ml TM or vehicle, respectively, 0-48hrs prior to 
a secondary treatment of 5.0μg/ml TM.  Similarly, for Thaps preconditioned (P) and non-
preconditioned (NP) treatments hTERT-HM cells were given a 24hr treatment of 10nM 
TH or vehicle, respectively, 48hrs prior to a secondary treatment of 250nM Thaps. In both 
conditions, media was replaced 1hr after the secondary treatment was given and cells 
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and media were collected 47hrs later. 
Cytosol and Nuclear Protein Fractionation from Cells 
Cytoplasmic and nuclear protein fractions from hTERT-HM cells were prepared as 
previously mentioned. Initially, cells were rinsed in ice-cold PBS and centrifuged at 956 X 
g. The pellet was re-suspended and evenly homogenized in ice-cold NE1 buffer (10mM 
Hepes pH 7.5, 10mM MgCl2, 5mM KCl, 0.1% Triton X-100 with 1X EDTA-free 
protease/phosphatase inhibitor mini tablet). The homogenate was then centrifuged at 
2655 X g, the supernatant was retained as the cytoplasmic protein fraction and the pellet 
was washed in NE1 buffer and suspended in ice-cold NE2 buffer [20mM Hepes pH 7.9, 
500mM NaCl, 1.5mM MgCl2, 0.2mM EDTA pH 8.0, 25% (vol/vol) glycerol with 1X EDTA-
free protease/phosphatase inhibitor mini tablet]. The homogenate was vortexed for 30sec 
every 5min and after 1hr, centrifuged at 10,621 X g. The supernatant was then retained 
as the nuclear fraction. Protein estimation was performed using a bicinchoninic acid 
(BCA) assay, equal amounts of protein were loaded for immunoblotting, PDI and NCOA3 
were utilized as loading controls for the cytoplasmic and nuclear fractions, respectively. 
Immunoblotting and Densitometric Analysis 
Equal amounts of protein were separated via electrophoresis on NuPAGE 4-12% 
gradient precast polyacrylamide gels (Life Technologies, Carlsbad, CA). Proteins were 
transferred onto Hybond-P PVDF membranes (Millipore, Billerica, MA) and blocked for 
1hr at room temperature in 5% non-fat milk prepared in Tris Buffered Saline with 
0.1%Tween-20 (vol/vol). Membranes were incubated with primary antibodies overnight 
at 4°C. Primary antibody concentrations were as follows: GRP78 (1:1000; Cat#3177), Cl 
CASP3 (1:250; Cat#9664), GADD153 (1:500; Cat#5554), Cl PARP (1:1000; Cat#9541), 
AFT4 (1:500; Cat#11815), p-eIF2α (1:500; Cat#3398), NFB (1:1000; Cat#8242), XIAP 
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(1:250; Cat#2042) and PDI (1:5000; Cat#3501) were obtained from Cell Signaling 
Technologies; XBP1s (1:500; Cat#37152) was obtained from Abcam; ATF6 (1:500; 
Cat#24169-1-AP) was obtained from Proteintech; MCL-1 (1:1000; Cat#sc-819) was 
obtained from Santa Cruz Biotechnology, and NCOA3 (1:5000; Cat#PA1-845) was 
obtained from ThermoScientific. Following primary incubation, immunoreactivity was 
detected using horseradish peroxidase-conjugated secondary antibodies and visualized 
using an enhanced-chemiluminescence detection system (ThermoScientific, Rockford, 
IL). Immunoreactive band density was then quantified using ImageJ software. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Media samples were loaded into Amicon Ultra Centrifugal Filters (Millipore, 
cat#UFC500396) and centrifuged for 30 minutes at 14,000 x g to concentrate media 
approximately 10X. The level of human tumor necrosis factor-alpha (TNFα) was then 
measured in 10X concentrated media using an ELISA. Specifically, the MSD Multi-Spot 
TNFα ELISA (Meso Scale Diagnostics, Rockville, MD, Cat#K151QWD) was performed 
according to the manufacturer’s instructions and results were read via the Meso Scale 
Discovery 1300 microplate reader. Each sample measurement was read in duplicate and 
the computed averages were taken based on the calculated standard curve. 
Statistical Analysis 
All data represent at least three individual experiments performed in triplicate. For 
the direct comparison of three or more conditions a one-way analysis of variance was 
performed, with multiple comparisons analyzed via Newmans-Keuls multiple 
comparisons test. When directly comparing two conditions a two-tailed student-t test was 
performed. All comparisons were considered significant with p-values less than 0.05. 
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Results 
Appropriate In Vitro UPR-Preconditioning Renders CASP3 Non-Apoptotic in Human 
Uterine Myocytes 
Activation of the UPR, CASP3 and apoptotic indices were examined by 
immunoblotting in control, preconditioned (0.1g/ml, 24hrs TM) and non-preconditioned 
(vehicle, 24hrs) hTERT-HM cells, given a 0, 4, 24 and 48hr recovery period prior to a 
subsequent known cytotoxic dose of TM (5.0g/ml, 1hr) (Figure 1).385 A robust activation 
of the UPR was observed in the levels of GRP78 and CASP3 in both the TM 
preconditioned and non-preconditioned cells compared to the vehicle control (Figure 1A, 
B and C) for each recovery period. Examination of apoptotic indices, as quantified by 
cleavage of the nuclear DNA repair molecule Poly ADP ribose polymerase (Cl PARP), 
demonstrated that CASP3 activation and PARP cleavage levels were equivalent at all 
recovery time points examined except at the 48hr recovery time frame. With an allotted 
48hr recovery period, the uterine myocytes of the preconditioned and non-preconditioned 
cells displayed equal levels of CASP3 cleavage, however remarkably the preconditioned 
cells had a 4 fold decrease in PARP cleavage compared to non-preconditioned cells 
suggesting that preconditioned cells given a 48hr recovery period between the 
preconditioning and cytotoxic stimuli have significantly reduced levels of apoptosis and 
that the observed active CASP3 is non-apoptotic in nature. Decreased cell viability of the 
non-preconditioned cells (NP) in comparison to control (C) and preconditioned (P) 
myocytes was further validated using a trypan blue assay (Figure. 2).   These   results   
demonstrate that 1) preconditioning the UPR provides 
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Figure 1. UPR preconditioning renders the hTERT-HM uterine myocyte CASP3 non-apoptotic. (A) 
Elevated levels of cytoplasmic GRP78 and Cl CASP3, and nuclear Cl PARP are observed in 
preconditioned (P) and non-preconditioned (NP) uterine myocytes as compared to controls (C) (n=3 per 
condition), when exposed to a cytotoxic dose of TM 0, 4, 24 and 48 hrs post TM preconditioning. At 48hrs 
to recovery there is equal activation of GRP78 (B) and Cl CASP3 (C) in both P and NP uterine myocytes. 
In contrast, Cl PARP (D) is significantly decreased in the P versus NP cells. PDIA2 and NCOA3 are utilized 
as cytoplasmic and nuclear protein loading controls. A representative blot from this experiment is shown. 
Statistical comparisons were performed using one-way ANOVA, and subsequent Newman-Keuls multiple-
comparison tests. Data labeled with different letters are significantly different from each other (p<0.05). 
Figure 2. UPR preconditioning increases cell viability of 
the hTERT-HM uterine myocyte in the presence of 
active non-apoptotic CASP3. Decreased cell viability 
was observed in non-preconditioned (NP) uterine 
myocytes as compared to controls (C) and 
preconditioned myocytes (P) (n=3 per condition), when 
exposed to a cytotoxic dose of TM 48 hrs post TM 
preconditioning as measured using a trypan blue 
assay. Statistical comparisons were performed using a 
one-way ANOVA, and subsequent Newman-Keuls 
multiple-comparison tests. *p≤0.05 and **p≤0.01 
compared with controls. 
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resistance to the apoptotic consequences of 
CASP3 activation (Figures 1D) and 2) UPR 
preconditioning-mediated cytoprotection is 
dependent on the amount of recovery time 
between the preconditioning stimuli (0.1g/ml, 
24hrs) and the subsequent damaging/lethal stress  
(5.0g/ml, 1hr) TM stimulus. Additionally, the 
preconditioning dose of TM used was tested and 
found to activate the UPR, as seen by increased 
levels of GRP78, without inducing apoptosis 
shown by lack of GADD153 and CASP3 
activation, or PARP cleavage (Figure 3). 
 
 
 
 
  
Figure 3. Preconditioning dose of TM has negligible 
impact on UPR, inflammatory, pro and anti-apoptotic 
indices in the hTERT-HM uterine myocyte. GRP78, 
ATF4, NFB, CASP3, XIAP, and GADD135 levels were 
measured in vehicle treated (C) uterine myocytes and 
preconditioned (P) myocytes exposed to a minor UPR 
stress (TM, 0.1𝜇g/ml, 24hrs).  GRP78 levels were 
modified significantly whereas all others remained 
unchanged, indicating the lack of downstream 
consequences of the preconditioning stress alone in 
vitro. A representative blot from each experiment is 
shown. PDIA2 and NCOA3 are utilized as our 
cytoplasmic and nuclear protein loading controls. 
Statistical comparisons were done using a two-tailed 
student t-tests. Data labeled with different letters are 
significantly different from each other (p<0.05). 
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Cytoprotection Afforded by In Vitro UPR-Preconditioning in Human Uterine Myocytes is 
Independent of the Preconditioning Modality Employed 
To validate that the observed anti-apoptotic effects of preconditioning were not 
modality-dependent, we repeated our preconditioning protocol using Thaps. 
Subsequently, hTERT-HM cells were preconditioned (10nM, 24hrs Thaps), given a 48hr 
recovery and compared to non-preconditioned (vehicle) cells following the administration 
of a known cytotoxic dose of Thaps (250nM, 1hr) (Figure 4). Again, we observed 
activation of the UPR as increased levels of 
GRP78 and CASP3 in both the Thaps 
preconditioned and non-preconditioned cells 
compared to the vehicle control (Figure 4A, B and 
C). Importantly, in a manner similar to the TM 
protocol, Thaps-preconditioning reduced PARP 
cleavage by 2 fold (Figure 4D) in the presence of 
a 25-fold increase in CASP3 activation (Figure 4C) 
at the 48hr recovery time point post 
Figure 4. Thaps mediated UPR preconditioning renders 
the hTERT-HM uterine myocyte CASP3 non-apoptotic. (A) 
Elevated levels of cytoplasmic GRP78, nuclear CL CASP3 
and CL PARP are observed in preconditioned (P) and non-
preconditioned (NP) uterine myocytes as compared to 
controls (C) (n=3 per condition), when exposed to a known 
cytotoxic dose of Thaps (250nM, 1hr), 48 hrs post Thaps 
preconditioning (10nM, 24hrs). (B) At 48hrs to recovery 
there is equal activation of GRP78 and (C) Cl CASP3 in 
both P and NP uterine myocytes. (D) In contrast, Cl PARP 
is significantly decreased in the P versus NP cells. PDIA2 
and NCOA3 are utilized as our cytoplasmic and nuclear 
protein loading controls. A representative blot from this 
experiment is shown. Statistical comparisons were 
performed using a one-way ANOVA, and subsequent 
Newman-Keuls multiple-comparison tests. Data labeled 
with different letters are significantly different from each 
other (p<0.05). 
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preconditioning, suggesting the cytoprotective effect of preconditioning the UPR is not 
modality-dependent. 
Preconditioning the UPR Inhibits Inflammation in the Human Uterine Myocyte In Vitro 
To define the mediators facilitating resistance to the apoptotic consequences of 
CASP3, NFκB activation in the nuclear compartment of the uterine myocyte was 
examined in control (C), preconditioned (P) and non-preconditioned (NP) cells exposed 
to TM or Thaps or vehicle treatment. Cells were collected 0.25, 2, 4 and 24hrs post 
administration of the cytotoxic bolus and compared to vehicle-treated controls. As seen 
in Figure 5A and B, non-preconditioned cells display a robust 5.5 fold activation of NFB 
2hrs post administration of the subsequent damaging stress whereas NFB activation 
remains barely detectable in non-preconditioned cells at all time points examined post the 
lethal stress (0.25, 2, 4, 24hrs). Enzyme linked immunosorbent assays (ELISA) performed 
on control preconditioned and non-preconditioned hTERT-HM cells collected 48hrs post 
TM bolus revealed TNF secretion was suppressed 0.5 fold in the preconditioned cells 
whereas, non-preconditioned cells (Figure 5C) demonstrated a 0.5 fold increase in levels 
compared to non-treated controls. Similar results were found when cells were 
preconditioned and stressed with Thaps (Figure 5D). NFB activation and TNF secretion 
was increased 19 fold 2hrs post and 4 fold 48hrs post exposure to the cytotoxic stress 
(Figure 5E and F) respectively, within non-preconditioned cells and remained inactive 
within the preconditioned cells. 
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Figure 5. UPR preconditioning ablates NFB activation in the hTERT-HM uterine myocyte. (A, B, D, E) 
Activation of NFκB was significantly increased in both TM and Thaps non-preconditioned (NP) cells and 
reduced to barely detectable levels in preconditioned (P) cells 2hrs post administration of a cytotoxic dose 
of TM/Thaps. (C, F) TNFα secretion was also reduced in P versus NP cells. A representative blot from each 
experiment is shown. NCOA3 is utilized as nuclear protein loading control. Statistical comparisons were 
performed using one-way ANOVA, and subsequent Newman-Keuls multiple-comparison tests. Data 
labeled with different letters are significantly different from each other (p<0.05). 
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Preconditioning Downregulates UPR Activated Apoptotic Signaling In Vitro 
We quantified stress-mediated activation of the UPR pro-survival (spliced XBP1 
(XBP1s) and phospho-elongation initiation factor 2 (p-eIF2α)) and pro-apoptotic 
(activating transcription factor 4 (ATF4) and dna damage inducible transcript 3 
(GADD153)) signaling pathways by immunoblotting immediately following the application 
of the TM or Thaps bolus (0.25, 2, 4, or 24hrs post bolus) in control, preconditioned and 
non-preconditioned hTERT-HM cells (Figure 6A and F). p-eIF2 α levels remain 
unchanged between preconditioned and non-preconditioned cells, TM or Thaps (Figure 
6B and G). XBP-1s levels were suppressed 4hrs post bolus in TM-preconditioned cells 
(Figure 6C), whereas no change in expression is observed between Thaps-
preconditioned and non-preconditioned cells (Figure 6H). Pro-apoptotic signaling 
pathways in contrast, were significantly downregulated in both TM and Thaps 
preconditioned versus non-preconditioned cells.  A 2 fold decrease in ATF4 at 24hrs 
(Figure 6D) and a 7 and 5 fold reduction of GADD153 at 4 and 24hrs respectively (Figure 
6E) was observed in TM preconditioned cells. Similarly, a 0.5 fold reduction in ATF4 at 
24hrs (Figure 6I) and a 2 fold reduction in GADD153 at 2, 4 and 24hrs (Fig. 6J) was 
observed in Thaps-preconditioned compared to non-preconditioned hTERT-HM cells. 
Anti-apoptotic factors XIAP and MCL1 were preferentially maintained in TM 
preconditioned cells (Figure 7). 
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Figure 6. UPR 
preconditioning differentially 
regulates activation of the pro 
and anti apoptotic arms of the 
UPR in the hTERT-HM 
uterine myocyte (A-J).  TM 
(A) or Thaps (F) mediated 
preconditioning blocked 
activation of the pro-apoptotic 
arms of the UPR with ATF4 
(D, I) and GADD153 (E, J) 
and TM preconditioning 
maintained activation of the 
anti-apoptotic arm of the UPR 
with XBP1s (C) significantly 
upregulated in preconditioned 
(P) versus non-
preconditioned (NP) cells 
post administration of a 
cytotoxic dose of TM/Thaps. 
No changes in XBP1s  (H) 
upon Thaps treatment, and p-
eIF2 (B, G) upon TM and 
Thaps treatment. PDIA2 and 
NCOA3 are utilized as 
cytoplasmic and nuclear 
protein loading controls. A 
representative blot from each 
experiment is shown. 
Statistical comparisons were 
performed using one-way 
ANOVA, and subsequent 
Newman-Keuls multiple-
comparison tests. *p<0.05, 
**p<0.01 and ***p<0.001 
compared with controls. 
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Figure 7. Increased maintenance of pro-survival molecules with TM mediated UPR preconditioning in the 
human uterine myocyte. (A) Pro-survival molecules XIAP and Mcl-1 were analyzed 48hrs post TM-bolus in 
non-preconditioned (NP), TM-preconditioned cells given a 48hr recovery period (P) and vehicle treated 
controls (C). (B) and (C) Both Mcl-1 and XIAP were significantly elevated in TM-preconditioned cells when 
compared to non-preconditioned myocytes. (D) The experiment was repeated using Thaps as a 
preconditioning and bolus stimuli. (E) and (F) Neither Mcl-1 or XIAP were significantly different between 
Thaps-preconditioned and non-preconditioned myocytes. A representative blot from this experiment is 
shown. PDIA2 is utilized as our cytoplasmic loading control. Statistical comparisons were done using a one-
tailed student t-tests. Data labeled with different letters are significantly different from each other (p<0.05). 
Discussion 
We have previously demonstrated the critical role that the UPR plays in CASP3 
activation within the uterine compartment during pregnancy.350 As recent studies have 
demonstrated preconditioning events, such as ischemia, that lead to the activation of the 
UPR can maintain active CASP3 in a non-apoptotic state following subsequent damaging 
stress, we hypothesis that the act of preconditioning the uterine UPR during pregnancy 
is essential in protecting the pregnant myometrium against a CASP3 mediated apoptotic 
fate. This is important because the loss of non-apoptotic CASP3 tocolytic action within 
the pregnant mouse myometrium initiates the onset of preterm birth.350 Here we utilized 
a preconditioning protocol in which minor amounts of ER stress were given to hTERT-HM 
cells prior to the exposure of a large damaging stress to test the hypothesis UPR 
preconditioning facilitates the maintenance of non-apoptotic CASP3 in myometrial cells. 
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We report for the first time that preconditioning the UPR inhibits uterine myocyte 
apoptosis in the presence of highly abundant levels of active CASP3. To note, UPR 
preconditioning afforded cytoprotection that was independent of the stress modality 
employed and acted to suppress downstream stress-dependent apoptotic pathways 
(ATF4 and GADD153) and inflammatory responses (NFB and TNF release) with a 
dependency on the recovery time given between the preconditioning stress and the 
subsequent cytotoxic bolus. 
In many studies the activation of CASP3 is used as a cellular marker for the 
induction of apoptosis (see Chapter 1 Apoptosis for more detail). In the context of the 
pregnant uterus, we have previously demonstrated that active CASP3 is not participating 
in the initiation of apoptosis and that instead it is functioning in a non-apoptotic state to 
inhibit muscle contractility, as demonstrated in other tissue types such as the heart, 
diaphragm and bladder. In this study, we argue that preconditioning the UPR is one 
mechanism in which the myocyte can capacitate CASP3 activity in the absence of cellular 
apoptosis, allowing for the maintenance of uterine quiescence in a non-apoptotic CASP3 
dependent manner. Prolonged or severe ER stress can mediate both mitochondrial-
dependent and independent apoptosis, and consequently ERSR signaling is implicated 
in many diseases associated with cellular dysfunction and cytotoxicity.414,415 The initial 
signaling responses however, via PERK/eIF2α, IRE1 and ATF6 do not induce cell death 
and instead activate a subset of genes that aid in the restoration of cellular homeostasis, 
as described in Chapter 1 Activation of the Unfolded Protein Response.  To do so, UPR-
activated genes increase chaperone protein expression e.g. GRP78, attenuate protein 
translation and increase ER associated degradation of unfolded proteins.310,314,416 
Multiple in vitro studies have proven that preconditioning the endoplasmic reticulum stress 
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response with minor insults of stress stimulates a protective adaptive UPR promoting 
resistance to the apoptotic processes associated with subsequent, more damaging 
stresses.385,388,417 Many and varied perturbations such as stress mediated inflammation, 
hypoxia and cytotoxins have been demonstrated to successfully induce a preconditioning 
afforded cytoprotection.382,385,418 The most basic of these approaches is to activate the 
UPR by chemically inducing an accumulation of unfolded proteins within the ER.  Two 
small molecules commonly used are Thaps and TM.  Thaps, originally identified as a 
tumor promoting sequiterpene lactone, dysregulates calcium (Ca2+) homeostasis by 
binding and inhibiting the ATP-sensitive Ca2+ pump within the endoplasmic reticulum, 
causing an increase in free cytosolic Ca2+.419 Because Ca2+ binding is an important 
function of multiple ER resident chaperone proteins, decreased ER Ca2+ stores cause an 
accumulation of unfolded proteins in the ER and reduced protein synthesis.420-422 In 
contrast, Tm inhibits N-linked glycosylation that is necessary for the recognition of 
unfolded proteins by ER chaperones, such as GRP78 and calnexin.423 Our in vitro data 
reveals preconditioning of the uterine myocyte UPR with stress (TM or Thaps) promoted 
non-apoptotic CASP3 activation during periods of cellular stress (Figures1 and 4). As can 
be observed in Figure 1, despite equally elevated levels of CASP3 activation (Figure 1C) 
in preconditioned and non-preconditioned cells 48hrs post receiving a bolus (Figure 1), 
the preconditioned cells demonstrated a newly acquired resistance to CASP3 mediated 
apoptotic cell death as indicated by decreased PARP cleavage (Figure 1.D). These data 
show preconditioning the UPR in the uterine myocyte maintains non-apoptotic CASP3, 
suggesting in vivo preconditioning may be the mechanism in which myometrial CASP3 is 
maintained in a non-apoptotic state to fulfill its tocolytic action, inhibiting labor. 
Increased resistance to apoptotic cell death in the preconditioned myocytes was 
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most likely due to the presence of elevated levels of cellular GRP78 prior to delivery of 
the bolus. As seen in Figure 3, the adaptive arms of the ERSR were activated from the 
preconditioning stimuli, whereas pro-apoptotic indices remained the same as controls. In 
the event of ER stress and increased accumulation of unfolded proteins, prophylactic 
increases in the concentration of GRP78 are advantageous for maintaining ER 
homeostasis. In studies examining the cardioprotective effects of stress preconditioning, 
pre-induction of GRP78 has been identified as a key mechanism for affording 
cytoprotection. In support of this claim, Yuan and colleagues demonstrated inhibition of 
GRP78 expression using anti-sense oligonucleotides ablated cardioprotection afforded 
by late hypoxic preconditioning.424 In our preconditioning paradigm, cytoprotection was 
not afforded unless the cells were given a 48hr recovery period between the initial 
stimulus and the bolus. This is like other preconditioning paradigms where a recovery 
period is required for facilitating cytoprotection, such as in ischemic preconditioning. This 
suggests prophylactic GRP78 is not the sole mechanism of afforded cell viability as 
GRP78 levels are substantially increased 24hrs prior to the initial preconditioning 
stimulus.374 Other studies have implicated GRP78 as being only partially responsible for 
preconditioning-mediated cytoprotection. One study by Harama and colleagues 
demonstrated ER stress preconditioning prevented lipopolysaccharide/TNFα induced 
inflammatory responses while decreasing full length GRP78 expression in a time 
dependent manner.392 
In addition to an increase in prophylactic GRP78, we also witnessed suppressed 
activation of the UPR-mediated apoptotic-signaling pathway, ATF4-GADD153 (Figure 6). 
As previously mentioned, the first response to stress through UPR signaling is to initiate 
pro-survival processes, such as p-eIF2 mediated transcriptional inhibition, to promote 
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the return to luminal homeostasis. In case of severe or prolonged stress however, internal 
ribosomal entry site-dependent transcription of ATF4 occurs and the secondary apoptotic 
UPR signaling pathway is activated.425 One of the main mechanisms preconditioning has 
been demonstrated to increase cell viability is through the depression of apoptotic UPR 
signaling.398,426 While testing the effectiveness of LPS-preconditioning in the prevention 
of renal dysfunction and hepatosteatosis, Woo and colleagues demonstrated pre-
activation of toll-like receptors 3 and 4 prior to TM-induced ER stress inhibited GADD153 
expression and reduced apoptosis in splenic macrophage, renal tubule cells and 
hepatocytes. Importantly, pre-activation of the toll-like receptors did not alter the pro-
survival pathways. In our study, we similarly found TM and Thaps-preconditioning 
reduced expression levels of ATF4 and GADD153 without altering pro-survival signaling 
transducers (p-eIF2 and XBP1s) (Figure 6), suggesting one mechanism in which 
preconditioning may be preventing CASP3-dependent apoptosis is through inhibition of 
pro-apoptotic signaling pathways. 
Another pathway significantly linked to UPR-dependent apoptosis is NFB-
mediated inflammatory signaling, as discussed in Chapter 1 The UPR and Inflammation. 
Growing evidence suggests, that the coupling of the ERSR and inflammation is important 
in the pathogenesis of multiple diseases.  In atherosclerosis, the development of plaque 
lesions on the endothelial lining of blood vessels has been linked to activation of the UPR 
and inflammation. With the loading of free cholesterol into ER membranes in circulating 
macrophages, UPR signaling is thought, in part to mediate activation of inflammatory 
transcription factors NFB and janus kinase.427 Further, it has been demonstrated that 
the induction of GADD153, ATF4 and XBP1s is necessary to produce IL-6 and potentially 
other chemokines such as IL-8, CXC-chemokine ligand 2 and 3.428 Similar to 
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atherosclerosis, the cross talk between the ERSR and inflammation is prominent in 
human inflammatory bowel disease. Interestingly, Blumberg and colleagues 
demonstrated the stress of rapid proliferation in paneth cells is sufficient to instigate a 
pro-inflammatory response and that in these same cells the absence of appropriate UPR 
signaling there is a significant induction in apoptotic cell death.391 Interestingly, it has been 
demonstrated that preconditioning the UPR can mitigate UPR-mediated activation of 
inflammatory signaling pathways and subsequent apoptosis, please see Chapter 1 
Preconditioning for more details.  For example, a study by Rao and colleagues recently 
showed preconditioning mice with low-doses of LPS prior to ischemia/reperfusion injury 
in the liver 1) inhibited NFB and downstream inflammatory signaling proteins TNF and 
IL-6, 2) blocked GADD153/CASP3 dependent apoptosis and 3) promoted anti-
inflammatory signaling of IL-10.426 In our studies we also observe that preconditioning the 
UPR in uterine myocytes blocked the activation of NFB and consequently decreased the 
secretion of its downstream target the inflammatory mediator TNF following the delivery 
of the TM bolus (Figure 2B and C).  In the context of pregnancy, the inhibition of premature 
NFB signaling and the resulting downstream inflammatory mediators within the 
myometrium is extremely important as heightened inflammation initiates many processes 
necessary for the induction of labor, as discussed in Chapter 1 Parturition. 
Taken together these data demonstrate that preconditioning the UPR plays a 
critical role in maintaining the uterine myocyte in a CAPS3 positive, non-apoptotic, anti-
inflammatory, pro-survival state in vitro. These findings highlight a potential mechanism 
whereby CASP3 can fulfill its tocolytic function, while avoiding apoptosis in the uterine 
myocyte. Further, they suggest in vivo preconditioning may also be important in 
maintaining quiescence through the inhibition of contractile associated inflammatory 
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signaling pathways, e.g. NFB and TNF. From these studies, it would next be important 
to examine the function of preconditioning in vivo in the pregnant uterus and its potential 
role in the regulation of myometrial quiescence. 
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CHAPTER 3 
Introduction 
In this chapter we will discuss the functional relevance of in vivo preconditioning in 
the maintenance of uterine quiescence. As previously mentioned, our laboratory has 
established that the preservation of non-apoptotic CASP3 activity in the myometrium is 
an integral part of the maintenance of uterine quiescence. Further, I have shown in vitro 
that CASP3 activity in the uterine myocyte can be maintained in a non-apoptotic state 
through preconditioning of the UPR. Current literature has established that throughout a 
normal gestation the uterine compartment is exposed to and must tolerate a variety of 
cellular stresses, i.e. hypoxia, hyperplasia, hypertrophy, hormone fluctuation and 
mechanical stretch, to reach term. Therefore, we hypothesize that in vivo transient 
incremental ER stress insults experienced by the uterus during gestation act to capacitate 
the myometrium to withstand additional subsequent stressors while maintaining the 
tocolytic action of non-apoptotic CASP3, thus preventing premature uterine contractility. 
Beginning with implantation and continuing until labor, the myometrium 
experiences various modalities of stress that have been demonstrated in other organ 
systems to illicit an ERSR.  One of the simplest forms of ER stress that may be 
contributing to this process is a gestationally regulated increase in uterine myocyte protein 
synthesis. In the pregnant rat, immunoblotting for proliferating cell nuclear antigen in 
conjunction with bromodeoxyuridine incorporation assays have shown that significant 
myometrial hyperplasia occurs between gestation days 6-14 and tapers off by E15-16 to 
accommodate the growing fetus.429 While there is no direct evidence linking myometrial 
proliferation to activation of the ERSR, increased protein synthesis leading to an 
accumulation of unfolded protein has been repeatedly demonstrated to upregulate the 
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ERSR.430 During mid-gestation uterine myocytes transition into a hypertrophic state and 
begin to stretch and increase in size, to further accommodate the growing fetus.429 
Unrelated studies, examining hypertrophic zones of the epiphyseal plate in models of 
metaphyseal chondrodysplasia, have demonstrated hypertrophy-dependent activation of 
each canonical ER stress sensors (IRE1α, PERK, and ATF6) further lending evidence 
that myometrial hypertrophy throughout early and mid-gestation causes activation of the 
UPR.431 With increased fetal growth, the myometrium also experiences elevated 
mechanical stretch and subsequent bouts of transient hypoxia.432 Both of which have the 
potential to initiate the ERSR. Finally, prior to the onset of labor the uterine compartment 
experiences a surge in reactive oxygen species and inflammation, which have also been 
demonstrated to activate an ERSR. While it is remains elusive which stress insults 
contribute to the activation of the UPR in utero, it is clear that the myometrium is 
experiencing stress as the ERSR markers XBP1, GADD153, GRP78, and CASP3 are all 
upregulated at different time points of gestation.403 
Herein we tested the hypothesis that appropriate in vivo preconditioning of the 
uterine UPR during pregnancy facilitates the maintenance of non-apoptotic CASP3-
dependent tocolysis and thus is essential for the regulation of gestational length. To do 
so, we utilized a novel pregnant mouse model where downstream stress-mediated UPR 
preconditioning effects were ablated by heightening tolerance to the gestational stresses 
through the administration of the chemical chaperone phenyl butyric acid (PBA). We 
observed increased apoptotic CASP3 action in the stressed-sub-preconditioned uterine 
compartment, resulting in the onset of preterm birth in over 50% of the mice, whereas 
83% of endogenously preconditioned mice delivered at term when exposed to the same 
exogenous stress. Importantly we have discovered the downstream consequences of 
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apoptotic CASP3 action in the uterine compartment to be activation of the inflammatory 
and prostaglandin-signaling cascades normally associated with the onset of term labor. 
Overall these studies these findings represent a paradigm shift in our understanding of 
the regulation of the timing of labor, revealing the critical role endogenous uterine 
preconditioning plays in promoting the maintenance of uterine quiescence to term by 
preventing the premature activation of apoptotic CASP3 within the endometrium, 
inflammatory signaling and thus the onset of luteolysis.  
Materials and Methods 
Animals 
The Institutional Animal Care and Use Committee of Wayne State University 
approved all animal studies. Timed pregnant female CD-1 mice (6-8wks; gestation day 9) 
(Charles River Laboratories, Wilmington, MA) were housed in AALAC-accredited facilities 
according to IACUC guidelines. Accordingly, mice were given a standard pellet diet and 
water ad libitum. 
Tunicamycin and Phenyl Butyric Acid Treatments 
PBA was directly dissolved into phosphate buffered saline (PBS) at pH 8.0 (Santa 
Cruz Biotechnology, Dallas, TX; sc-200652). TM (Calbiochem, San Diego, CA; 
Cat#654380) was initially dissolved in 20μl 10M sodium hydroxide and then suspended 
in PBS, pH 8.0. Sub-preconditioned pregnant CD-1 female mice (E10-15) were 
administered twice-daily intraperitoneal injections (i.p) of 50mg/kg PBA, while 
preconditioned controls were administered PBS. At E16, stressed mice were 
administered 0.2mg/kg TM i.p, while controls were given volume matched PBS. Following 
TM injections, the length of gestation was then monitored and compared between a 
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subset of sub-preconditioned and endogenously preconditioned mice. Uteri, ovaries and 
serum were harvested at E17 in the additional mice. 
Cytosol and Nuclear Protein Fractionation from Tissues 
Cytoplasmic and nuclear protein extracts were prepared from frozen mouse 
tissues by pulverizing the tissues in liquid nitrogen and homogenizing them in ice-cold 
NE1 buffer (10mM Hepes pH 7.5, 10mM MgCl2, 5mM KCl, 0.1% Triton X-100 with 1X 
EDTA-free protease/phosphatase inhibitor mini tablet). The homogenate was then 
centrifuged at 2655 X g, the supernatant was retained as the cytoplasmic protein fraction 
and the pellet was washed in NE1 buffer and suspended in ice-cold NE2 buffer [20mM 
Hepes pH 7.9, 500mM NaCl, 1.5mM MgCl2, 0.2mM EDTA pH 8.0, 25% (vol/vol) glycerol 
with 1X EDTA-free protease/phosphatase inhibitor mini tablet]. The homogenate was 
vortexed for 30sec every 5min and after 1hr, centrifuged at 10,621 X g. The supernatant 
was then retained as the nuclear fraction. Protein estimation was performed using a BCA 
assay, equal amounts of protein were loaded for immunoblotting and PDI and NCOA3 
were utilized as loading controls for the cytoplasmic and nuclear fractions, respectively. 
Immunoblotting and Densitometric Analysis 
Equal amounts of protein were separated via electrophoresis on NuPAGE 4-12% 
gradient precast polyacrylamide gels (Life Technologies, Carlsbad, CA). Proteins were 
transferred onto Hybond-P PVDF membranes (Millipore, Billerica, MA) and blocked for 
1hr at room temperature in 5% non-fat milk prepared in Tris Buffered Saline with 
0.1%Tween-20 (vol/vol). Membranes were incubated with primary antibodies overnight 
at 4°C. Primary antibody concentrations were as follows: GRP78 (1:1000; Cat#3177), Cl 
CASP3 (1:250; Cat#9664), Cl PARP (1:1000; Cat#9541), pNFB (1:500; Cat#3033), 
COX-1 (1:1000; Cat#4841), PDI (1:5000; Cat#3501) and GAPDH (1:1000; Cat#5174) 
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were obtained from Cell Signaling Technologies; iPLA2 (1:1000; Cat#07-169-1) was 
obtained from Millipore; HSD3B2 (1:1000; Cat#80500) was obtained from Abcam; and 
NCOA3 (1:5000; Cat#PA1-845) was obtained from ThermoScientific. Following primary 
incubation, immunoreactivity was detected using horseradish peroxidase-conjugated 
secondary antibodies and visualized using an enhanced-chemiluminescence detection 
system (ThermoScientific, Rockford, IL). Immunoreactive band density was then 
quantified using ImageJ software. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
The level of progesterone (P4) was then measured in pregnant mouse serum using 
an ELISA. Specifically, the P4 ELISA Kit (Alpha Diagnostic International, San Antonio, 
TX, Cat#1955) was performed according to the manufacturer’s instructions and results 
were read via the Molecular Devices, SpectraMax M2 microplate reader. Each sample 
measurement was read in duplicate and the computed averages were taken based on 
the calculated standard curve. 
Terminal Deoxynucleotidyl Transferase dUTP Nicked-End Labeling Assay 
Tissues collected at E17, imbedded in optimal cutting temperature compound 
(Sakura Finetek USA Inc, Torrance, CA) were sectioned (10μm thick), mounted onto 
Superfrost Plus Micro Slides, and stored at -20°C. Sections were removed from storage 
and fixed in 4% paraformaldehyde for 15 minutes. Additionally, sectioned paraffin wax 
imbedded tissues were de-paraffinized and rehydrated and treated with 10g/ml 
Proteinase K for 15min at 37°C. Analysis of apoptosis in all tissues was quantified using 
the In Situ Cell Death Detection Kit, AP (Roche, Indianapolis, IN, Cat#11684809910) 
according to the manufacturer’s instructions. 
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Small Molecule Liquid Chromatography-Mass Spectrometry Analysis 
Dissected uterine tissues separated into endometrial and myometrial 
compartments, flash frozen in liquid nitrogen, were removed from -80°C storage and 
tissue weights were immediately recorded. Samples were then suspended in 1ml cold 
PBS pH 7.4, homogenized via bead homogenization, and centrifuged at 10,621 x g for 
10 minutes. Supernatants were removed, and protein concentrations were determined 
using a BCA assay. Equal volume of protein (850μl) was then spiked with 5ng of internal 
standards suspended in 15% methanol dissolved in water (150μl), mixed thoroughly and 
purified using a C18 solid-phase cartridges. Prior to applying the sample, the cartridges 
were first washed with 1ml of 100% methanol followed by 1ml of 15% methanol. After the 
addition of the sample, tubes were rinsed twice with 1ml of PBS and the rinse was passed 
through the cartridges. Subsequently, the cartridges were rinsed with 2ml of hexane, 
vacuum dried for 30sec and proteins were eluted with 1ml of methanol containing 0.1% 
formic acid. All samples were evaporated to dryness with a gentle stream of nitrogen at 
40°C, residues were re-suspended in 30μl methanol and stored at -20°C until LC-MS 
analysis. Prior to analysis, each sample was further diluted with 30μl 25mM aqueous 
ammonium acetate. Specific methods utilized for liquid chromatography mass 
spectrometry can be referenced in Yoon Park et al. 2014. 
Immunofluorescence 
Tissues collected at E17, embedded in optimal cutting temperature compound 
(OCT) (Sakura Finetek USA Inc, Torrance, CA) were sectioned (10μm thick), mounted 
onto Superfrost Plus Micro Slides, and stored at -20°C. Sections removed from storage 
were fixed in 4% paraformaldehyde for 2 minutes. Fixed sections were incubated with 
primary antibody overnight at 4°C and examined for primary immunoreactivity using a 
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conjugated secondary antibody. The primary and secondary antibody concentrations 
were as follows: F4/80+ (1:250, Abcam, Cat#ab6640) diluted in PBS and detected by 
secondary goat anti-rat antibody conjugated to Alexa Fluor 488 (1:500, Abcam, 
Cat#150157), NFB (1:400, Cell Signaling Technologies, Cat#8242) diluted in PBS and 
detected by secondary donkey anti-rabbit antibody conjugated to Cy3 (1:500, Jackson 
Immunoresearch, Cat#711-165-152). 
Statistical Analysis 
All data represent at least three individual experiments performed in triplicate. For 
the direct comparison of three or more conditions a one-way analysis of variance was 
performed, with multiple comparisons analyzed via Newmans-Keuls multiple 
comparisons test. When directly comparing two conditions a student-t test was 
performed. All comparisons were considered significant with p-values less than 0.05. 
Results 
Pregnant Mice Display Increased Incidence of Preterm Birth when Exposed to a Minor 
Exogenous Stress 
We examined the timing of labor following a minor stress (0.2mg/kg TM) on 
gestation day 16 in a sub-preconditioned (TM+PBA) and an endogenously preconditioned 
(TM) population of timed pregnant mice (n=7 and n=6, respectively). The effects of PBA 
and vehicle (Con) alone were also examined (n=3 for both groups). Using live-video 
recording, we observed that 57% of TM+PBA mice (4/7) delivered preterm, with an 
average delivery time of 30hrs post TM administration (Table 1). In contrast, the mice that 
experienced normal endogenous gestational stressors prior to the delivery of a minor 
stress (TM) had a preterm birth rate of 17% (Table 1). No effects were observed in the 
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timing of birth from the mice administered PBA alone (3/3), similar to Con mice (3/3) which 
delivered at term on E19 (Table 1). All animals that delivered at term resulted in live pups. 
Table 1. The Effects of In Vivo Preconditioning on Uterine Quiescence 
 Term Birth Preterm Birth Percent Preterm 
Control 3 0 0% 
PBA 3 0 0% 
TM+PBA 4 3 57% 
TM 1 5 17% 
 
Preconditioning Suppresses Pregnant Uterine Inflammatory Signaling In Vivo 
We examined components of the inflammatory signaling cascade in the uteri 
collected from Con, PBA, TM+PBA and TM treated pregnant mice at E17 prior to the 
onset of term and preterm birth. Uterine NFB activation, macrophage infiltration, COX-1 
and COX-2 levels were examined (Figure 8). Premature uterine activation of NFB occurs 
in the stressed-sub-preconditioned (TM+PBA) mice prior to the onset of labor; a 2.7 fold 
increase in p65 nuclear translocation was observed when compared to control animals 
(Figure 8A). Immunohistochemistry validated the observed increased NFB activation in 
stressed-sub-preconditioned mice and revealed the increase in activity occurred within 
both the myometrial and endometrial compartments (Figure 9A and B, respectively). This 
is demonstrated by enhanced nuclear translocation of NFB within the stressed-sub-
preconditioned mice compared to controls. While COX-2 levels remained undetectable, 
COX-1 levels significantly increased over 3 fold in the stressed-sub-preconditioned uteri 
(TM+PBA) (Figure 8B) in comparison to Con uteri.  Macrophage infiltration of the uterine 
tissue of the Con, PBA, TM+PBA and TM treated mice was examined by F4/80 
immunofluorescence analysis and a greater than 10 fold increase in the number of 
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macrophages was observed in the TM+PBA uteri that consequently undergo preterm 
birth in comparison to endogenously preconditioned uteri (TM and Con) and PBA controls 
(Figure 8C).  
 
Figure 8. Endogenous preconditioning prevents premature activation of uterine inflammation in the 
pregnant mouse. Uteri collected from vehicle treated (Con), sub-preconditioned (PBA), exogenously 
stressed sub-preconditioned (TM+PBA) and exogenously stressed preconditioned (TM) mice on E17 prior 
to the onset of preterm or term birth were examined for (A) NFB, (B) COX and (C) macrophage infiltration. 
Increased NFκB activation, COX1 expression and elevated levels of macrophage infiltration were isolated 
to the TM+PBA uteri. PDIA2 and GAPDH are utilized as cytoplasmic loading controls. A representative blot 
or immunohistochemical image from each experiment is shown. Statistical comparisons were performed 
using one-way ANOVA, and subsequent Newman-Keuls multiple-comparison tests. Data labeled with 
different letters are significantly different from each other (p<0.05). 
 
78 
 
 
Figure 9. Endogenous preconditioning prevents premature activation of NFκB in the myometrial and 
endometrial compartments of the pregnant mouse. Uteri collected from vehicle treated (Con), sub-
preconditioned (PBA), exogenously stressed sub-preconditioned (TM+PBA) and exogenously stressed 
preconditioned (TM) mice on E17 prior to the onset of preterm or term birth were examined for activation 
of NFB in the (A) myometrium and (B) endometrial compartments via immunohistochemistry. Heightened 
NFκB activation was observed in both the (A) myometrium and (B) endometrium of the TM+PBA uteri. 
 
Preconditioning Suppresses Apoptotic CASP3 Activity in the Pregnant Uterus In Vivo 
Uteri isolated from Con, PBA, TM+PBA and TM mice were examined prior to the 
onset of term or preterm labor at E17 by immunoblotting for CASP3 activation. Levels of 
CASP3 activation were not significantly changed between the 4 groups examined (Figure 
10A). However, the stressed-sub-preconditioned uteri (TM+PBA) demonstrate increased 
incidence of apoptotic CASP3 activation as indicated by a 4.6 fold increase in the levels 
of uterine PARP cleavage (Figure 10B) when compared to endogenously preconditioned 
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(TM and Con) and PBA controls uteri. Positive terminal deoxynucleotidyl transferase 
dUTP nicked-end labeling (TUNEL) staining in the sub-preconditioned uteri isolated from 
the endometrial compartment, but not endogenously preconditioned (TM and Con) and 
PBA controls uteri validated these results (Figure 10C). 
 
Figure 10. Endogenous preconditioning facilitates the maintenance of non-apoptotic CASP3 and 
suppresses iPLA2 activation in the pregnant mouse uterus. Uteri collected from vehicle treated (Con), sub-
preconditioned (PBA), exogenously stressed sub-preconditioned (TM+PBA) and exogenously stressed 
preconditioned (TM) mice on E17 prior to the onset of preterm and term birth were examined for (A) active 
Cl CASP3. (B) Cl PARP and (C) TUNEL staining were used as a measure of apoptotic cell death. iPLA2t 
levels as an indirect measure of iPLA2 activation (D).  Cl CASP3 levels remained unchanged across all 4 
groups examined however increased Cl PARP and TUNEL activity and decreased levels of the inactive 
iPLA2t were isolated to the TM+PBA treated mice.  (E) In the hTERT-HM cells the cleaved active 
monomeric form of iPLA2 (iPLA2cm) was elevated in a relative manner to the levels of apoptotic CASP3 
present in the preconditioned and non-preconditioned cells (Fig. 1A). A representative blot or image from 
each experiment is shown. PDIA2 and NCOA3 are utilized as cytoplasmic and nuclear protein loading 
controls. Statistical comparisons were performed using one-way ANOVA, and subsequent Newman-Keuls 
multiple-comparison tests. Data labeled with different letters are significantly different from each other 
(p<0.05). 
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As CASP3 has been demonstrated to activate calcium-independent 
phospholipase A2 (iPLA2), we further examined iPLA2 expression in the presence or 
absence of preconditioning in vivo and in vitro via immunoblotting (Figure 10). We 
observed a 2 fold decline in the homotetromeric non-active form of iPLA2 (Figure 10D) in 
the apoptotic CASP3 positive (Figure 10A and B) TM+PBA uteri in comparison to the Con 
and PBA treated uteri. In the hTERT-HM we were able to detect the cleaved active form 
of iPLA2 and observed a 2 fold increase (Figure 10E) isolated to the non-preconditioned 
cells which also display elevated levels of apoptotic CASP3 as indicated by the pattern of 
PARP cleavage in Figure 1A. 
Preconditioning Prevents Premature Prostaglandin (PG) Production 
Uteri isolated from endogenously preconditioned (Con), sub-preconditioned 
(PBA), stressed-sub-preconditioned (TM+PBA) and stressed-endogenously 
preconditioned (TM) containing both the endometrial and myometrial compartment were 
mice examined at E17 for prostaglandin production utilizing targeted-small molecule liquid 
chromatography and tandem mass spectrometry. Significantly elevated levels of PGE2, 
PGE1 and PGD3 were isolated to the sub-preconditioned mice exposed to a minor 
exogenous stress (TM+PBA) (Figure 11A, B and D). Furthermore, downstream by-
products of arachidonic acid metabolism, e.g. 11-HETE and 13-HODE, were also 
significantly elevated in sub-preconditioned mice compared to preconditioned controls 
(Figure 12). As apoptotic CASP3, as measured by TUNEL, and presumably iPLA2 
activity, is contained within the endometrial compartment, we next further examined 
prostaglandin production specifically within endometrial and myometrial tissue collected 
from TM+PBA and Con mice on E17. Results demonstrated elevated prostaglandin 
synthesis (i.e. PGE2, PGD3 and PGA2) within the endometrium of sub-preconditioned 
81 
 
stressed mice (TM+PBA) compared to the myometrial compartment (Figure 13). These 
differences do not appear between the control mice, suggesting CASP3 must be in an 
apoptotic state to induce iPLA2-dependent increases in prostaglandin production. 
 
Figure 11. Preconditioning facilitates the suppression of prostaglandin synthesis thereby preventing 
premature luteolysis and P4 withdrawal. Uteri collected from vehicle treated (Con), sub-preconditioned 
(PBA), exogenously stressed sub-preconditioned (TM+PBA) and exogenously stressed preconditioned 
(TM) mice on E17 prior to the onset of preterm and term birth were examined for prostaglandin production. 
Significantly elevated levels of (A) PGE1, (B) PGE2 and (D) PGD3 were isolated to TM+PBA uteri. (E) 
Ovarian HSD3B2 and (F) serum P4 levels were significantly decreased in the TM+PBA treated mice. A 
representative blot from each experiment is shown. PDIA2 is utilized as cytoplasmic protein loading control. 
Statistical comparisons were performed using one-way ANOVA, subsequent Newman-Keuls multiple-
comparison tests and student-t test. *p≤0.05 and **p≤0.01 compared with controls. 
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Figure 12. UPR Preconditioning in vivo suppresses local uterine prostaglandin production. Uteri collected 
from vehicle treated (Con), sub-preconditioned (PBA), exogenously stressed sub-preconditioned 
(TM+PBA) and vehicle treated (TM) mice on E17 prior to the onset of preterm and term birth, were examined 
for prostaglandin levels. Significantly elevated levels of PGE1, PGE2, PGD3 were isolated to the sub-
preconditioned mice exposed to a minor exogenous stress (TM+PBA). Further, downstream products of 
arachidonic acid metabolism were also elevated in stressed-sub-preconditioned mice compared to 
preconditioned control. 
 
 
Figure 13. Premature apoptotic CASP3 in the endometrium increases prostaglandin synthesis. Myometrial 
(Myo) and endometrial (Endo) tissue collected separately from exogenously stressed sub-preconditioned 
(TM+PBA) and control (Con) mice on E17 prior to the onset of preterm and term birth were examined for 
prostaglandin production. Concentrations of PGE2 and PGD3 were significantly elevated in the Endo 
isolated from TM+PBA uteri. Statistical comparisons were performed between Myo and Endo samples 
using a student-t test. *p≤0.05 and **p≤0.01 compared with controls. 
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Preconditioning Prevents Premature Luteolysis and P4 Withdrawal 
Ovaries collected from Con, PBA, TM+PBA and TM treated pregnant mice on E17 
were analyzed for HSD3B2, which declines with the onset of luteolysis, as discussed in 
Chapter 1 Luteolysis and Progesterone Decline in Lower Mammalian Species. As seen 
in Figure 11E, there was a significant reduction (2.2 fold) in HSD3B2 expression in the 
ovaries of the TM+PBA mice in comparison to Con, PBA and TM ovaries. To validate pre-
mature luteolysis in TM+PBA pregnant mice, serum collected on E17 from each cohort of 
mice was analyzed with ELISA for circulating P4 levels. As observed in the TM+PBA mice 
that undergo preterm delivery (Table 1), there was a significant decline (2.4 fold) in 
circulating P4 levels in comparison to Con, PBA and TM treated mice (Figure 11F). 
Discussion 
Our laboratory, as well as others has proven biological preconditioning to be viable 
mechanism for the maintenance of non-apoptotic CASP3. As CASP3 tocolysis plays an 
integral role in inhibiting myometrial contractility in the absence of apoptosis, we 
hypothesize that endogenous cellular stress throughout the course of a normal pregnancy 
is acting in a preconditioning-like manner to support its non-apoptotic action. In this aim 
we demonstrate that appropriate preconditioning of the uterine UPR during pregnancy 
promotes prolonged uterine myocyte quiescence through the suppression of 
inflammation and apoptotic CASP3. In turn, we demonstrate that apoptotic CASP3 
activation in the sub-preconditioned stressed mice mediates activation of two 
interdependent signaling pathways, the inflammatory and iPLA2-prostaglandin signaling 
cascade leading to a significant increase in the proportion of mice that delivered preterm. 
Overall this work shows that appropriate UPR preconditioning within the pregnant uterus 
prevents early onset activation of the normal signaling cascades associated with normal 
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term labor, e.g. apoptotic CASP3-inducted iPLA2/prostaglandin signaling, to inhibit 
premature luteolysis and preterm labor. Thus, we propose pregnant women may be 
placed at increased risk for precocious apoptotic CASP3 activation and a heightened 
incidence of preterm birth in the absence of appropriate preconditioning. 
Our previous in vitro studies revealed UPR preconditioning facilitates the 
maintenance of non-apoptotic CASP3 in uterine myocytes. To test whether stress across 
gestation preconditions the uterine myocyte to capacitate the tocolytic function of CASP3 
in its non-apoptotic state, we removed the downstream action of endogenous 
preconditioning stimuli by alleviating the ER protein load with reoccurring treatments the 
chemical chaperone PBA. Herein we found the absence of appropriate UPR 
preconditioning across gestation placed stressed-sub-preconditioned pregnant mice 
(TM+PBA) at an increased risk of preterm birth (57%) in comparison to mice that 
experienced normal endogenous preconditioning prior to the delivery of a minor 
exogenous stress (TM), which displayed a preterm birth rate of only 17% (Table 1). As 
anticipated, these results suggest the preconditioning-action of endogenous pregnancy 
related stress regulates gestational length and is necessary for the maintenance of 
uterine quiescence. As non-apoptotic CASP3 action has previously been demonstrated 
to maintain quiescence, we looked to characterize the state of CASP3 in our sub-
preconditioned (TM+PBA) and preconditioned (TM) stressed mice. Analysis of CASP3-
dependent apoptosis and activity in the pregnant uterus reveal preconditioning protects 
the endogenously stressed uterine compartment from undergoing a precocious apoptotic 
CASP3 mediated cell death. While uterine CASP3 activation remained unmodified across 
treatments (Figure 10A), the stressed-sub-preconditioned mice (TM+PBA) displayed 
increased uterine apoptotic CASP3 as indicated by both increased PARP cleavage 
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(Figure 10B) and elevated TUNEL staining, like that observed in laboring tissue on E19. 
Importantly, apoptotic CASP3 action was observed primarily within the endometrial 
compartment (Figure 10C), similar to our previous studies demonstrating complete 
avoidance of myometrial apoptosis prior to labor and post-partum.433 
As the endometrial compartment is non-apoptotic prior to the induction of labor, as 
seen in Con, PBA and TM stressed mice we next looked to identify the role of apoptotic 
CASP3 found within the endometrium of stressed-sub-preconditioned mice. It has 
previously been established that CASP3 activity is a critical upstream component in 
prostaglandin production through cleavage and activation of iPLA2 allowing the release 
of free arachidonic acid to be converted into prostaglandins in a COX1/2 and NFB 
dependent manner, as discussed previously in Chapter 1 Luteolysis and Progesterone 
Decline in Lower Mammalian Species and observed in Figure 10.434,435 Specifically, iPLA2 
exists in three separate states 1) an inactive tetrameric form that is approximately 350kD, 
2) an active 72kD monomeric form and 2) a highly active truncated form weighing roughly 
25kD.436 Within the active monomeric form there are multiple putative CASP3 cleave 
motifs, in which CASP3 targets and cleaves, resulting in truncated iPLA2 that has 
increased activity compared to monomeric iPLA2.436 Interestingly, a study by Huang and 
colleagues in breast cancer cells (4T1) demonstrated that only apoptotic CASP3 action 
was sufficient for the activation of iPLA2-induced prostaglandin production.348 If cells were 
not actively undergoing apoptosis or lacking iPLA2 no changes were observed in 
prostaglandin signaling.  The production of uterine prostaglandins is an extremely 
important process in the induction of labor, as prostaglandin signaling 1) stimulates 
luteolysis resulting in the decline in circulating progesterone and 2) increases intracellular 
calcium levels in the myocyte necessary for uterine contraction, as described in Chapter 
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1 Smooth Muscle Contraction. Interestingly, this study reveals that apoptotic CASP3 
activity is required for appropriate initiation of prostaglandin synthesis while non-apoptotic 
CASP3 though active is unable to do so. Upon apoptotic CASP3 activation (TM+PBA) we 
observed decreased levels of the inactive uterine iPLA2 in vivo (Figure 10C, D).  In vitro 
the cleaved active form of iPLA2 was readily detectable (Figure 10E) and found to be 
significantly upregulated in the presence of apoptotic CASP3 and reduced in the presence 
of non-apoptotic CASP3 (48hr P versus NP Figure 1A). As iPLA2 functions to increase 
the concentration of free arachidonic acid, these data suggest activation of apoptotic 
CASP3 should increase prostaglandin synthesis. Subsequently, we observed 
concomitant to increased apoptotic CASP3 action within the endometrium of stress-sub-
preconditioned mice, increased prostaglandin signaling within the endometrial 
compartment compared to the non-apoptotic CASP3 positive myometrial compartment 
(Figure 13). 
Typically, increased uterine inflammatory and prostaglandin signaling herald the 
end of gestation and are normally associated with the onset of labor in both human and 
mouse.437 Specifically, NFB-dependent activation of COX1/2 leads to increased 
prostaglandin synthesis and thus enhanced uterotonic sensitivity. In preterm and term 
pregnancies alike, activation of NFB is observed prior to the onset of labor.438 Our 
previous in vitro data suggest that the lack of UPR preconditioning allows for precious 
activation of inflammatory signaling (Figure 5). Further, multiple studies examining 
inflammation-derived diseases have demonstrated that preconditioning can abrogate 
stress-induced inflammatory signaling. In a study analyzing the use of heat 
preconditioning for the protection of kidney tubules against ischemia /reperfusion injury in 
mice, preconditioning was found to significantly blunt the activation of NFB through the 
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inhibition of IB kinase and inhibit tubular cell apoptosis.439 Similarly, Zhang and 
colleagues demonstrate ER stress preconditioning reduces TNF-dependent vascular 
leakage in the mouse retina. Based on in vitro studies, they postulate the mechanism of 
TNF inhibition is likely inhibition of NFB activation. In this study we observed that 
appropriate endogenous preconditioning helps maintain the uterus’ capacity to suppress 
inflammatory signaling cascades late in gestation. Specifically, in Figure 8A both the 
myometrium and endometrium of the TM+PBA mice demonstrated significantly elevated 
levels of NFB activation compared to the uteri of preconditioned controls (Figures 8A 
and 9). As the result of increased NFB activation, uteri from sub-preconditioned stressed 
mice were also found to have increased COX1 expression and macrophage infiltration, 
demonstrating an overall heightened inflammation (Figure 8B and C). Subsequently, 
heightened inflammation and augmented NFB-dependent increases in COX1 
expression resulted in increased prostaglandin production, allowing for the conversion of 
free arachidonic acid into PGG2 and subsequently PGH2 in stressed-sub-preconditioned 
mice (TM+PBA mice) (Figure 12). Importantly, precocious prostaglandin production 
(Figure 11) within the TM+PBA mice was found to trigger premature luteolysis as 
evidenced by decreased ovarian HSD3B2 (Figure 11E).440 Consequently, luteolysis 
decreased circulating P4 levels (Figure 11F), which lead to the onset of preterm birth 
within the stressed-sub-preconditioned (TM+PBA) mice (Table 1). 
Overall these data demonstrate that normal endogenous uterine preconditioning, 
acting to suppress premature apoptotic CASP3 activation and inflammation, is for the first 
time placed upstream of regulating the timing of normal parturition by actively preventing 
the well-established endogenous uterotonic signaling cascades such as prostaglandin 
synthesis, luteolysis and consequently P4 withdrawal that herald the onset of normal term 
88 
 
labor in the pregnant mouse. These findings are critical for the future advancement of 
tocolytic therapies, as they provide a solid foundation for the mechanism in which non-
apoptotic CASP3 can fulfill its tocolytic function in the uterine myocyte in the absence of 
myometrial apoptosis and how apoptotic CASP3 is associated with the onset of normal 
signaling cascades that result in term labor, which may be being altered in the context of 
preterm birth. 
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CHAPTER 4 
Introduction  
One mechanism in which effective remote preconditioning occurs is through the 
dissemination of a protective signal with the secretion of a unique paracrine or endocrine 
secretome from cells experiencing the original prophylactic stress.396 It is well 
characterized that cells of many varieties respond to stress by the secretion of a unique 
secretome.441-443 In the pregnant mouse model, we have demonstrated that 
preconditioning-like stress events that activate the UPR and are experienced by the 
pregnant uterus across gestation are critical for maintaining non-apoptotic CASP3-
dependent tocolysis and inhibition of local uterine inflammation. Separate studies 
examining the function of the UPR-generated secretome have found secretory factors 
such as GRP78 can inhibit systemic inflammation though the modulation of circulating 
peripheral mononuclear cells. Thus, we propose preconditioning-like events result in the 
generation of a novel preconditioned uterine secretome, which acts to propagate the 
tocolytic phenotype in an endocrine and paracrine manner. In this aim we looked to 1) 
characterize the stress-mediated myometrial secretome and 2) elucidate the 
physiological function of UPR-mediated protein secretion during normal and pathological 
pregnancies. 
Preeclampsia is a common cardiovascular disease distinguished by the onset 
gestational hypertension that affects approximately 3-8% of pregnancies and remains one 
of the leading cause of maternal death in the United States.444 Women affected by 
preeclampsia are at risk for intracerebral hemorrhage, placental abruption, and 
intrauterine death.445 Additionally, babies born from preeclamptic pregnancies have an 
increased chance of intrauterine growth retardation.445 Clinically, the major diagnostic 
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symptom associated with preeclampsia in humans is an increased mean arterial pressure 
(MAP) greater than 140/90mmHg, as seen with high peripheral vascular resistance and 
decreased cardiac output.446 Along with increased MAP, women with preeclampsia also 
frequently present with increased proteinuria, peripheral edema and liver 
dysfunction.446,447 It has been long speculated that preeclampsia is initiated by placental 
stress-mediated inflammation leading to endothelial dysfunctional, which further results 
in improper spiral artery invasion into the uterus, increased maternal peripheral resistance 
and a further decline in perfusion pressure of the placenta.448,449 More specifically, 
placental ischemia in preeclamptic pregnancies increases the activation of the UPR within 
the placenta of preeclamptic compared to normal pregnancies.450,451 In conjunction with 
increased levels of oxidative stress, also found in the placenta during preeclampsia 
pregnancies, ER stress augments the production and secretion of placental inflammatory 
cytokines, such as TNFα, IL-1,IL-6 and IL-10, 2).452 Placental cytokines subsequently 
increase 1) systemic activation of granulocytes and monocytes, 3) circulating reactive 
oxygen species 3) and diminished concentrations of circulating vascular endothelial 
growth factor which is all thought to contribute to maternal endothelial damage.449 
Moreover, an overall shift in the inflammatory cytokines within the extracellular milieu 
drives polarization of decidual macrophages into an M1 or inflammatory state further 
promoting trophoblast cell death and endothelial dysfunction.453 While there are limited 
studies examining the role of ER stress in endothelial damage in the context of 
preeclampsia, it has been extensively studied and identify as an important component in 
atherogenesis.454,455 In turn endothelial dysfunction results in inappropriate spiral artery 
remodeling and thus poor placentation during the first half of pregnancy and manifests as 
the outward clinical symptoms listed above during the second half of the pregnancy.456,457 
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Additionally, the proteomic profile of urine from women with preeclampsia identified 
differential secretion of many proteins associated with UPR protein compared to normal 
controls.458 Interestingly, women who smoke prior to and during their pregnancies 1) have 
a decreased risk of developing preeclampsia and 2) tend to have less severe symptoms 
when developing preeclampsia.472 As smoking acts as a transient hypoxic stress, 
primarily to the lungs, we suspect smoking may be acting in a remote preconditioning-like 
manner to increase the tolerance of the maternal vasculature and potentially the placenta 
to increased ER stress, as seen with preeclampsia. Overall, preeclampsia can be 
characterized by precocious activation of the ERSR within placenta that result in 
heightened systemic inflammation and subsequently the onset of endothelial dysfunction 
and reduced placental perfusion. 
The secretion of a signature set of proteins following cellular insults, such as 
inflammatory cytokines or ER stress, is a primitive form of cell-to-cell communication that 
has been demonstrated to provide prophylactic cellular adaption in a paracrine and 
endocrine manner. Defining discrete clusters of proteins secreted from cells during 
specific normal and physiological states has become a useful for the discovery of 
circulating biomarkers, as well as the development of novel therapeutics.441,459 A simple 
was to characterize a novel secretome for the first time is to utilize in vitro cell culture 
together with high-throughput protein quantification methods like liquid chromatography 
tandem mass spectrometry (LC/MS/MS).  One caveat with this method however, is that 
fetal bovine serum which is typically necessary to sustain cell viability in culture, contains 
an abundant level of innate proteins that can act to mask the unknown secretome or 
inhibit the identification of proteins being secreted from the cell type of interest. To resolve 
this issue protein labeling techniques such as stable isotope amino acid labeling in culture 
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(SILAC), allow for selective targeted protein identification.460 As many amino acids have 
more than one isotope present, it is possible when using SILAC to directly quantify and 
compare differences in secreted protein concentrations between two or more distinct 
protein sets.461 Utilizing SILAC techniques, Gronburg and colleague distinguished a 
unique set of 145 proteins secreted from cancerous pancreatic ductal cells, including 
several that had never been associated with pancreatic cancer, that may be effective as 
potential biomarkers for clinicians and early pancreatic cancer screens.442 Of interest, a 
similar study defining the stress-generated secretome in pancreatic islet cells, found the 
secretion of multiple proteins that aid in sustaining adaptive UPR-signaling responses.443 
The propagation of systemic adaptive signaling responses during the process of 
remote preconditioning provides protective cellular responses to a secondary remote 
tissue.394,396 While the mechanisms of remote preconditioning have not been fully 
elucidated, multiple studies suggest the secretion of humoral factors (i.e. proteins, 
peptides, ssRNA or DNA) from the cells being directly conditioned can interact with and 
mount intracellular signaling responses in secondary cells/tissues.330,462 Importantly, 
many times the activation of intracellular signaling responses in remote tissues has been 
proven to be cytoprotective against subsequent stresses. One of the earliest studies 
demonstrated this, by Przyklenk and colleagues found effluent taken from ischemic 
myocardial tissues was effective in remotely preconditioning naïve myocardial against 
subsequent damaging ischemic events.463 The use of remote ischemic preconditioning 
has since been greatly expanded upon, proving to be effective in protecting additional 
parenchymal tissues as well, including but not limited to the kidneys, lungs and ovaries.464 
In addition to remote ischemic preconditioning, recent studies show targeted UPR 
preconditioning is also effective in affording cytoprotection to remote secondary tissues, 
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as previously discussed in Chapter 1 Remote Preconditioning of the Endoplasmic 
Reticulum Stress Response. Overall, these studies strongly suggest that low dose stress 
can successfully propagate a circulatory signal that induces systemic cellular adaptation. 
In this aim we examined the ability of myometrial cells undergoing active ER stress 
to transmit a distinct UPR-derived secretome and test whether the propagation of the 
secretome has any paracrine and/or endocrine function, particularly in modulating remote 
cellular UPR and systemic inflammation. Initially, the secretome from TM-treated hTERT-
HM cells that were labeled with stable isotope amino acid labeling in culture (SILAC), was 
examined via liquid chromatography tandem mass spectrometry and compared to the 
secretome of non-stressed cells. LC/MS/MS identified over 90 validated secreted 
proteins, which were bone-fide components of the UPR activated uterine myocyte 
secretome. Of interest, the secretion of GRP78 was substantially increased by stress and 
this was validated using ELISA. For preliminary analysis of the bioactivity of the stress-
generated secretome, conditioned media (stress and vehicle conditioned) was incubated 
with a secondary set of naïve hTERT-HM cells and activation of the UPR in the naïve 
hTERT-HM cells was quantified. Results revealed that the UPR mediated secretome 
actively propagated activation of the UPR in the naïve untreated uterine myocytes, as 
observed by increased GRP78, GADD153 and active CASP3. Conclusively, as the 
pathology of preeclampsia has been tightly linked to systemic inflammation stemming 
from exaggerated ER stress within the placenta, we examined UPR proteins within the 
serum of women with and without preeclampsia. As cigarette smoking prior to and during 
pregnancy has been identified as protective against developing preeclampsia, we further 
analyzed differences between serum from women that participated in or refrained from 
cigarette smoking, with or without preeclampsia. Preliminary results suggest serum 
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GRP78 and GADD153 levels are altered in a stress-dependent manner and that 
increased circulating GRP78 may promote maternal anti-inflammatory signaling to 
decrease the risk of preeclampsia. Consequently, we propose that endocrine and/or 
paracrine transmission and propagation of the uterine myocyte UPR allows for local 
uterine myocyte tissue type fidelity and systemic conditioning of the vasculature and 
immune response during pregnancy. 
Methods 
Cell Culture 
For the in vitro cell culture model system we utilized hTERT-HM cells.413 hTERT-
HM cells were cultured in Dulbecco modified Eagle/F12 low glucose media (DMEM-F12) 
(Invitrogen Carlsbad, CA), supplemented with 10% fetal bovine serum (vol/vol) 
(Invitrogen) and antibiotic/antimycotic (10,000 U/ml; Invitrogen), and incubated at 37°C 
with 95% air and 5% CO2. 
Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) 
hTERT-HM cells were grown in DMEM/F12 (Invitrogen) media with 10% (vol/vol) 
dialyzed fetal bovine serum (Invitrogen) in preparation for SILAC and supplemented with 
antibiotic/antimycotic (10,000U/ml; Invitrogen) at 37°C in a 5% CO2 incubator.  Cells were 
then passaged every three days, after reaching 70-80% confluency, for a total of 6 
passages in the SILAC media with heavy labeled arginine and lysine or SILAC media with 
light labeled arginine and lysine (Thermo Scientific, Cat# 1862636). Specifically, heavy 
SILAC media was prepared by combining 500mls DMEM/F12 media with 10% dialyzed 
FBS, antibiotic/antimycotic (10,000U/ml), 50mg of 13C6 L-Lysine-2HCl and 50mg of 13C6 
L-Arginine-HCl. Whereas, light SILAC media was prepared by combining 500mls 
DMEM/F12 media with 10% dialyzed FBS, antibiotic/antimycotic (10,000U/ml), 50mg of 
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L-Lysine-2HCl and 50mg of L-Arginine-HCl. Following 6 passages in SILAC media, it is 
assumed that incorporation of heavy L-lysine and heavy L-arginine should be greater than 
95%.465 Subsequently, the incorporation of the heavy amino acids into newly synthesized 
peptides leads to 6Da mass shift compared to non-labeled peptides, easily picked up with 
LC/MS/MS proteomic analysis.460 
Tunicamycin Treatments and Media Conditioning 
For all in vitro experiments, TM was suspended in 20μl 10M sodium hydroxide and 
brought to a final concentration of 1.0μg/ml in DMEM-12 media with 10% FBS and 
antibiotic/antimycotic. To analyze the UPR-generated secretome, heavy-labeled and 
light-labeled SILAC treated hTERT-HM cells, were treated with 5.0μg/ml TM for 24hrs, 
washed three times and incubated with fresh media. After 24hrs of conditioning, the fresh 
media (TM-CM) containing SILAC-labeled proteins was removed and analyzed via 
LC/MS/MS. Additionally, control media collected after 24hr incubations with heavy-
labeled and light-labeled SILAC treated hTERT-HM cells, was analyzed via LC/MS/MS. 
To analyze the function of the UPR-generated secretome, hTERT-HM cells were 
treated with 5.0μg/ml TM or vehicle (volume matched sodium hydroxide media) for 24hrs, 
washed three times and incubated with fresh media. After 24hrs of conditioning, the fresh 
media (TM-CM or vehicle conditioned control media) was collected for analysis or placed 
on second set of naïve hTERT-HM cells. The second set of naïve hTERT-HM cells were 
collected after 48hrs of incubation with the TM-CM or vehicle conditioned control media. 
To validate UPR propagation was not induced by TM-contamination, hTERT-HM 
cells were treated with 5.0μg/ml TM for 0, 24 or 48hrs. However, in this experiment the 
TM was prepared in media containing 0, 5 or 10% FBS. After TM treatment, hTERT-HM 
were washed three times like normal and incubated with fresh media. After 24hrs of 
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conditioning, the fresh media was placed on a second set of naïve hTERT-HM cells. The 
second set of naïve hTERT-HM cells were collected after 48hrs of incubation with the 0, 
1 or 24hr TM-CM. 
Cytosol and Nuclear Protein Fractionation from Cells 
Cytoplasmic and nuclear protein fractions from hTERT-HM cells were prepared as 
previously mentioned. Initially, cells were rinsed in ice-cold PBS and centrifuged at 956 X 
g. The pellet was re-suspended and evenly homogenized in ice-cold NE1 buffer (10mM 
Hepes pH 7.5, 10mM MgCl2, 5mM KCl, 0.1% Triton X-100 with 1X EDTA-free 
protease/phosphatase inhibitor mini tablet). The homogenate was then centrifuged at 
2655 X g, the supernatant was retained as the cytoplasmic protein fraction and the pellet 
was washed in NE1 buffer and suspended in ice-cold NE2 buffer [20mM Hepes pH 7.9, 
500mM NaCl, 1.5mM MgCl2, 0.2mM EDTA pH 8.0, 25% (vol/vol) glycerol with 1X EDTA-
free protease/phosphatase inhibitor mini tablet]. The homogenate was vortexed for 30sec 
every 5min and after 1hr, centrifuged at 10,621 X g. The supernatant was then retained 
as the nuclear fraction. Protein estimation was performed using a BCA assay, equal 
amounts of protein were loaded for immunoblotting and PDI and NCOA3 were utilized as 
loading controls for the cytoplasmic and nuclear fractions, respectively. 
Immunoblotting and Densitometric Analysis 
Equal amounts of protein were separated via electrophoresis on NuPAGE 4-12% 
gradient precast polyacrylamide gels (Life Technologies, Carlsbad, CA). Proteins were 
transferred onto Hybond-P PVDF membranes (Millipore, Billerica, MA) and blocked for 
1hr at room temperature in 5% non-fat milk prepared in Tris Buffered Saline with 
0.1%Tween-20 (vol/vol). Membranes were incubated with primary antibodies overnight 
at 4°C. Primary antibody concentrations were as follows: GRP78 (1:1000; Cat#3177), Cl 
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CASP3 (1:250; Cat#9664), GADD153 (1:500; Cat#5554), Cl PARP (1:1000; Cat#9541), 
AFT4 (1:500; Cat#11815), p-eIF2α (1:500; Cat#3398), p65 (1:1000; Cat#8242), XIAP 
(1:250; Cat#2042), PDI (1:5000; Cat#3501) and GAPDH (1:1000; Cat#5174) were 
obtained from Cell Signaling Technologies; XBP1s (1:500; Cat#37152) was obtained from 
Abcam; ATF6 (1:500; Cat#24169-1-AP) was obtained from Proteintech; MCL-1 (1:1000; 
Cat#sc-819) was obtained from Santa Cruz Biotechnology, and NCOA3 (1:5000; 
Cat#PA1-845) was obtained from ThermoScientific. Following primary incubation, 
immunoreactivity was detected using horseradish peroxidase-conjugated secondary 
antibodies and visualized using an enhanced-chemiluminescence detection system 
(ThermoScientific, Rockford, IL). Immunoreactive band density was then quantified using 
ImageJ software. 
Liquid Chromatography Tandem Mass Spectrometry 
All SILAC labeled media samples underwent 40% ethanol precipitation for 2hrs, 
followed by 10,000g centrifugation to remove albumin. The heavy and light SILAC labeled 
precipitates were then washed, resuspended in 2% lithium dodecasulfate and subjected 
to high-energy sonification. Protein concentrations were determined utilizing the 
bicinchoninic acid method. Equal amounts of protein from SILAC heavy and light lysates 
were combined, reduced with dithiothreitol and then alkylated with iodoacetamide. SILAC 
samples were initially separated with SDS-PAGE on 10% polyacrylamide gels. Each 
sample lane was divided into 21 fractions and excised from the gel. The protein gels were 
trypsin digested overnight, proteins were eluted from the gel and then solubilized in 0.1% 
formic acid. Subsequent samples underwent reverse phase liquid chromatography using 
an Easy nLC ultra-high-pressure liquid chromatography system (Thermo). Collected 
effluent fractions were then ionized with an ADVANCED Ion Source (Michrom) and 
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introduced into an LTQ-XL linear ion trap mass spectrometer. Peptide concentrations 
were analyzed with Proteome Discover using the Mascot search algorithm and further 
analyzed using MaxQuant. 
Enzyme-Linked Immunosorbent Assay (ELISA) 
The level of GRP78 and GADD153 were measured in serum taken from pregnant 
women who with or without clinically diagnosed preeclampsia, who did or did not 
participate smoke cigarettes while pregnant using an ELISA. Specifically, the GRP78/BiP 
ELISA Kit (Enzo Life Sciences Inc., Farmingdale, NY, Cat# ADI-900-214) and the Human 
DDIT3 ELISA Kit (LifeSpan Biosciences Inc., Seattle, WA, Cat#LS-F11284) were 
performed according to the manufacturer’s instructions and results were read via the 
Molecular Devices, SpectraMax M2 microplate reader. Each sample measurement was 
read in duplicate and the computed averages were taken based on the calculated 
standard curve. 
Statistical Analysis 
All data represent at least three individual experiments performed in triplicate. For 
the direct comparison of three or more conditions a one-way analysis of variance was 
performed, with multiple comparisons analyzed via Newmans-Keuls multiple 
comparisons test. When directly comparing two conditions a student-t test was 
performed. All comparisons were considered significant with p-values less than 0.05. 
Results 
hTERT-HM Cells Generate a Unique Secretome in Response to TM-Dependent 
Activation of the UPR 
To define the myometrial secretome generated by the activation of the UPR, 
hTERT-HM cells first that underwent 6 passages of SILAC treatment to incorporate 
heavy-labeled and light-labeled amino acids (Lysine and Arginine), allowing for targeted 
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detection of heavy-labeled peptides with LC/MS/MS proteomic analysis, in proteins 
exclusively secreted from the cell and not innate to the FBS used for the maintenance of 
cell growth within the media (Figure 14A). SILAC heavy-labeled and light-labeled hTERT- 
HM cells were then exposed to TM (5.0g/ml) for one hour, washed thoroughly with fresh 
media to remove TM contamination and then incubated with fresh media for an additional 
24hrs. The media that had been incubated with TM-treated cells for 24hrs was then 
removed, labeled as TM stressed-conditioned media (TM-CM) and analyzed via 
LC/MS/MS for cell-secreted SILAC-labeled proteins. Additionally, control media collected 
after a 24hr incubation with either naïve SILAC heavy-labeled and light-labeled hTERT-
Figure 14. SILAC-dependent identification and quantification of TM-induced protein secretion in hTERT-
HM cells. (A) Quantitative mass spectrometry workflow in which 24hr TM-CM was collected from heavy-
labeled hTERT-HM cells and 0hr TM-CM (control media) was collected from light-labeled hTERT-HM 
cells, mixed at a 1 to 1 ratio and analyzed using LC/MS/MS. (B) Heat map comparisons of differential 
protein expression in 24hr TM-CM treated hTERT-HM cells and 0hr TM-CM treated hTERT-HM cells. 
Green is representative of higher relative protein expression, whereas red indicates lower relative 
protein expression. 
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HM cells, that had not been previously exposed to TM, was also analyzed via LC/MS/MS 
for cell-secreted SILAC-labeled proteins. LC/MS/MS identified 96 heavy-labeled secreted 
proteins validated in from both TM-CM media and control media, 53 of which were found 
to be upregulated or downregulated by a fold of two or more with TM-treatment (Figure 
14B). UPR activation up-regulated secreted proteins that are largely associated with 
adaptation to pregnancy, anti-inflammatory action and smooth muscle tocolysis (Table 
2). The most upregulated protein is GRP78 (27 fold), has the ability in a cell-free capacity 
to be an act in a pro-survival anti-inflammatory manner, as previously discussed in section 
Extracellular Functions of the Unfolded Protein Response. Stress-dependent secretion of 
GRP78 from the uterine myocyte was further validated in cell culture, utilizing an ELISA 
(Figure 15). Accordingly, UPR action also down-regulates secreted proteins that are 
largely associated with pro-apoptotic signaling and pro-inflammatory response (Table 3). 
For example, biglycan, fibronectin and versican core protein were all down-regulated by 
at least 9 fold and have been identified as pro-inflammatory mediators, which will be 
discussed in more detail in Chapter 2 Discussion. Cell viability assays performed on TM-
treated hTERT-HM cells using Trypan Blue staining revealed negligible membrane 
permeability at the time in which the TM-CM was collected, demonstrating the secretome 
analyzed was not due to TM-mediated cell lysis (Figure 16). 
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Table 2. Proteins with Increased Stress-Induced Secretion 
Swiss-Prot 
accession no. 
Description Control TM treated 
Fold 
change 
P11021 78 kDa glucose-regulated protein  5.47E+07 2.19E+06 24.95 
P04899 
Guanine nucleotide-binding protein G(i) 
subunit -2  
1.63E+06 2.13E+05 7.67 
P23396 40S ribosomal protein 1.91E+06 4.77E+05 3.99 
P29966 Myristoylated alanine-rich C-kinase substrate  6.14E+06 1.61E+06 3.81 
P62081 40S ribosomal protein S7  4.70E+05 1.30E+05 3.61 
O00560 Syntenin-1 1.08E+06 3.07E+05 3.52 
P20594 Atrial natriuretic peptide receptor  2.46E+07 7.70E+06 3.20 
P62987 Ubiquitin-60S ribosomal protein 1.41E+07 4.45E+06 3.16 
Q99880 Histone H2B type 1-L 9.29E+06 3.09E+06 3.01 
Q562R1 -actin-like protein 2  1.24E+07 4.23E+06 2.94 
P09382 Galectin-1  1.46E+07 5.17E+06 2.83 
Q15758 Neutral amino acid transporter B(0)  3.04E+06 1.10E+06 2.75 
P51149 Ras-related protein 8.03E+05 3.52E+05 2.28 
Q9Y696 Chloride intracellular channel protein 4  7.05E+05 3.21E+05 2.20 
Q14019 Coactosin-like protein  6.13E+05 2.94E+05 2.09 
P35579 Myosin-9  9.43E+05 4.75E+05 1.98 
P60033 CD81 antigen  7.54E+06 3.93E+06 1.92 
P68363 Tubulin -1B chain 7.31E+06 4.39E+06 1.67 
P62805 Histone H4  6.25E+06 3.88E+06 1.61 
P61923 Coatomer subunit -1 2.19E+05 1.38E+05 1.59 
 
 
Figure 15. GRP78 is actively secreted from 
uterine myocytes in a stress-dependent 
manner. hTERT-HM cells were treated with 
0, 0.1 or 5.0g/ml TM for 24hrs, washed 
three times and then incubated with fresh 
media for 24hrs (TM-CM). GRP78 
concentrations were then analyzed in 0, 0.1 
and 5.0g/ml TM-CM with an ELISA and 
found to increase in a stress-dependent 
manner. Statistical comparisons were 
performed using one-way ANOVA, 
subsequent Newman-Keuls multiple-
comparison tests and student-t test. *p≤0.05 
and **p≤0.01 compared with controls.  
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Table 3. Proteins with Decreased Stress-Induced Secretion 
Swiss-Prot 
accession no. 
Description Control TM treated Fold change 
Q9Y613 FH1/FH2 domain-containing protein 5.55E+05 4.25E+07 76.58 
P07996 Thrombospondin-1 9.37E+06 6.15E+08 65.64 
P35442 Thrombospondin-2 6.54E+06 4.20E+08 64.22 
P02452 Collagen alpha-1(I) chain  1.77E+07 1.04E+09 58.76 
P02751 Fibronectin  8.45E+07 3.04E+09 35.98 
P21810 Biglycan 7.12E+06 2.45E+08 34.41 
P12110 Collagen alpha-2(VI) chain 2.83E+06 5.98E+07 21.13 
Q76M96 Coiled-coil domain-containing protein 80 7.61E+05 1.39E+07 18.27 
P07093 Glia-derived nexin 2.36E+06 3.37E+07 14.28 
P08123 Collagen -2(I) chain  1.86E+07 2.42E+08 13.01 
P20908 Collagen -1(V) chain  2.82E+06 3.55E+07 12.59 
P12109 Collagen -1(VI) chain 6.99E+06 8.01E+07 11.46 
P24593 Insulin-like growth factor-binding protein 1.08E+06 1.19E+07 11.02 
P13611 Versican core protein 1.36E+06 1.29E+07 9.49 
P05121 Plasminogen activator inhibitor 1 4.27E+07 3.62E+08 8.48 
Q15113 Procollagen C-endopeptidase enhancer 1 5.94E+06 5.03E+07 8.47 
P13639 Elongation factor 2  6.12E+05 4.72E+06 7.71 
P23284 Peptidyl-prolyl cis-trans isomerase B 4.16E+05 2.76E+06 6.63 
P05388 60S acidic ribosomal protein 1.01E+06 5.18E+06 5.13 
Q9Y6C2 EMILIN-1 4.84E+06 2.37E+07 4.90 
 
 
 
 
 
Figure 16. hTERT-HM cell plasma membranes are intact at the time of media collection. No significant 
differences in cell viability were observed between 0hr (control) and 24hr TM-treated normal, light and 
heavy-labeled hTERT-HM cells at the time of TM-CM collection. Statistical comparisons were performed 
using a one-way ANOVA, and subsequent Newman-Keuls multiple-comparison tests. *p≤0.05 and **p≤0.01 
compared with controls. 
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Naïve hTERT-HM Cells Mount an UPR When Exposed to TM Stress-Conditioned Media 
We next examined the ability of the stress-generated secretome to propagate the 
UPR by exposing naïve hTERT-HM cells to TM-CM for 48hrs and immunoblotting for 
activation of the UPR, CASP3 and apoptotic indices. Specifically, conditioned media was 
incubated for 24hrs with hTERT-HM cells that had been directly treated with TM 
(5.0g/ml) for 0, 1, 4 or 24hrs and washed three times, collected and further incubated 
with naïve hTERT-HM cells that had never experienced stress. Our results demonstrate 
that naïve uterine myocytes exposed to 1, 4 and 24hr TM-CM mount an UPR, as seen by 
increased expression of GRP78, GADD153 and CASP3 in cells compared to TM-CM 
controls (Figure 17A). To validate that activation of the UPR is in fact driven by the
  
Figure 17. TM-dependent activation of the 
myometrial UPR generates a unique 
stress-specific secretome. (A) The 
induction of the UPR, CASP3 and 
apoptotic indices were analyzed in hTERT-
HM cells directly treated with 5.0g/ml TM 
for 0, 1, 4 or 24hrs (TM), naïve hTERT-HM 
cells (NT) or naïve hTERT-HM cells 
incubated with TM-CM (0, 1, 4, and 24hr). 
Activation of UPR markers GRP78 and 
GADD153, CASP3 and Cl PARP was 
significantly increased in all TM and TM-
CM treated myocytes compared to 0hr TM 
and NT controls. Further, augmentation of 
UPR, Cl CASP3 and Cl PARP in TM-CM 
treated hTERTs positively correlated to the 
initial exposer time of TM. (B) No Cl PARP 
expression was observed in hTERT-HM 
cells treated with 0 or 0.05g/ml TM for 
234hrs. (C) PARP cleavage in hTERT-HM 
cells treated with 5.0g/ml TM for 0, 1 or 
24hrs in the presence of 0, 5 or 10% FBS 
was positively correlated to the exposer 
time of TM and further increased with the 
depletion of FBS, in a dose-dependent 
manner. PDIA2 and NCOA3 are utilized as 
cytoplasmic and nuclear protein loading 
controls. A representative blot from each 
experiment is shown. 
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stress-generated secretome and not TM contamination, we next analyzed the TM 
concentration in 1 and 24hr TM-CM via liquid chromatography tandem mass spectrometry 
(LC/MS/MS) and found an average of approximately 0.05g/ml of TM per ml of CM. 
Subsequently, naïve hTERT-HM cells were directly treated with 0.05g/ml TM for 48hrs 
and examined for apoptotic indices. The absence of Cl PARP in TM treated hTERT-HM 
cells (Figure 17B), suggests the previously observed transmission of the UPR in naïve 
hTERT-HM cells was secretome mediated and not due to TM contamination. To further 
validate this, we added an additional chemical-free stress (FBS depletion) during the 
same period of TM treatment prior to TM-CM media conditioning. Subsequently, any 
changes observed in the activation of the UPR in naïve hTERT-HM cells would be due to 
increased stress in the TM treated cells and not TM contamination. We observed 
chemical free stress-dependent increases in Cl PARP in naïve hTERT-HM cells treated 
with TM-CM from hTERT-HM cells treated 5.0g/ml TM for 1 or 24hrs with media depleted 
of FBS in various concentrations (0, 5 and 10% FBS) (Figure 17C). As no chemicals were 
used to increase the stress in TM treated hTERT-HM cells used to condition the TM-CM, 
we are confident the induction in the UPR in TM-CM treated naïve cells is derived from 
the stress-generated secretome. 
Smoking Promotes a Systemic Anti-Inflammatory Profile in Pregnant Women and Without 
Preeclampsia 
To characterize the effects of a “preconditioning-like” transient stress stimulus 
during pregnancy on markers of the UPR in the circulation, we analyzed serum GRP78 
and GADD153 concentrations in women with normal and preeclamptic pregnancies that 
participated or refrained from cigarette smoking while pregnant. As previously identified, 
we found GRP78 levels to be higher in women without preeclampsia versus women with 
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preeclampsia (Figure 18A). Interestingly, we found a trend of increased serum GRP78 in 
women who smoked cigarettes compared to non-smokers, in both preeclamptic and 
normal pregnancies.  Further, serum GADD153 was decreased with smoking in normal 
and preeclamptic pregnancies, with overall normal pregnancies showing reduced serum 
GADD153 compared to women with preeclampsia (Figure 18B). In each cohort, GRP78 
concentrations were inversely proportional to serum GADD153.  
 
Figure 18. Serum GRP78 and GADD153 concentrations from normal and preeclamptic pregnancies in 
women who participated or refrained from cigarette smoking. Serum samples collected from non-laboring 
smoking (NLS), non-laboring non-smoking (NLNL), preeclamptic smoking (PES) and preeclamptic non-
smoking (PENS) during the 3rd trimester, were analyzed with GRP78 and GADD153 ELISAs. (A) GRP78 
was reduced in preeclamptic pregnancies with a further smoking-dependent decrease, (B) while GADD153 
augmented in preeclamptic pregnancies with a further smoking-dependent increase. 
 
Discussion 
In this study we 1) characterized the stress-dependent secretome generated by 
the uterine myocyte and 2) examined its physiological function within the uterine 
compartment and circulation. With SILAC labeled hTERT-HM cells we were able to 
confidently define the UPR-mediated secretome, which consisted of over 90 validated 
proteins using LC/MS/MS.  Further, we described novel signal transduction of the UPR 
from the stress cells to the naïve cells as a result of extracellular factors secreted into TM-
CM. Importantly, while examining the role of the UPR secretome in pregnant women we 
found the secretion of GRP78 was decreased with clinically diagnosed preeclampsia but 
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was partially restored with the introduction of cigarette smoking, which is thought to 
generate transient remote preconditioning-like systemic stress. Taken together these 
data confirm our hypothesis that the generation and transmission of the uterine secretome 
is in part a UPR regulated process that has the potential to propagate UPR-derived 
tocolysis and abrogate systemic inflammatory processes, which can result in preterm 
labor. 
Initially, we proposed local uterine myocyte UPR stressors act to stimulate the 
secretion of a uterine secretome throughout the course of gestation. Here we were able 
to identify for the first time, a discrete set of proteins secreted from the uterine myocyte in 
stress-dependent manner (Figure 13). As expected many of the proteins identified have 
been demonstrated to modify the ER stress and inflammatory responses (Tables 2 and 
3).466,467 Numerous proteins with TM-dependent decreased secretion, e.g. versican core 
protein, fibronectin and biglycan were found to participate in the propagation of 
inflammation.468-470 During pregnancy, abrogation of these circulating pro-inflammatory 
proteins would be critical in the maintenance of uterine quiescence. As previously 
discussed in Chapter 1 Initiation of Uterine Activation, heightened inflammation in the 
pregnant uterus and maternal circulation contributes to the positive feedback pathway in 
which active NFB increases expression of CAPs necessary for the induction of labor. In 
this case, the inability of stress to abrogate the secretion of pro-inflammatory proteins 
such as versican core protein or fibronectin may prematurely increase maternal 
inflammatory signaling, resulting in preterm labor. In contrast, atrial natriuretic peptide 
(ANP) receptor 2, galectin-1 and GRP78 each had increased secretion in response to 
TM-induced stress. Importantly, ANP acting through the ANP receptor 2 can act as a 
tocolytic agent, while galectin-1 and GRP78 have both been demonstrated to possess 
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anti-inflammatory properties.471 ANP/ANP receptor 2-dependent increases in cyclic 
guanine monophosphate is important for inhibiting MLCK and inducing muscle relaxation 
in smooth muscle tissues, such as the aorta.472 While the importance of ANP/ANP 
receptor 2 activity has not been studied in the context of myometrial relaxation, it has 
been shown that ANP receptors are present in relatively high abundance within the 
pregnant human myometrium and decidua.473 Together these data suggest, stress-
dependent increases in ANP receptor 2 from the myometrium may be important in 
modulating uterine quiescence. Of additional interest, galectin-1 and GRP78 both play a 
role in regulating the ER stress and inflammatory responses. Specifically, the knockout 
of galectin-1 impaired appropriate ERSR signaling, while appropriate galectin-1 signaling 
inhibits NFB-mediated inflammation and promotes immune tolerance during 
pregnancy.466,474 Conclusively, we propose that enhanced GRP78 secretion upon 
activation of the UPR (Figure 14) plays a significant role inhibiting myometrial contractility 
to maintain quiescence as it has previously been shown to promote anti-inflammatory 
signaling responses.  Please refer to Chapter 1 Extracellular Functions of the Unfolded 
Protein Response for more detail. 
After confirming the presence of a novel UPR-generated secretome from the 
uterine myocyte, we speculated that these specific secreted factors might have the 
capacity to transmit and propagate the tocolytic-preconditioned phenotype to adjacent 
naive cells. In other studies, it has been demonstrated that mice injected with conditioned 
media isolated from stressed tumor cells, mounted an ER stress response within the liver 
which did occur when media was conditioned with unstressed cells.330  In our 
experiments, these results were recapitulated when we demonstrated stressed 
conditioned media (TM-CM) but not unstressed control media activated the UPR in naïve 
108 
 
hTERT-HM cells (Figure 16).  Similarly, cell-cell interactions mediated by soluble secreted 
factors have frequently been defined in the extracellular matrix of tumors, where this 
phenomenon has been implicated in modulating tumor cell progression.475 Cancer 
associated fibroblasts have been demonstrated to secrete factors that promote the 
multipotent mesenchymal stem cells to differentiate into cancer associated fibroblast 
contributing further to tumor development. Size fractionation and mass spectrometry 
analysis identified conclusively that GRP78 was the factor promoting the transition from 
mesenchymal stem cell to cancer-associated fibroblast.476 Further the active 
translocation of GRP78 to the membrane and release into the extracellular space in 
tumors is directly correlated to tumor resistance and decreased apoptosis following the 
application of chemotherapeutic agents.477,478 This is primarily thought to due to the 
activated plasma proteinase inhibitor 2-macroglobulin binding to GRP78 and inducing 
cell proliferation and survival via RAS-MAPK, PI 3-kinase/AKT, cAMP-dependent and 
UPR signaling.479-481 These data clearly indicate an exciting potential mechanism 
whereby the stressed pregnant uterus gives rise to a uterine secretome which is secreted 
into the circulation to provide a systemic alert or update to circulating immune cells, other 
somatic cell types or remote organs of the need to adapt, accommodate or protect 
themselves against a possible stress events. 
In other words, we propose that a uterine myocyte derived UPR secretome, in the 
circulation of pregnant women is necessary for systemic remote preconditioning of other 
maternal tissues during pregnancy, such as macrophages and vascular endothelial cells, 
to allow for improved resistance to and increased tolerance of normal gestational stresses 
every pregnancy experiences and promote the maintenance of quiescence. 
Subsequently, a wide range of normal gestational stressors that affect the uterine 
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myocyte, e.g. hypoxia, hyperplasia, mechanical stretch would be critical in promoting 
preconditioning-mediated systemic adaptations and thus the propagation of tocolysis. 
While there is no direct evidence for this, studies have found pregnancy-dependent 
attenuation of pathophysiological cardiac function, which may be in part the result of 
remote UPR preconditioning experienced explicitly during pregnancy.482 Specifically, in a 
mouse model of left ventricular pressure overload, pregnancy was found to mitigate 
pathological LV remodeling, pulmonary congestion and transverse aortic constriction-
dependent gene expression.482 It is also speculated that the hemodynamic changes 
experienced during pregnancy may reduce a women’s risk of cardiovascular disease 
later, which suggests pregnancy-dependent uterine UPR positively influences maternal 
systemic vascular function. Interestingly, having been pregnant also significantly reduces 
your risk of developing certain types of cancer.483 For instance, an increase in the 
cumulative months of being pregnant correlates to a decrease in the risk of a woman 
developing epithelial ovarian cancer.484 Overall, these data lend evidence to the idea that 
systemic UPR signaling from the myometrium are important in facilitating systemic 
adaptations that contribute to the maintenance of uterine quiescence. 
One mechanism whereby the UPR secretome may modulate systemic 
conditioning is through the propagation of anti-inflammatory signaling. Extracellular 
GRP78 specifically, has been demonstrated in multiple studies, both in vitro and in vivo, 
to play an anti-inflammatory immunomodulatory role. Upon UPR activation GRP78 levels 
increase in the stressed cell and translocate to the surface with high amounts being 
released into the culture media.319,324 Cells that secrete GRP78 into their extracellular 
environment were found to gain the ability to promote a pro-survival and anti-apoptotic 
phenotype displaying resistance to anti-angiogenic chemotherapeutic agents such as 
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Bortezomib.319 In vivo, elevated extracellular cell-free GRP78 is found in the synovial fluid 
of patients with rheumatoid arthritis, saliva, serum and oviductal fluid.320-323 It was 
determined in this context that GRP78 also performed anti-inflammatory and 
immunomodulatory functions. When exposed to cell free GRP78, human peripheral blood 
mononuclear cells displayed a dose dependent increase in the anti-inflammatory 
cytokines TNFα and IL-10 secretion. In stimulated PBMCs, the presence of extracellular 
GRP78 lowered the levels of IL-1 beta and increased the levels of interleukin 1 receptor 
antagonist. The concentration of soluble TNFRII levels, which act to suppress the pro-
inflammatory activities of TNFα also increased, confirming the role of extracellular GRP78 
as a propagator of an anti-inflammatory signaling cascade.321 It has become apparent 
that extracellular GRP78 has remarkable anti-inflammatory and immunomodulatory 
properties. In animal models of collagen-induced arthritis, prophylactic administration of 
recombinant GRP78 one week before the initiation collagen immunization was sufficient 
to prevent the induction of collagen induced arthritis.485 Administration of GRP78 at the 
onset of collagen-induced arthritis was also successful in suppressing the development 
of arthritis.459 Further, suppression of collagen-induced arthritis was achieved by 
parenteral (gavage) administration of lentiviral vectors expressing GRP78. A single dose 
of exogenous GRP78 was sufficient to induce permanent remission of inflammation in 
collagen induced arthritis, suggesting not only does GRP78 mediate anti-inflammatory 
actions, but is also capable of driving resolution of inflammation, likely through immune 
cell differentiation.459 The effects of serum GRP78 have been found to be at least partially 
dependent of IL-4, as the suppressive effects of GRP78 are abrogated in the IL4-/- 
mouse. These analyses suggest, that administration of exogenous extracellular GRP78 
can allow for increased resistance to and active resolution of inflammatory challenges. In 
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a similar manner, in our recent PNAS paper, we administered 4-phenyl butyric acid, a 
chemical chaperone that mimics GRP78 action, and found we could reverse ER stress 
induced preterm birth.350 
While the protective effects of cigarette smoking do not outweigh its harmful 
consequences, women who participate in cigarette smoking compared to non-smokers 
have a reduced risk of developing preeclampsia.486 It has been well established that 
smoking a cigarette is a transient stress that decreases the level of tissue oxygen for a 
short period of time following inhalation of nicotine.487 Interestingly, smoking has been 
demonstrated to promote an anti-inflammatory milieu with the suppression of M1 
polarized macrophage related inflammatory genes and the upregulation of M2 
polarization programs.488  In this study, we have identified that 1) transient stress 
promotes the active secretion of GRP78 from uterine myocytes (Table. 2 and Figure 14) 
and 2) women with preeclampsia tend to have lower levels of serum GRP78 compared 
to women who do not, but that GRP78 levels are restored to approximately normal levels 
in women that smoke (Figure 17), which suggests the transitory systemic hypoxic stress 
from smoking in pregnant women increases the secretion of GRP78. Subsequently, we 
propose smoking may act to remotely precondition the vascular endothelium through 
GRP78-mediated anti-inflammatory signaling, allowing pregnant smoking women who 
become preeclamptic to avoid endothelial dysfunction. Additionally, these data suggest 
the serum GRP78 may be a novel therapeutic approach for promoting endothelial 
sufficiency and/or a proficient biomarker for myometrial viability and disease severity in 
women with preeclampsia.  
Conclusively, these data demonstrate that activation of the myometrial UPR 
generates and propagates a unique secretome that has the potential to transmit uterine 
112 
 
tocolysis and suppress systemic inflammation, which can result in pregnancy disorders 
such as preeclampsia or preterm labor. Importantly, these data set the stage for the 
development of novel tocolytic strategies and potentially new biomarkers for advanced 
identification of women who are at risk for undergoing multiple pregnancy disorders. 
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CHAPTER 5 
Conclusion and Synthesis 
This collection of studies focuses on how active CASP3 is maintained within the 
pregnant uterine myocyte in a non-apoptotic state to fulfill its tocolytic function of inhibiting 
myometrial contractility for the preservation of uterine quiescence. Subsequently, we 
hypothesized that preconditioning the myometrial UPR would allow for the maintenance 
of non-apoptotic CASP3 activity and thus sustain uterine quiescence. To test this 
hypothesis all experiments were performed utilizing an immortalized human myometrial 
cell line in vitro, a timed-pregnant CD-1 mouse model or serum from pregnant women 
with or without preeclampsia who participated in or refrained from cigarette smoking. The 
main findings of this work are that appropriate uterine UPR preconditioning 1) maintains 
non-apoptotic CASP3 by mitigating apoptotic stress pathways and inflammation, 2) 
reduces the risk of preterm birth 3) inhibits the precocious transition of CASP3 into an 
apoptotic state within the endometrium where it participates in iPLA2/prostaglandin-
dependent initiation of luteolysis, 4) produces and transmits a unique stress-dependent 
secretome and 5) promotes systemic adaptive signaling. From this data we suggest 
endogenous pregnant-dependent stress stimuli experienced across gestation act in a 
preconditioning-like manner to sustain the tocolytic action of non-apoptotic CASP3 within 
the pregnant uterus in the presence of ensuing stresses and promote an all-around 
adaptive environment through paracrine and endocrine propagation of a myometrial 
stress-derived secretome. Furthermore, from these results we speculate that women who 
are unable to host an appropriate preconditioning response to gestational stresses are at 
a significantly increased risk of undergoing spontaneous preterm. 
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If a woman walked into the emergency room today undergoing premature uterine 
contractions, there are absolutely no drugs available that could be administered to 
prevent premature birth from occurring. With three limited treatments:  progesterone; 
cervical cerclage; and possibly cervical pessary, the ability to accurately predict and 
prevent preterm labor remains one of the most critical challenges facing modern 
obstetrics.23,26,30 Cervical length measurement and a previous preterm birth are currently 
the strongest predictors for a subsequent preterm birth, however nulliparous women with 
no past obstetrical history remain at a heightened risk.16 With such a large subset of 
women unidentifiable or unresponsive to the currently available treatments, two major 
questions remain 1) what cellular mechanisms lead to the initiation of premature uterine 
contractility and 2) what therapies can be developed to predict and inhibit spontaneous 
preterm labor in all women? Previous studies from our laboratory have demonstrated that 
the uterine UPR plays a large role in modulating myometrial quiescence and that 
exogenous progesterone, the most successful of preventative treatments, and 
progesterone receptor inhibitors modify the local uterine UPR drastically in favor of 
quiescence or labor, respectively. Specifically, we demonstrated using a CD-1 pregnant 
mouse model, that the balance between adaptive GRP78 and tocolytic non-apoptotic 
CASP3 is crucial for the maintenance of quiescence. Throughout early and mid-gestation 
we observed sufficient ER stress-dependent GADD153/CASP3 activity is needed to 
degrade and disable the myometrial contractile architecture ( and  actin, CX43) to inhibit 
contraction.399 Equally important, at the end of gestation increases in gestationally 
generated stress stimuli that upregulate adaptive UPR signaling causes GRP78-
dependent resolution of ER stress and thus a decline in GADD153/CASP3 tocolytic 
action.403 This was abundantly evident in previous studies from our lab where precocious 
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doses of stress (TM, 1.0mg/kg, E15) administered to timed-pregnant mice prematurely 
augmented GRP78 action, which lead to diminished CASP3 tocolysis and subsequently 
preterm birth.350 Interestingly, in this same study a smaller dose of stress (TM, 0.2mg/kg) 
acted to increase both GADD153/CASP3 activity and GRP78. As the induction of GRP78 
was not large enough to completely resolve the corresponding ER stress, GADD153 and 
CASP3 activity remained intact decreasing the occurrence of preterm birth compared to 
animals injected with 1.0mg/kg TM. These data further highlight the importance of 
GADD153/CASP3 action in tocolysis and how the balance between GRP78 and CASP3 
maintains quiescence.  Subsequently, in the first chapter we hypothesized increasing the 
capacity of the uterine myocyte to tolerate extraneous stress may act as a buffer for 
maintaining the balance between active non-apoptotic CASP3 and adaptive GRP78 
signaling, which in vivo is important for preventing premature contractility to maintain an 
appropriate gestational length. Starting at the level of the individual uterine myocyte 
(hTERT-HM), we demonstrate that indeed UPR preconditioning may be a plausible 
mechanism by which CASP3 activity is maintained in a non-apoptotic state in the 
presence of precocious cellular stress-challenges.  As seen in Figure 1, hTERT-HM cells 
challenged with a cytotoxic dose of stress maintained active CASP3 in the absence of 
apoptosis and in the presence of abundant levels of GRP78.  Based on these studies it 
is reasonable to speculate that spontaneous preterm birth in women may in part be due 
to the mismanagement of stress that dysregulates tocolytic and adaptive signaling in a 
way that CASP3 activity is prematurely diminished due to precocious activation of 
adaptive GRP78. Indirect evidence supporting this hypothesis is the fact that exercising 
during pregnancy has been demonstrated to decrease the risk of preterm birth.489 
Exercise, while providing exponential benefits, has clearly been identified as a transient 
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stress to the body that challenges homeostasis at both a cellular and systemic level and 
may be acting in a preconditioning-like manner to reduce the risk of preterm birth.490,491 
While our in vitro data work did not directly examine the role of pregnancy-dependent 
stress stimuli in preconditioning the myocyte, it importantly provided a potential 
mechanism for how similar gestational stress-stimuli could be acting in vivo to maintain 
active non-apoptotic CASP3 and appropriately manages tocolytic and adaptive signaling 
responses. 
Approximately 45% of all preterm births currently are spontaneous occurring and 
idiopathic in nature, occurring in the absence of maternal or fetal infection or premature 
preterm rupture of the membranes (PPROM).17 Many of the discernable maternal risk 
factors associated with the onset of spontaneous preterm have been directly and 
indirectly associated with the onset of severe ER stress, i.e. increased mechanical stretch 
due to twin pregnancy or redox stress due to advanced maternal age.492-495 Having 
previously demonstrated in Aim 1 that UPR preconditioning enables the maintenance of 
non-apoptotic CASP3 in the presence of exaggerated ER stress, we hypothesized 
appropriate UPR preconditioning from endogenous pregnancy-generated stress stimuli, 
e.g. hypoxia, hyperplasia, hormone fluctuation, hypertrophy and mechanical stretch, may 
be critical for the preservation of the tocolytic action of CASP3.  When we tested this using 
our model of sub-preconditioned stressed mice (TM+PBA), inappropriate UPR 
preconditioning in the presence of even a minor stress was sufficient to increase the 
occurrence of preterm birth as predicted.  Subsequently, this data suggests pregnant 
women who do not efficiently or are unable to host a preconditioning response to 
gestational stresses due to innate maternal factors such as advanced age or preexisting 
chronic stress would be at a heightened risk of preterm delivery, as already clinically 
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observed. An example of this would be a pregnant woman with a preexisting chronic 
inflammatory disease such as diabetes or rheumatoid arthritis. In this context, we believe 
major chronic inflammation would act to disrupt appropriate uterine preconditioning, as it 
a continuous non-transient stress that would burden the myometrial ERSR instead of 
prompting it to facilitate adaptation. Accordingly, rheumatoid arthritis and diabetes 
milletus have been proven to increase the risk of preterm birth.496,497 Of note, premature 
induction of labor in each of these cases can occur in the absence of maternal/fetal 
infection and PPROM, as seen in our sub-preconditioned stressed mice. Interestingly, it 
has been demonstrated that a large portion of patients (approximately 26%) of women 
that present with preterm labor and intact fetal membranes have intra-amniotic 
inflammation in the absence of microbial-associated infection.498 In non-preconditioned 
cells and sub-preconditioned stressed mice, we similarly observed heightened levels of 
uterine and systemic inflammation, as seen by increased NFB signaling and enhanced 
TNF secretion, in the absence of appropriate preconditioning, like that of sterile 
inflammation in the amniotic fluid of some women that deliver preterm.  These data 
suggest that appropriate UPR preconditioning is not only important for the maintenance 
of non-apoptotic CASP3-mediated tocolysis but is also necessary for inhibiting premature 
precocious induction of inflammation which is associated with the onset of labor. 
Subsequently, there are multiple pharmaceutical agents, currently used for the treatment 
of UPR-dependent diseases that could be repurposed for preconditioning therapies like 
those currently being utilized in the field of liver and cardiovascular 
ischemia/reperfusion.499,500 TUDCA, in particular, has already been shown to alleviate 
extreme UPR stress in other pregnancy related disease and may be a promising agent 
for the restoring of a preconditioning-like uterine profile.501 Overall, this work offers a novel 
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mechanism, to explain why women undergo spontaneous preterm labor and what may 
increase a woman’s susceptibility to premature labor. Further, it suggests that drugs that 
aid in the management of the UPR may be effective in alleviating the occurrence of 
preterm birth. 
Prior to this work being done it was already well understood due to previous work 
from our group that non-apoptotic CASP3 was functioning in the uterus to inhibit 
myometrial contractility and with the addition of these studies we further understood that 
gestationally regulated UPR preconditioning contributes to the maintenance of non-
apoptotic CASP3 activity and thus regulates gestational length. In contrast, our laboratory 
had previously observed the activation of apoptotic CASP3 within the endometrial 
compartment associated with the onset of term labor without having resolved its function. 
Knowing that 1) the endometrial compartment primarily participates in prostaglandin 
synthesis, which is an important process for the induction of labor and that 2) apoptotic 
CASP3 action activates iPLA2 to enhance prostaglandin signaling in breast tissue we 
examined the role of apoptotic endometrial CASP3 in prostaglandin synthesis. Like in 
breast tissue, our in vitro data revealed enhanced iPLA2 activation in response to 
apoptotic CASP3 action, but not non-apoptotic CASP3. In vivo, we indirectly 
demonstrated increased iPLA2 activity resulting in heightened prostaglandin synthesis 
only in the preterm laboring endometrium where inappropriate preconditioning lead to the 
transition of endometrial CASP3 from a non-apoptotic to apoptotic state. In the context of 
pregnancy these data add credence to the importance of appropriate uterine UPR 
preconditioning in the inhibition of contraction and suggests a new mechanism in the 
regulation of prostaglandin production for both term and preterm pregnancies. Central to 
the importance of these studies, is the possibility of designing new therapeutic 
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interventions targeting this novel-signaling pathway. Compared to other PLA2 enzymes, 
the function of iPLA2 and its role in modulating disease has only recently been 
discovered. Subsequently, the development of iPLA2 inhibitors is relatively limited. There 
are however, a few trifluoromethyl ketones of fatty acids that act to reversibly inhibit Group 
VI iPLA2 enzymes, with the most important of these being bromoenol lactone (BEL).502 
In rat mesangial cells, BEL-dependent inhibition of iPLA2 significantly attenuated IL-1-
induced PGE2 production.503 Interestingly, it has further been demonstrated that the BEL 
treatment to vascular smooth muscle, significantly decreases basal concentration of free 
arachidonic acid and inhibits smooth muscle contraction.504 This study, however did not 
examine the subsequent effects of BEL on prostaglandin synthesis. Together, these 
preliminary studies characterizing the effects of iPLA2 inhibition on prostaglandin 
synthesis and muscle contractility are promising for the future development of myometrial 
tocolytic agents. 
In the absence of effective tocolytic agents, the use of predictive biomarkers would 
greatly improve our understanding and treatment of preterm birth. The discovery and 
validation of clinical biomarkers that can act in a predictive or prognostic manner is an 
important area of research today. In oncology specifically, many biomarkers are being 
used to diagnose cancer and also predict the efficacy of chemotheraputic agents in the 
treatment of cancer.505 Serum miR-21 for example is an onco-microRNA that is 
significantly elevated in patients with hormone-refractory prostate cancer.506 In addition 
to acting as a predictive biomarker for the presence of hormone-refractory prostate 
cancer, the serum levels of miR-21 have been found to correlated with the tumor 
resistance to docetaxel-based chemotherapy.507 Similarly, serum miR-200c was recently 
identified as a prognostic biomarker in patients with colorectal cancer that additionally 
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effective in predicting metastasis.508 Unfortunately, in the context of preterm birth there 
have been no biomarkers identified to date that effectively predict whether a woman will 
deliver preterm or not.  As previously mentioned is Chapter 1 Preterm Birth, mid-trimester 
cervical length is the only accurate predictor of determining the future occurrence of 
preterm birth. In a literature review examining research from the last four decades, one 
study states 116 distinct biomarkers have been analyzed in hopes of identifying a strong 
predictive biomarker for the onset of preterm labor without success.509 Within the 217 
studies included, these biomarkers were assayed approximately 758 times to no avail.509 
A more recent review utilizing multivariate adaptive regression splines generated model, 
found multiple biomarkers when data was stratified based on race.510 While stratification 
of biomarkers by race did highlight a limited number of proteins, such as TNF, TNFR1 
and TGF-1 within the serum, cord blood and amniotic fluid from African American and 
Caucasian women that were associated with preterm birth, no biomarkers were found to 
be predictive in nature. However, knowing that 1) many tissues respond to ER stress by 
propagating the secretion of a discrete collection of proteins unique to the stressed cell 
type and 2) gestationally-regulated myometrial ER stress stimuli are key for the 
maintenance of uterine quiescence and inhibition of preterm labor, we proposed targeting 
and characterizing the UPR-generated secretome from the uterine myocyte may lead to 
the discovery of a predictive biomarker of preterm birth. As seen in Aim 3 Figure 14, we 
successfully identified and quantified a novel UPR-generated secretome in hTERT-HM 
cells using a SILAC-targeted model of LC/MS/MS proteomic analysis. While many of the 
proteins identified were new in the scope of labor, some were known to be related to 
preterm birth and pregnancy. Plasminogen activating inhibitor 1, versican core protein, 
thrombospondin 1 and syntenin for example have all been demonstrated to participate in 
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various processes throughout the course of gestation, suggesting the collection of 
proteins we characterized as the uterine myocyte secretome is most likely an accurate 
depiction of the proteins secreted from pregnant myometrium in vivo in response to 
gestationally regulated stresses.511-514 Although, this analysis of the uterine myocyte 
UPR-derived secretome is preliminary, it is an incredibly important foundation for the 
future studies and the elucidation of a useful biomarker for the prediction and potential 
prognosis of preterm labor. 
In addition to providing important potential biomarkers for the recognition of 
preterm birth, we further predict the extracellular uterine secretome resulting from 
gestationally regulated stress stimuli within the myometrium, participates in the 
maintenance of uterine quiescence. In Aim 3, our data shows a stress-generated 
secretome from a uterine myocyte has the capacity to propagate the activation of UPR in 
a paracrine manner to non-stress naïve hTERT-HM cells (Figure 17A). Having also 
demonstrated in Aim 1 that the pre-induction of the UPR prior to a lethal stress affords 
significant cytoprotection, it is easy speculate that UPR activation in naïve hTERT-HM 
following incubation with TM-CM (Figure 17A) could also afford cytoprotection against a 
subsequent stress. As previously mentioned in Chapter 1 Remote Preconditioning of the 
Endoplasmic Reticulum Stress Response, in the process of remote preconditioning the 
application of stress to a discrete tissue/organ can provide systemic adaptations and 
global cytoprotection against additional stresses. While we did not further stress the naïve 
hTERT-HM cells that mounted an UPR following incubation with TM-CM media, I would 
hypothesize those cells might demonstrate an increased resistance to stress-mediated 
apoptosis. This hypothesis is indirectly supported by our in vivo data, which demonstrates 
increased concentrations of GRP78, which was found to be differentially secreted in a 
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stress-dependent manner, in the serum of pregnant women without preeclampsia 
compared to pregnant women with preeclampsia. These data suggest women unable to 
host an appropriate uterine response to stress resulting in reduced circulating GRP78, 
are at an increased risk of developing preeclampsia. Further, as preeclampsia has been 
identified as a pregnancy disorder associated with dysfunctional UPR signaling within the 
placenta and maternal endothelium we propose decreased signaling from the stressed 
uterus may disrupt normal remote preconditioning and peripheral adaptations necessary 
for the maintenance of a normal pregnancy. Subsequently, we hypothesize the 
dysregulation of balance between secretome-dependent maternal adaptation and uterine 
stress may play a role in the etiology of pregnancy-dependent complications, such as 
IUGR and tobacco smoke induced utero-placental hypoxia. In this context, we speculate 
the severity of stress evoked by these conditions and other uterine stressors correlated 
with preterm birth (e.g. twin pregnancy or preeclampsia) may alter the uterine-derived 
secretome and thus the prophylactic remote preconditioning it promotes, resulting in a 
maladaptive pro-labor phenotype. Interestingly, pregnant women that smoked had 
increased serum concentrations of GRP78 compared to those that did not, in both normal 
and preeclamptic pregnancies. As it is already known that pregnant women that smoke 
are at a reduced risk of developing preeclampsia, this data suggests UPR 
preconditioning, similar to that of smoking without the carcinogenic effects, may be a 
potential therapy for treating women who are at an increased risk of developing 
preeclampsia and other UPR-associated pregnancy disorders. 
Conclusively, my hypothesis represents a paradigm shift in how the UPR controls 
cellular homeostasis in an autocrine, paracrine and endocrine manner during pregnancy 
and how dysfunctional regulation of this system may lead to deleterious pregnancy 
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outcomes. Gaining a greater understanding of the mechanisms associated with the onset 
of preterm birth will ultimately allow for enhanced preterm birth diagnostics, novel tocolytic 
drug design and more accurate preventative intervention protocols. 
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ABSTRACT 
APPROPRIATE PRECONDITIONING OF THE UTERINE ENDOPLASMIC 
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Introduction: In this study, we are testing the overarching hypothesis that 
preconditioning the myometrial UPR allows for the maintenance of non-apoptotic CASP3 
activity and thus sustains uterine quiescence. We have previously demonstrated that the 
pregnant uterus facilitates uterine quiescence through UPR mediated activation of non-
apoptotic CASP3, yet the mechanism in which CASP3 utilizes to avoid its apoptotic cell 
fate is unresolved. There is a growing body of evidence including our own that 
demonstrates remote and direct preconditioning with minor stresses propagates 
cytoprotective mechanisms that allow for the avoidance of apoptotic cell death upon 
exposure to a subsequent more damaging stress, through modulation of the UPR. In this 
study we demonstrate endogenous pregnant-dependent stress stimuli experienced 
across gestation act in a preconditioning-like manner to sustain the tocolytic action of non-
apoptotic CASP3 within the pregnant uterus in the presence of ensuing stresses and 
promote an all-around adaptive environment through paracrine and endocrine 
propagation of a myometrial stress-derived secretome. 
Methods: In vitro preconditioning: utilizing the hTERT-HM cell line, uterine 
myocytes were preconditioned with a minor UPR stress (0.1g/ml TM) or vehicle and 
191 
 
exposed 48 hrs later to a lethal UPR stress (5g/ml TM) (n=3). In vivo sub-
preconditioning: we generated a sub-preconditioned pregnant mouse model (TM+PBA) 
by inhibiting the effect UPR mediated stress across gestation (50mg/kg PBA (i.p, E10-
15)) or vehicle. Endogenous preconditioned and sub-preconditioned mice were exposed 
to a mild exogenous stress at E16. Time of delivery was noted. From both the in vitro and 
in vivo models apoptotic and inflammatory indices were examined. In vitro secretome 
analysis: SILAC labeled hTERT-HM cells underwent UPR activation by exposure to TM, 
5.0g/ml, 1hr or vehicle. Additionally, SILAC labeled proteins transmitted from the UPR 
activated myocyte into the media were analyzed via LC/MS/MS to define the UPR 
generated secretome. In a separate experiment the conditioned media was incubated 
with a secondary set of naïve hTERT-HM cells, which were examined for UPR activation 
48hrs later. 
Results: Preconditioning the hTERT-HM cell activated CASP3 in the absence of 
apoptotic consequences. Reduced NFB activation and TNF secretion were also 
observed. In vivo, the sub-preconditioned mouse experienced CASP3 activation in the 
uterine compartment, which transitioned into an apoptotic state within the endometrial 
compartment upon exposure to a mild exogenous stress. Furthermore endometrial 
apoptotic CASP3-dependent iPLA2 activation, increased NFB activation and COX1 
expression upregulated prostaglandin synthesis, which resulted in a progesterone 
withdrawal and subsequently a 57% preterm birth rate in the preconditioned mice in 
comparison to 14% in the endogenously preconditioned animals. Further activation of the 
UPR in hTERT-HM cells generates a unique stress-generated secretome made up of 
roughly 90 bone-fide proteins, which propagate systemic adaptive signaling. 
Conclusion: We speculate that women who are unable to host an appropriate 
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preconditioning response to gestational stresses are at a significantly increased risk of 
undergoing spontaneous preterm. 
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